[go: up one dir, main page]

TW202208600A - Compound, liquid crystal composition, and liquid crystal display element - Google Patents

Compound, liquid crystal composition, and liquid crystal display element Download PDF

Info

Publication number
TW202208600A
TW202208600A TW110116194A TW110116194A TW202208600A TW 202208600 A TW202208600 A TW 202208600A TW 110116194 A TW110116194 A TW 110116194A TW 110116194 A TW110116194 A TW 110116194A TW 202208600 A TW202208600 A TW 202208600A
Authority
TW
Taiwan
Prior art keywords
substituted
formula
fluorine
hydrogen
chlorine
Prior art date
Application number
TW110116194A
Other languages
Chinese (zh)
Other versions
TWI874651B (en
Inventor
矢野智広
Original Assignee
日商捷恩智股份有限公司
日商捷恩智石油化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商捷恩智股份有限公司, 日商捷恩智石油化學股份有限公司 filed Critical 日商捷恩智股份有限公司
Publication of TW202208600A publication Critical patent/TW202208600A/en
Application granted granted Critical
Publication of TWI874651B publication Critical patent/TWI874651B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3444Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine
    • C09K19/3447Pyridine condensed or bridged with another ring system, e.g. quinoline or acridine
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The present invention provides a compound having at least one characteristic: high chemical stability, high ability to align liquid crystal molecules horizontally, high alignment in a wide range of addition concentrations, appropriate reactivity, and high solubility in liquid crystal compositions. The present invention provides a compound having the following formula (1). In formula (1), a and b are independently 0, 1, or 2, and the sum of a and b is 0, 1, 2, or 3. Ring A1, ring A2, ring A3, and ring A4 are independently, for example, 1, 4 -cyclohexylene. Z1, Z2, Z3, Z4 and Z5 are independently a single bond or an alkylene group having 1 to 10 carbons. Sp1 and Sp2 are independently a single bond or an alkylene group having 1 to 10 carbons. P1 and P2 are independently a specific polymerizable group.

Description

化合物、液晶組成物及液晶顯示元件Compound, liquid crystal composition and liquid crystal display element

本發明涉及一種化合物、液晶組成物及液晶顯示元件。進而,詳細而言是涉及一種在分子內具有9,10-二氫菲型縮合環的聚合性的極性化合物、包含所述化合物且介電各向異性為正或負的液晶組成物及包含所述組成物的液晶顯示元件。The present invention relates to a compound, a liquid crystal composition and a liquid crystal display element. Furthermore, in detail, it relates to a polymerizable polar compound having a 9,10-dihydrophenanthrene-type condensed ring in the molecule, a liquid crystal composition comprising the compound and having positive or negative dielectric anisotropy, and a liquid crystal composition comprising the compound. The liquid crystal display element of the composition.

液晶顯示元件中,基於液晶分子的運行模式的分類為相變(phase change,PC)、扭轉向列(twisted nematic,TN)、超扭轉向列(super twisted nematic,STN)、電控雙折射(electrically controlled birefringence,ECB)、光學補償彎曲(optically compensated bend,OCB)、面內切換(in-plane switching,IPS)、垂直配向(vertical alignment,VA)、邊緣場切換(fringe field switching,FFS)、電場感應光反應配向(field-induced photo-reactive alignment,FPA)等模式。基於元件的驅動方式的分類為被動矩陣(passive matrix,PM)與主動矩陣(active matrix,AM)。PM被分類為靜態式(static)、多路複用式(multiplex)等,AM被分類為薄膜電晶體(thin film transistor,TFT)、金屬-絕緣體-金屬(metal insulator metal,MIM)等。TFT的分類為非晶矽(amorphous silicon)及多晶矽(polycrystal silicon)。後者根據製造步驟而分類為高溫型與低溫型。基於光源的分類為利用自然光的反射型、利用背光的透過型、以及利用自然光與背光這兩者的半透過型。In liquid crystal display elements, the classification based on the operation mode of liquid crystal molecules is phase change (PC), twisted nematic (TN), super twisted nematic (STN), electronically controlled birefringence ( Electrically controlled birefringence (ECB), optically compensated bend (OCB), in-plane switching (IPS), vertical alignment (VA), fringe field switching (FFS), Field-induced photo-reactive alignment (FPA) and other modes. Component-based driving methods are classified into passive matrix (PM) and active matrix (AM). PM is classified into static type (static), multiplex type (multiplex), etc., AM is classified into thin film transistor (TFT), metal insulator metal (MIM), and the like. TFTs are classified into amorphous silicon and polycrystal silicon. The latter are classified into high temperature type and low temperature type according to the manufacturing steps. The light source is classified into a reflective type using natural light, a transmissive type using a backlight, and a transflective type using both natural light and backlight.

液晶顯示元件含有具有向列相的液晶組成物。所述組成物具有適當的特性。通過提高所述組成物的特性,可獲得具有良好特性的AM元件。將兩種特性中的關聯歸納於下述表1中。基於市售的AM元件來對組成物的特性進一步進行說明。向列相的溫度範圍與元件可使用的溫度範圍相關聯。向列相的優選上限溫度為約70℃以上,而且向列相的優選下限溫度為約-10℃以下。組成物的黏度與元件的響應時間相關聯。為了利用元件顯示動態影像,優選為響應時間短。理想為短於1毫秒的響應時間。因此,優選為組成物的黏度小。更優選為低溫下的黏度小。The liquid crystal display element contains a liquid crystal composition having a nematic phase. The composition has suitable properties. By improving the properties of the composition, an AM device having good properties can be obtained. The associations between the two properties are summarized in Table 1 below. The properties of the composition will be further described based on a commercially available AM device. The temperature range of the nematic phase correlates to the temperature range over which the element can be used. The preferable upper limit temperature of the nematic phase is about 70°C or more, and the preferable lower limit temperature of the nematic phase is about -10°C or less. The viscosity of the composition correlates with the response time of the component. In order to display a moving image using an element, it is preferable that the response time is short. The ideal is a response time of less than 1 millisecond. Therefore, the viscosity of the composition is preferably small. More preferably, the viscosity at low temperature is small.

表1. 組成物與AM元件的特性    編號 組成物的特性 AM元件的特性 1 向列相的溫度範圍廣 可使用的溫度範圍廣 2 黏度小1 響應時間短 3 光學各向異性適當 對比度比大 4 正或負的介電各向異性大 閾電壓低、消耗電力小 對比度比大 5 比電阻大 電壓保持率大、對比度比大 6 對紫外線及熱穩定 壽命長 7 彈性常數大 對比度比大、響應時間短 1)可縮短將組成物注入至液晶顯示元件中的時間 Table 1. Properties of composition and AM device Numbering Properties of the composition Characteristics of AM Components 1 Wide temperature range for nematic phase Wide temperature range available 2 Low viscosity 1 ) short response time 3 Optical anisotropy is appropriate high contrast ratio 4 Positive or negative dielectric anisotropy Low threshold voltage and low power consumption high contrast ratio 5 larger than resistance High voltage holding ratio and high contrast ratio 6 UV and heat stable long life 7 high elastic constant High contrast ratio and short response time 1) The time for injecting the composition into the liquid crystal display element can be shortened

組成物的光學各向異性與元件的對比度比相關聯。根據元件的模式,而需要大的光學各向異性或小的光學各向異性,即適當的光學各向異性。組成物的光學各向異性(Δn)與元件的單元間隙(d)的積(Δn×d)被設計成使對比度比為最大。積的適當值依存於運行模式的種類。TN之類的模式的元件中,所述值為約0.45 μm。VA模式的元件中,所述值為約0.30 μm至約0.40 μm的範圍,IPS模式或FFS模式的元件中,所述值為約0.20 μm至約0.30 μm的範圍。這些情況下,對於單元間隙小的元件而言優選為具有大的光學各向異性的組成物。組成物的介電各向異性大有助於元件的閾電壓低、消耗電力小與對比度比大。因此,優選為大的正或負介電各向異性。組成物的比電阻大有助於元件的電壓保持率大與對比度比大。因此,優選為在初始階段中,不僅在室溫下而且在接近向列相的上限溫度的溫度下也具有大的比電阻的組成物。優選為在長時間使用後,不僅在室溫下而且在接近向列相的上限溫度的溫度下也具有大的比電阻的組成物。組成物對紫外線及熱的穩定性與元件的壽命相關聯。當所述穩定性高時,元件的壽命長。此種特性對於液晶投影儀、液晶電視等中所使用的AM元件而言優選。The optical anisotropy of the composition is related to the contrast ratio of the element. Depending on the mode of the element, a large optical anisotropy or a small optical anisotropy, that is, an appropriate optical anisotropy, is required. The product (Δn×d) of the optical anisotropy (Δn) of the composition and the cell gap (d) of the element is designed to maximize the contrast ratio. The appropriate value of the product depends on the type of operation mode. In elements of a mode such as TN, the value is about 0.45 μm. In the element of the VA mode, the value is in the range of about 0.30 μm to about 0.40 μm, and in the element of the IPS mode or the FFS mode, the value is in the range of about 0.20 μm to about 0.30 μm. In these cases, a composition having a large optical anisotropy is preferable for an element with a small cell gap. The large dielectric anisotropy of the composition contributes to the low threshold voltage, low power consumption and high contrast ratio of the device. Therefore, a large positive or negative dielectric anisotropy is preferred. The large specific resistance of the composition contributes to the high voltage holding ratio and the high contrast ratio of the element. Therefore, it is preferable to use a composition having a large specific resistance not only at room temperature but also at a temperature close to the upper limit temperature of the nematic phase in the initial stage. It is preferable to use a composition having a large specific resistance not only at room temperature but also at a temperature close to the upper limit temperature of the nematic phase after long-term use. The stability of the composition to UV light and heat correlates with the life of the element. When the stability is high, the life of the element is long. Such characteristics are preferable for AM elements used in liquid crystal projectors, liquid crystal televisions, and the like.

具有TN模式的AM元件中使用具有正的介電各向異性的組成物。具有VA模式的AM元件中使用具有負的介電各向異性的組成物。具有IPS模式或FFS模式的AM元件中使用具有正或負的介電各向異性的組成物。 聚合物穩定配向(polymer sustained alignment,PSA)型AM元件中使用具有正或負的介電各向異性的組成物。聚合物穩定配向(polymer sustained alignment,PSA)型液晶顯示元件中使用含有聚合物的液晶組成物。首先,將添加有少量聚合性化合物的組成物注入至元件中。繼而,一邊對所述元件的基板之間施加電壓,一邊對組成物照射紫外線。聚合性化合物進行聚合而在組成物中生成聚合物的網狀結構。所述組成物中,可通過聚合物來控制液晶分子的配向,因此元件的響應時間縮短,圖像的燒痕得到改善。具有TN、ECB、OCB、IPS、VA、FFS、FPA之類的模式的元件可期待聚合物的此種效果。A composition having positive dielectric anisotropy is used in an AM element having a TN mode. A composition having negative dielectric anisotropy is used in an AM element having a VA mode. A composition having positive or negative dielectric anisotropy is used in an AM element having an IPS mode or an FFS mode. A polymer sustained alignment (PSA) type AM device uses a composition having positive or negative dielectric anisotropy. A liquid crystal composition containing a polymer is used for a polymer sustained alignment (PSA) type liquid crystal display element. First, a composition to which a small amount of a polymerizable compound is added is injected into the element. Next, the composition was irradiated with ultraviolet rays while applying a voltage between the substrates of the element. The polymerizable compound is polymerized to form a polymer network structure in the composition. In the composition, the alignment of the liquid crystal molecules can be controlled by the polymer, so the response time of the element is shortened and the burn marks of the image are improved. This effect of polymers can be expected for elements with modes such as TN, ECB, OCB, IPS, VA, FFS, FPA.

報告有如下方法:代替聚醯亞胺之類的配向膜而使用具有肉桂酸酯基的低分子化合物或具有聚肉桂酸乙烯酯(polyvinyl cinnamate)、查耳酮結構的低分子化合物、具有偶氮苯結構的低分子化合物或樹枝狀聚合物來控制液晶的配向(專利文獻1、專利文獻2或專利文獻3)。專利文獻1、專利文獻2或專利文獻3的方法中,首先,使所述低分子化合物或聚合物以添加物的形式溶解於液晶組成物中。繼而,通過使所述添加物相分離而在基板上生成包含所述低分子化合物或聚合物的薄膜。最後,在高於液晶組成物的上限溫度的溫度下對基板照射直線偏光。當低分子化合物或聚合物通過所述直線偏光而進行二聚化或異構化時,其分子在一定方向上進行排列。所述方法中,通過選擇低分子化合物或聚合物的種類,可製造IPS或FFS之類的水平配向模式的元件與VA之類的垂直配向模式的元件。所述方法中,重要的是低分子化合物或聚合物在高於液晶組成物的上限溫度的溫度下容易溶解,當恢復至室溫時,所述化合物容易自液晶組成物進行相分離。其中,難以確保低分子化合物或聚合物與液晶組成物的相容性。The following methods are reported: instead of an alignment film such as polyimide, a low molecular weight compound having a cinnamate group or a low molecular weight compound having a polyvinyl cinnamate (polyvinyl cinnamate) and a chalcone structure, a low molecular weight compound having an azo A low molecular weight compound or a dendrimer of a benzene structure controls the alignment of the liquid crystal (Patent Document 1, Patent Document 2, or Patent Document 3). In the method of Patent Document 1, Patent Document 2 or Patent Document 3, first, the low molecular weight compound or polymer is dissolved in the liquid crystal composition as an additive. Then, by phase-separating the additive, a thin film containing the low-molecular-weight compound or polymer is formed on the substrate. Finally, the substrate is irradiated with linearly polarized light at a temperature higher than the upper limit temperature of the liquid crystal composition. When the low molecular compound or polymer undergoes dimerization or isomerization through the linearly polarized light, its molecules are arranged in a certain direction. In this method, by selecting the type of the low molecular weight compound or polymer, a device of a horizontal alignment mode such as IPS or FFS and a device of a vertical alignment mode such as VA can be produced. In the method, it is important that the low molecular weight compound or polymer is easily dissolved at a temperature higher than the upper limit temperature of the liquid crystal composition, and when returned to room temperature, the compound is easily phase-separated from the liquid crystal composition. Among them, it is difficult to secure the compatibility of the low molecular weight compound or polymer with the liquid crystal composition.

迄今為止,不具有配向膜的液晶顯示元件中,作為可使液晶分子水平配向的化合物,專利文獻2中記載有化合物(S-1)(說明書的段落0034的[化2]),專利文獻3中記載有化合物(S-2)(說明書中的P176的化合物[14])等。但是,使用這些化合物製成的液晶顯示元件的諸特性並不充分,期望加以改善。In a liquid crystal display element without an alignment film so far, as a compound capable of aligning liquid crystal molecules horizontally, the compound (S-1) is described in Patent Document 2 ([Chem. 2] in paragraph 0034 of the specification), and Patent Document 3 Compound (S-2) (compound [14] of P176 in the specification) and the like are described in . However, the characteristics of the liquid crystal display element produced using these compounds are insufficient, and improvement is desired.

Figure 02_image003
[現有技術文獻] [專利文獻]
Figure 02_image003
[Prior Art Document] [Patent Document]

[專利文獻1]國際公開第2015/146369號 [專利文獻2]國際公開第2017/057162號 [專利文獻3]國際公開第2017/102068號[Patent Document 1] International Publication No. 2015/146369 [Patent Document 2] International Publication No. 2017/057162 [Patent Document 3] International Publication No. 2017/102068

[發明所要解決的問題] 本發明的第一課題為提供一種化合物,其具有化學穩定性高、使液晶分子水平配向的能力高、廣添加濃度範圍內的配向性高、反應性適當及在液晶組成物中的溶解度高的至少一種特性,而且可期待用於液晶顯示元件時的電壓保持率大。第二課題為提供一種液晶組成物,其包含所述化合物,而且滿足向列相的上限溫度高、向列相的下限溫度低、黏度小、光學各向異性適當、正或負的介電各向異性大、比電阻大、對紫外線的穩定性高、對熱的穩定性高、彈性常數大等特性的至少一種。第三課題為提供一種液晶顯示元件,其包含所述組成物,在通過對所述組成物照射紫外線而使極性化合物在元件內形成膜時,所述膜具有硬度適當、接觸成分的滲透性低、耐候性高、體積電阻值適當的至少一種特性,並且所述液晶顯示元件具有可使用元件的溫度範圍廣、響應時間短、電壓保持率高、閾電壓低、對比度比大、壽命長、AC殘像低的至少一種特性。 [解決問題的技術手段][Problems to be Solved by Invention] The first object of the present invention is to provide a compound having high chemical stability, high ability to align liquid crystal molecules horizontally, high alignment in a wide range of addition concentrations, appropriate reactivity, and high solubility in liquid crystal compositions. At least one characteristic, and it can be expected to have a high voltage holding ratio when used in a liquid crystal display element. The second problem is to provide a liquid crystal composition including the compound, which satisfies the requirements of high upper limit temperature of nematic phase, low minimum temperature of nematic phase, low viscosity, suitable optical anisotropy, and positive or negative dielectric properties. At least one of the characteristics of large anisotropy, large specific resistance, high stability to ultraviolet rays, high stability to heat, and large elastic constant. The third problem is to provide a liquid crystal display element including the composition, wherein when a polar compound is formed into a film in the element by irradiating the composition with ultraviolet rays, the film has appropriate hardness and low permeability of contact components , At least one characteristic of high weather resistance and appropriate volume resistance value, and the liquid crystal display element has a wide temperature range of usable elements, a short response time, high voltage retention rate, low threshold voltage, large contrast ratio, long life, AC At least one characteristic of low afterimage. [Technical means to solve the problem]

本發明者們發現以下的式(1)所表示的化合物可解決所述課題,從而完成了發明。

Figure 02_image005
(式中的記號的說明將在下文敘述) 本發明包含下述項等。 一種化合物,由式(1)表示。
Figure 02_image001
式(1)中, a及b獨立地為0、1或2,a及b的和為0、1、2或3; 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、式(A-1)或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2)所表示的基,式(A-1)及式(A-2)中,Q1 及Q2 獨立地為-CH2 -、-O-、-N(-R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況;
Figure 02_image007
當a為2時,兩個環A1 可不同,當b為2時,兩個環A4 可不同; Z1 、Z2 、Z3 、Z4 及Z5 獨立地為單鍵或碳數1至10的伸烷基,所述Z1 、Z2 、Z3 、Z4 及Z5 中,至少一個-CH2 -可經-O-、-S-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但Z2 、Z3 或Z4 中的至少一個為-COS-、-SCO-、-CH=CHCOS-、-SCOCH=CH-、-COO-、-OCO-、-CH=CH-、-CH=CHCO-或-COCH=CH-,當a為2時,兩個Z1 可不同,當b為2時,兩個Z5 可不同; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代; 在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 02_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 獨立地為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。 一種液晶組成物,含有至少一種所述的化合物。 一種液晶顯示元件,含有所述的液晶組成物。 [發明的效果]The present inventors discovered that the compound represented by the following formula (1) can solve the above-mentioned problem, and completed the invention.
Figure 02_image005
(The description of the symbols in the formula will be described later.) The present invention includes the following items and the like. A compound represented by formula (1).
Figure 02_image001
In formula (1), a and b are independently 0, 1 or 2, and the sum of a and b is 0, 1, 2 or 3; Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl, 1,2, 3,4-Tetrahydronaphthalene-2,6-diyl, Tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, Pyrimidine-2,5-diyl , pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta[a]phenanthrene-3,17 -diyl, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecylhydrocyclopenta[a]phenanthrene-3,17-diyl, In the group represented by the formula (A-1) or the formula (A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be replaced by fluorine, chlorine, carbon number of 1 to 12 Alkyl, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyl with 2 to 11 carbons, -Sp 1 -P 1 or -Sp 2 -P 2 are substituted, these alkanes In the radical, alkenyl, alkoxy, alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine, wherein ring A 1 , ring A 2 , ring A At least one of 3 or ring A 4 is a group represented by formula (A-1) or formula (A-2), and in formula (A-1) and formula (A-2), Q 1 and Q 2 are independently -CH 2 -, -O-, -N(-R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C-, at least one hydrogen may be substituted by fluorine or chlorine, but no R is present 8 is the case of fluorine or chlorine;
Figure 02_image007
When a is 2, the two rings A 1 may be different, and when b is 2, the two rings A 4 may be different; Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single bonds or carbon numbers 1 to 10 alkylene groups, in said Z 1 , Z 2 , Z 3 , Z 4 and Z 5 , at least one -CH 2 - may be through -O-, -S-, -CO-, -COO-, -OCO- or -OCOO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but Z 2 , Z 3 or At least one of Z 4 is -COS-, -SCO-, -CH=CHCOS-, -SCOCH=CH-, -COO-, -OCO-, -CH=CH-, -CH=CHCO-, or -COCH= CH-, when a is 2, the two Z 1 can be different, when b is 2, the two Z 5 can be different; Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbons, In the Sp 1 and Sp 2 , at least one -CH 2 - can be substituted by -O-, -CO-, -COO-, -OCO- or -OCOO-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 ; In the presence of multiple Sp 1 or Sp 2 , any Two may be different; P 1 and P 2 are independently a group represented by any one of formulas (1b) to (1h), and when there are multiple P 1 or P 2 , any two may be different;
Figure 02_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine Alkyl having 1 to 5 carbons; X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or alkyl having 1 to 15 carbons, and R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are independently hydrogen, fluorine, chlorine or an alkyl group with 1 to 5 carbons, and in said R 2 and R 6 , at least one hydrogen Can be substituted by fluorine or chlorine, at least one -CH 2 - can be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, the R 3 , Among R 4 , R 5 and R 7 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C- , at least one hydrogen can be replaced by fluorine or chlorine, but there is no case where R 5 and R 7 are fluorine or chlorine. A liquid crystal composition containing at least one of the compounds. A liquid crystal display element containing the liquid crystal composition. [Effect of invention]

本發明的第一優點為提供一種化合物,其具有高的化學穩定性、高的使液晶分子水平配向的能力、高的廣添加濃度範圍內的配向性、適當的反應性及高的在液晶組成物中的溶解度的至少一種,而且可期待用於液晶顯示元件時的電壓保持率大。第二優點為提供一種液晶組成物,其包含所述化合物,而且滿足向列相的上限溫度高、向列相的下限溫度低、黏度小、光學各向異性適當、正或負的介電各向異性大、比電阻大、對紫外線的穩定性高、對熱的穩定性高、彈性常數大等特性的至少一種。第三優點為提供一種液晶顯示元件,其包含所述組成物,在通過對所述組成物照射紫外線而使極性化合物在元件內形成膜時,所述膜具有硬度適當、接觸成分的滲透性低、耐候性高、體積電阻值適當的至少一種特性,並且所述液晶顯示元件具有可使用元件的溫度範圍廣、響應時間短、電壓保持率高、閾電壓低、對比度比大、壽命長、AC殘像低的至少一種特性。通過利用包含本發明的化合物的液晶組成物而不需要配向膜的形成步驟,因此可獲得減低了製造成本的液晶顯示元件。The first advantage of the present invention is to provide a compound with high chemical stability, high ability to align liquid crystal molecules horizontally, high alignment in a wide range of addition concentrations, appropriate reactivity, and high composition in liquid crystals At least one of the solubility in substances is expected to have a high voltage holding ratio when used in a liquid crystal display element. The second advantage is to provide a liquid crystal composition, which contains the compound, and satisfies the requirements of high upper limit temperature of nematic phase, low lower limit temperature of nematic phase, low viscosity, suitable optical anisotropy, and positive or negative dielectric properties. At least one of the characteristics of large anisotropy, large specific resistance, high stability to ultraviolet rays, high stability to heat, and large elastic constant. The third advantage is to provide a liquid crystal display element including the composition, which has suitable hardness and low permeability of contact components when a polar compound is formed into a film in the element by irradiating the composition with ultraviolet rays , At least one characteristic of high weather resistance and appropriate volume resistance value, and the liquid crystal display element has a wide temperature range of usable elements, a short response time, high voltage retention rate, low threshold voltage, large contrast ratio, long life, AC At least one characteristic of low afterimage. By using the liquid crystal composition containing the compound of the present invention, the formation step of the alignment film is not required, and therefore, a liquid crystal display element with a reduced manufacturing cost can be obtained.

本說明書中的用語的使用方法如下所述。有時將“液晶組成物”及“液晶顯示元件”的用語分別簡稱為“組成物”及“元件”。“液晶顯示元件”是液晶顯示面板及液晶顯示模組的總稱。“液晶性化合物”是具有向列相、層列相等液晶相的化合物,及雖不具有液晶相,但出於調節向列相的溫度範圍、黏度、介電各向異性之類的特性的目的而混合至組成物中的化合物的總稱。所述化合物具有例如1,4-伸環己基或1,4-伸苯基之類的六員環,且其分子結構為棒狀(rod like)。“聚合性化合物”是出於在組成物中生成聚合物的目的而添加的化合物。“極性化合物”通過極性基與基板表面相互作用而幫助液晶分子排列。How to use the terms in this specification is as follows. The terms "liquid crystal composition" and "liquid crystal display element" may be abbreviated as "composition" and "element", respectively. "Liquid crystal display element" is a general term for a liquid crystal display panel and a liquid crystal display module. "Liquid crystal compound" is a compound having a liquid crystal phase such as a nematic phase and a smectic phase, and it does not have a liquid crystal phase, but is used for the purpose of adjusting the temperature range, viscosity, and dielectric anisotropy of the nematic phase. On the other hand, a general term for compounds mixed into the composition. The compound has a six-membered ring such as 1,4-cyclohexylene or 1,4-phenylene, and its molecular structure is rod-like. The "polymerizable compound" is a compound added for the purpose of generating a polymer in the composition. "Polar compounds" help the liquid crystal molecules to align through the interaction of polar groups with the surface of the substrate.

液晶組成物是通過將多種液晶性化合物混合來製備。液晶性化合物的比例(含量)是以基於所述液晶組成物的重量的重量百分率(重量%)來表示。在所述液晶組成物中視需要來添加光學活性化合物、抗氧化劑、紫外線吸收劑、色素、消泡劑、聚合性化合物、聚合起始劑、聚合抑制劑、極性化合物之類的添加物。與液晶性化合物的比例同樣地,添加物的比例(添加量)是以基於液晶組成物的重量的重量百分率(重量%)來表示。有時也使用重量百萬分率(ppm)。聚合起始劑及聚合抑制劑的比例是例外地基於聚合性化合物的重量來表示。The liquid crystal composition is prepared by mixing a plurality of liquid crystal compounds. The ratio (content) of the liquid crystal compound is represented by the weight percentage (% by weight) based on the weight of the liquid crystal composition. Additives such as optically active compounds, antioxidants, ultraviolet absorbers, pigments, antifoaming agents, polymerizable compounds, polymerization initiators, polymerization inhibitors, and polar compounds are optionally added to the liquid crystal composition. Like the ratio of the liquid crystal compound, the ratio (addition amount) of the additive is represented by the weight percentage (% by weight) based on the weight of the liquid crystal composition. Parts per million (ppm) by weight are also sometimes used. The ratios of the polymerization initiator and the polymerization inhibitor are expressed based on the weight of the polymerizable compound exceptionally.

有時將式(1)所表示的化合物簡稱為“化合物(1)”。化合物(1)是指式(1)所表示的一種化合物、兩種化合物的混合物或三種以上化合物的混合物。所述規則也適用於選自式(2)所表示的化合物的群組中的至少一種化合物等。由六邊形包圍的B1 、C1 、F等記號分別與環B1 、環C1 、環F等相對應。六邊形表示環己烷環或苯環之類的六員環或者萘環之類的縮合環。橫切所述六邊形的斜線表示環上的任意的氫可經-Sp1 -P1 等基取代。e等下標表示經取代的基的個數。當下標為0時,不存在此種取代。The compound represented by formula (1) may be abbreviated as "compound (1)" in some cases. Compound (1) refers to one compound represented by formula (1), a mixture of two compounds, or a mixture of three or more compounds. The rule also applies to at least one compound selected from the group of compounds represented by formula (2), and the like. The symbols B 1 , C 1 , F, etc. surrounded by hexagons correspond to ring B 1 , ring C 1 , ring F, etc., respectively. The hexagon represents a six-membered ring such as a cyclohexane ring or a benzene ring, or a condensed ring such as a naphthalene ring. The oblique line across the hexagon indicates that any hydrogen on the ring can be substituted by groups such as -Sp 1 -P 1 . Subscripts such as e indicate the number of substituted groups. When the subscript is 0, there is no such substitution.

如後所述,將末端基R11 的記號用於多種成分化合物中。這些化合物中,任意的兩個R11 所表示的兩個基可相同,或也可不同。例如,有化合物(2)的R11 為乙基,化合物(3)的R11 為乙基的情況。也有化合物(2)的R11 為乙基,化合物(3)的R11 為丙基的情況。所述規則也適用於其他末端基、環、鍵結基等記號。後述的式(8)中,當i為2時,存在兩個環D1 。所述化合物中,兩個環D1 所表示的兩個基可相同,或也可不同。所述規則也適用於i大於2時的任意兩個環D1 。所述規則也適用於其他環、鍵結基等記號。As will be described later, the notation of the terminal group R 11 is used in various component compounds. In these compounds, the two groups represented by any two R 11 may be the same or different. For example, R 11 of the compound (2) may be an ethyl group, and R 11 of the compound (3) may be an ethyl group. In some cases, R 11 of the compound (2) is an ethyl group, and R 11 of the compound (3) is a propyl group. The rules also apply to other end groups, rings, linkage groups, etc. notation. In formula (8) described later, when i is 2, two rings D 1 exist. In the compound, the two groups represented by the two rings D 1 may be the same or different. The rules also apply to any two rings D 1 when i is greater than 2. The rules also apply to other notations of rings, bonding groups, and the like.

“至少一個‘A’”的表述是指‘A’的個數為任意。關於“至少一個‘A’可經‘B’取代”的表述,當‘A’的個數為一個時,‘A’的位置為任意,當‘A’的個數為兩個以上時,也可無限制地選擇這些‘A’的位置。所述規則也適用於“至少一個‘A’經‘B’取代”的表述。“至少一個A可經B、C或D取代”的表述是指包含至少一個A經B取代的情況、至少一個A經C取代的情況及至少一個A經D取代的情況、以及多個A經B、C、D的至少兩個取代的情況。例如至少一個-CH2 -(或-(CH2 )2 -)可經-O-(或-CH=CH-)取代的烷基中,包含烷基、烯基、烷氧基、烷氧基烷基、烷氧基烯基、烯氧基烷基。再者,連續的兩個-CH2 -經-O-取代而成為如-O-O-那樣的情況欠佳。The expression "at least one 'A'" means that the number of 'A's is arbitrary. Regarding the expression "at least one 'A' can be replaced by 'B'", when the number of 'A' is one, the position of 'A' is arbitrary, and when the number of 'A' is two or more, the The positions of these 'A's can be selected indefinitely. The rules also apply to the expression "at least one 'A' is substituted with 'B'". The expression "at least one A may be substituted by B, C, or D" is meant to include at least one case where A is substituted by B, where at least one A is substituted by C, and where at least one A is substituted by D, and multiple A's are substituted by D. The case of at least two substitutions of B, C, and D. For example, among the alkyl groups in which at least one -CH 2 - (or -(CH 2 ) 2 -) can be substituted by -O- (or -CH=CH-), including alkyl, alkenyl, alkoxy, alkoxy Alkyl, alkoxyalkenyl, alkenyloxyalkyl. Furthermore, it is not preferable that two consecutive -CH 2 - are substituted by -O- to become -OO-.

鹵素是指氟、氯、溴或碘。優選的鹵素為氟或氯。進而優選的鹵素為氟。烷基為直鏈狀或分支狀,且不包含環狀烷基。通常而言,直鏈狀烷基優於分支狀烷基。這些情況對於烷氧基、烯基等末端基而言也相同。關於與1,4-伸環己基有關的立體構型,為了提高向列相的上限溫度,反式構型優於順式構型。2-氟-1,4-伸苯基是指下述兩個二價基。化學式中,氟可向左(L),也可向右(R)。所述規則也適用於四氫吡喃-2,5-二基之類的通過自環中去除兩個氫而生成的非對稱的二價基。

Figure 02_image011
Halogen means fluorine, chlorine, bromine or iodine. Preferred halogens are fluorine or chlorine. A further preferred halogen is fluorine. The alkyl group is linear or branched, and does not include cyclic alkyl groups. In general, straight chain alkyl groups are preferred over branched alkyl groups. The same applies to terminal groups such as an alkoxy group and an alkenyl group. Regarding the stereo configuration related to 1,4-cyclohexylene, in order to increase the upper temperature limit of the nematic phase, the trans configuration is preferred to the cis configuration. The 2-fluoro-1,4-phenylene group refers to the following two divalent groups. In the chemical formula, fluorine can be left (L) or right (R). The rules also apply to asymmetric divalent radicals such as tetrahydropyran-2,5-diyl, which are formed by removing two hydrogens from the ring.
Figure 02_image011

本發明包含下述項等。The present invention includes the following items and the like.

項1 一種化合物,由式(1)表示。

Figure 02_image001
式(1)中, a及b獨立地為0、1或2,a及b的和為0、1、2或3; 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、式(A-1)或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2)所表示的基,式(A-1)及式(A-2)中,Q1 及Q2 獨立地為-CH2 -、-O-、-N(-R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況;
Figure 02_image007
當a為2時,兩個環A1 可不同,當b為2時,兩個環A4 可不同; Z1 、Z2 、Z3 、Z4 及Z5 獨立地為單鍵或碳數1至10的伸烷基,所述Z1 、Z2 、Z3 、Z4 及Z5 中,至少一個-CH2 -可經-O-、-S-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但Z2 、Z3 或Z4 中的至少一個為-COS-、-SCO-、-CH=CHCOS-、-SCOCH=CH-、-COO-、-OCO-、-CH=CH-、-CH=CHCO-或-COCH=CH-,當a為2時,兩個Z1 可不同,當b為2時,兩個Z5 可不同; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代; 在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 02_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 獨立地為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。Item 1 A compound represented by formula (1).
Figure 02_image001
In formula (1), a and b are independently 0, 1 or 2, and the sum of a and b is 0, 1, 2 or 3; Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl, 1,2, 3,4-Tetrahydronaphthalene-2,6-diyl, Tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, Pyrimidine-2,5-diyl , pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta[a]phenanthrene-3,17 -diyl, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecylhydrocyclopenta[a]phenanthrene-3,17-diyl, In the group represented by the formula (A-1) or the formula (A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be replaced by fluorine, chlorine, carbon number of 1 to 12 Alkyl, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, alkenyl with 2 to 11 carbons, -Sp 1 -P 1 or -Sp 2 -P 2 are substituted, these alkanes In the radical, alkenyl, alkoxy, alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine, wherein ring A 1 , ring A 2 , ring A At least one of 3 or ring A 4 is a group represented by formula (A-1) or formula (A-2), and in formula (A-1) and formula (A-2), Q 1 and Q 2 are independently -CH 2 -, -O-, -N(-R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C-, at least one hydrogen may be substituted by fluorine or chlorine, but no R is present 8 is the case of fluorine or chlorine;
Figure 02_image007
When a is 2, the two rings A 1 may be different, and when b is 2, the two rings A 4 may be different; Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single bonds or carbon numbers 1 to 10 alkylene groups, in said Z 1 , Z 2 , Z 3 , Z 4 and Z 5 , at least one -CH 2 - may be through -O-, -S-, -CO-, -COO-, -OCO- or -OCOO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but Z 2 , Z 3 or At least one of Z 4 is -COS-, -SCO-, -CH=CHCOS-, -SCOCH=CH-, -COO-, -OCO-, -CH=CH-, -CH=CHCO-, or -COCH= CH-, when a is 2, the two Z 1 can be different, when b is 2, the two Z 5 can be different; Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbons, In the Sp 1 and Sp 2 , at least one -CH 2 - can be substituted by -O-, -CO-, -COO-, -OCO- or -OCOO-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 ; In the presence of multiple Sp 1 or Sp 2 , any Two may be different; P 1 and P 2 are independently a base represented by any one of formulas (1b) to (1h), and when there are multiple P 1 or P 2 , any two may be different;
Figure 02_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine Alkyl having 1 to 5 carbons; X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or alkyl having 1 to 15 carbons, and said R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are independently hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen Can be substituted by fluorine or chlorine, at least one -CH 2 - can be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, the R 3 , Among R 4 , R 5 and R 7 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C- , at least one hydrogen can be replaced by fluorine or chlorine, but there is no case where R 5 and R 7 are fluorine or chlorine.

項2 根據項1所述的化合物,其中,式(1)中, a及b獨立地為0、1或2,a及b的和為0、1或2; 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、式(A-1)或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2)所表示的基,Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,

Figure 02_image007
當a為2時,兩個環A1 可不同,當b為2時,兩個環A4 可不同; Z1 、Z2 、Z3 、Z4 及Z5 獨立地為單鍵、-(CH2 )2 -、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-;當a為2時,兩個Z1 可不同,當b為2時,兩個Z5 可不同; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,分別可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 02_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基,X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。Item 2 The compound according to Item 1, wherein, in formula (1), a and b are independently 0, 1, or 2, and the sum of a and b is 0, 1, or 2; ring A 1 , ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, decalin-2 ,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl base, pyrimidine-2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocycle Pento[a]phenanthrene-3,17-diyl, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a ] phenanthrene-3,17-diyl, a group represented by the formula (A-1) or the formula (A-2), at least one hydrogen may be among these ring A 1 , ring A 2 , ring A 3 and ring A 4 Via fluorine, chlorine, alkyl group having 1 to 12 carbons, alkenyl having 2 to 12 carbons, alkoxy having 1 to 11 carbons, alkenyloxy having 2 to 11 carbons, -Sp 1 -P 1 or -Sp 2 -P 2 substituted, in these alkyl, alkenyl, alkoxy, alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine, wherein, At least one of ring A 1 , ring A 2 , ring A 3 or ring A 4 is a group represented by formula (A-1) or formula (A-2), and Q 1 and Q 2 are independently -CH 2 -, -O-, -N(R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - may be via -O- Or -S-substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but no R 8 is fluorine or chlorine Condition,
Figure 02_image007
When a is 2, the two rings A 1 may be different, and when b is 2, the two rings A 4 may be different; Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single bonds, -( CH 2 ) 2 -, -C≡C-, -C≡CC≡C-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -CF=CF-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH-, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; when a is 2, the two Z 1 can be different, when b is 2, the two Z 5 can be different; Sp 1 and Sp 2 are independently a single bond or an extension of carbon number 1 to 10 Alkyl, among the Sp 1 and Sp 2 , at least one -CH 2 - can be substituted by -O-, -COO- or -OCO-, and at least one -(CH 2 ) 2 - can be substituted by -CH=CH- , at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 , in the presence of multiple Sp 1 or Sp 2 , they can be different respectively; P 1 and P 2 are independently The group represented by any one of formula (1b) to formula (1h), when there are multiple P 1 or P 2 , any two may be different;
Figure 02_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine an alkyl group having 1 to 5 carbon atoms, X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and the R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen can be Fluorine or chlorine substitution, at least one -CH 2 - may be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, the R 3 , R 4 , R 5 and R 7 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one One hydrogen can be replaced by fluorine or chlorine, but there is no case where R5 and R7 are fluorine or chlorine.

項3 根據項1或項2所述的化合物,其由式(1-1)至式(1-3)的任一者表示。

Figure 02_image013
式(1-1)至式(1-3)中, 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸苯基、萘-2,6-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、式(A-1)或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2),Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,
Figure 02_image007
Z2 、Z3 及Z4 獨立地為單鍵、-(CH2 )2 -、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,分別可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 02_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。Item 3 The compound according to Item 1 or Item 2, which is represented by any one of Formula (1-1) to Formula (1-3).
Figure 02_image013
In formula (1-1) to formula (1-3), ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-cyclohexylene, 1,4-phenylene, naphthalene -2,6-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl In a diradical, a radical represented by formula (A-1) or formula (A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be replaced by fluorine, chlorine, carbon number Alkyl of 1 to 12, alkenyl of carbon number 2 to 12, alkoxy of carbon number of 1 to 11, alkenyloxy of carbon number of 2 to 11, -Sp 1 -P 1 or -Sp 2 -P 2 substituted , in these alkyl, alkenyl, alkoxy, alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine, wherein ring A 1 , ring A 2 , at least one of ring A 3 or ring A 4 is formula (A-1) or formula (A-2), and Q 1 and Q 2 are independently -CH 2 -, -O-, -N(R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least one -(CH 2 ) 2- can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine,
Figure 02_image007
Z 2 , Z 3 and Z 4 are independently a single bond, -(CH 2 ) 2 -, -C≡C-, -C≡CC≡C-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -CF=CF-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH -, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and the Sp 1 and Sp 2 Among them, at least one -CH 2 - can be substituted by -O-, -COO-, -OCOO- or -OCO-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, and at least one hydrogen can be substituted by -CH=CH- Fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 substituted, in the presence of multiple Sp 1 or Sp 2 , they may be different respectively; P 1 and P 2 are independently formula (1b) to formula (1h), when there are a plurality of P 1 or P 2 , any two of them may be different;
Figure 02_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine Alkyl having 1 to 5 carbons; X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or alkyl having 1 to 15 carbons, and R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group with 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen can be Fluorine or chlorine substitution, at least one -CH 2 - may be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, and said R 3 , R 4 , R 5 and R 7 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one One hydrogen can be replaced by fluorine or chlorine, but there is no case where R5 and R7 are fluorine or chlorine.

項4 根據項3所述的化合物,其中,式(1-1)至式(1-3)中, 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸苯基、萘-2,6-二基、芴-2,7-二基、菲-2,7-二基、式(A-1)或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2)所表示的基,Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,

Figure 02_image007
Z2 、Z3 及Z4 獨立地為單鍵、-(CH2 )2 -、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,分別可不同; P1 及P2 獨立地為式(1b)、式(1c)、式(1d)或式(1e)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 02_image017
式(1b)至式(1e)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基,X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 及R5 獨立地為氫或碳數1至15的烷基,所述R3 、R4 及R5 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 為氟或氯的情況。Item 4 The compound according to Item 3, wherein, in formulas (1-1) to (1-3), ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-extended Cyclohexyl, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, formula (A-1) or formula (A-2 ) represented by ), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be fluorine, chlorine, alkyl having 1 to 12 carbons, alkenyl having 2 to 12 carbons , alkoxy with 1 to 11 carbons, alkenyloxy with 2 to 11 carbons, -Sp 1 -P 1 or -Sp 2 -P 2 substituted, wherein, ring A 1 , ring A 2 , ring A 3 or At least one of ring A 4 is a group represented by formula (A-1) or formula (A-2), and Q 1 and Q 2 are independently -CH 2 -, -O-, -N(R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine,
Figure 02_image007
Z 2 , Z 3 and Z 4 are independently a single bond, -(CH 2 ) 2 -, -C≡CC≡C-, -C≡C-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH-, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; Sp 1 and Sp 2 independent is a single bond or an alkylene group having 1 to 10 carbon atoms, in the Sp 1 and Sp 2 , at least one -CH 2 - may be substituted by -O-, -COO-, -OCOO- or -OCO-, at least One -(CH 2 ) 2 - can be substituted by -CH=CH-, at least one hydrogen can be substituted by -Sp 1 -P 1 or -Sp 2 -P 2 , in the presence of multiple Sp 1 or Sp 2 , may be different; P 1 and P 2 are independently a group represented by any one of formula (1b), formula (1c), formula (1d) or formula (1e), and in the presence of a plurality of P 1 or P 2 case, any two can be different;
Figure 02_image017
In formula (1b) to formula (1e), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine an alkyl group having 1 to 5 carbon atoms, X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and the R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen can be Fluorine or chlorine substitution, at least one -CH 2 - may be substituted by -O-; R 3 , R 4 and R 5 are independently hydrogen or an alkyl group having 1 to 15 carbon atoms, and said R 3 , R 4 and R 5 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine is substituted, but there is no case where R5 is fluorine or chlorine.

項5 根據項3所述的化合物,其中,式(1-1)至式(1-3)中, 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸苯基、萘-2,6-二基、芴-2,7-二基、菲-2,7-二基、式(A-1)或式(A-2),這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、甲基或乙基取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2),Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,

Figure 02_image007
Z2 、Z3 及Z4 獨立地為單鍵、-(CH2 )2 -、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)所表示的基,
Figure 02_image019
式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)及式(1e-1)中, X2 、X3 、X4 、X5 及X6 獨立地為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況。Item 5 The compound according to Item 3, wherein, in formulas (1-1) to (1-3), ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-extended Cyclohexyl, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, formula (A-1) or formula (A-2 ), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be substituted by fluorine, chlorine, methyl or ethyl, wherein ring A 1 , ring A 2 , ring A 3 or At least one of ring A 4 is of formula (A-1) or formula (A-2), Q 1 and Q 2 are independently -CH 2 -, -O-, -N(R 8 )- or -S-, Here, R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - may be substituted by -O- or -S- Substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine,
Figure 02_image007
Z 2 , Z 3 and Z 4 are independently a single bond, -(CH 2 ) 2 -, -C≡CC≡C-, -C≡C-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH-, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; Sp 1 and Sp 2 independent is a single bond or an alkylene group having 1 to 10 carbon atoms, in the Sp 1 and Sp 2 , at least one -CH 2 - may be substituted by -O-, -COO-, -OCOO- or -OCO-, at least One -(CH 2 ) 2 - can be substituted by -CH=CH-, at least one hydrogen can be substituted by -Sp 1 -P 1 or -Sp 2 -P 2 , in the presence of multiple Sp 1 or Sp 2 , Any two can be different; P 1 and P 2 are independently formula (1b-1), formula (1b-2), formula (1b-3), formula (1b-4), formula (1b-5), formula (1c-1), the base represented by the formula (1d-1), the formula (1d-2) or the formula (1e-1),
Figure 02_image019
Equation (1b-1), Equation (1b-2), Equation (1b-3), Equation (1b-4), Equation (1b-5), Equation (1c-1), Equation (1d-1), Equation In (1d-2) and formula (1e-1), X 2 , X 3 , X 4 , X 5 and X 6 are independently -N(-R 9 )-, -O- or -S-, where , R 9 is hydrogen or an alkyl group with 1 to 15 carbon atoms, in said R 9 , at least one -CH 2 - can be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 9 is fluorine or chlorine.

項6 根據項3所述的化合物,其中,式(1-1)至式(1-3)所表示的化合物中,Z2 、Z3 或Z4 的任一個為-COO-或-OCO-,Q1 為-CH2 -或-N(R8 )-,Q2 為-N(R8 )-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況。Item 6 The compound according to Item 3, wherein, in the compounds represented by the formulae (1-1) to (1-3), any one of Z 2 , Z 3 or Z 4 is -COO- or -OCO- , Q 1 is -CH 2 - or -N(R 8 )-, Q 2 is -N(R 8 )-, here, R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in the R 8 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine substituted, but in the absence of R8 being fluoro or chloro.

項7 根據項1至項6中任一項所述的化合物,其由下述任一式表示。

Figure 02_image021
Figure 02_image023
Figure 02_image025
Figure 02_image027
這些式中, Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經-Sp1 -P1 或-Sp2 -P2 取代; P1 、P2 、Sp1 及Sp2 以外的部分結構中,至少一個氫可經氟、氯、甲基或乙基取代; Q1 為-CH2 -或-N(R8 )-,Q2 為-N(R8 )-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況, P1 及P2 獨立地為式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)所表示的基,
Figure 02_image019
式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)中,X2 、X3 、X4 、X5 及X6 獨立地為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況。Item 7 The compound according to any one of Items 1 to 6, which is represented by any one of the following formulae.
Figure 02_image021
Figure 02_image023
Figure 02_image025
Figure 02_image027
In these formulas, Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and in the Sp 1 and Sp 2 , at least one -CH 2 - may be through -O-, -COO-, -OCOO- or -OCO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, at least one hydrogen can be substituted by -Sp 1 -P 1 or -Sp 2 -P 2 ; P 1 , In partial structures other than P 2 , Sp 1 and Sp 2 , at least one hydrogen may be substituted by fluorine, chlorine, methyl or ethyl; Q 1 is -CH 2 - or -N(R 8 )-, Q 2 is - N(R 8 )-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one - (CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine, P 1 and P 2 are independently is formula (1b-1), formula (1b-2), formula (1b-3), formula (1b-4), formula (1b-5), formula (1c-1), formula (1d-1), The base represented by formula (1d-2) or formula (1e-1),
Figure 02_image019
Equation (1b-1), Equation (1b-2), Equation (1b-3), Equation (1b-4), Equation (1b-5), Equation (1c-1), Equation (1d-1), Equation In (1d-2) or formula (1e-1), X 2 , X 3 , X 4 , X 5 and X 6 are independently -N(-R 9 )-, -O- or -S-, where , R 9 is hydrogen or an alkyl group with 1 to 15 carbon atoms, in said R 9 , at least one -CH 2 - can be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 9 is fluorine or chlorine.

項8 根據項7所述的化合物,其中,式(1-1-11-1)至式(1-1-11-2)、式(1-2-11-1)至式(1-2-11-4)、式(1-1-12-1)至式(1-1-12-2)、式(1-2-12-1)至式(1-2-12-4)、式(1-1-21-1)至式(1-1-21-2)、式(1-2-21-1)至式(1-2-21-4)、式(1-1-22-1)至式(1-1-22-2)或式(1-2-22-1)至式(1-2-22-4)所表示的化合物中,Sp1 及Sp2 獨立地為碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代。Item 8 The compound according to Item 7, wherein formula (1-1-11-1) to formula (1-1-11-2), formula (1-2-11-1) to formula (1-2) -11-4), formula (1-1-12-1) to formula (1-1-12-2), formula (1-2-12-1) to formula (1-2-12-4), Equation (1-1-21-1) to Equation (1-1-21-2), Equation (1-2-21-1) to Equation (1-2-21-4), Equation (1-1- In the compounds represented by 22-1) to formula (1-1-22-2) or formula (1-2-22-1) to formula (1-2-22-4), Sp 1 and Sp 2 are independently is an alkylene group having 1 to 10 carbon atoms, among the Sp 1 and Sp 2 , at least one -CH 2 - can be substituted by -O-, and at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 or - Sp 2 -P 2 substituted.

項9 一種液晶組成物,含有至少一種根據項1至項8中任一項所述的化合物。Item 9 A liquid crystal composition containing at least one compound according to any one of Items 1 to 8.

項10 根據項9所述的液晶組成物,其還含有選自式(2)至式(4)所表示的化合物的群組中的至少一種化合物。

Figure 02_image029
式(2)至式(4)中, R11 及R12 獨立地為碳數1至10的烷基或碳數2至10的烯基,所述R11 及R12 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; 環B1 、環B2 、環B3 及環B4 獨立地為1,4-伸環己基、1,4-伸苯基、2-氟-1,4-伸苯基、2,5-二氟-1,4-伸苯基或嘧啶-2,5-二基; Z11 、Z12 及Z13 獨立地為單鍵、-(CH2 )2 -、-CH=CH-、-C≡C-或-COO-。Item 10 The liquid crystal composition according to Item 9, which further contains at least one compound selected from the group of compounds represented by formula (2) to formula (4).
Figure 02_image029
In formulas (2) to (4), R 11 and R 12 are independently an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 11 and R 12 , at least one -CH 2 - may be substituted by -O-, and at least one hydrogen may be substituted by fluorine; Ring B 1 , Ring B 2 , Ring B 3 and Ring B 4 are independently 1,4-cyclohexylene, 1,4-phenylene , 2-fluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene or pyrimidine-2,5-diyl; Z 11 , Z 12 and Z 13 are independently single bonds , -(CH 2 ) 2 -, -CH=CH-, -C≡C- or -COO-.

項11 根據項9或項10所述的液晶組成物,其還含有選自式(5)至式(7)所表示的化合物的群組中的至少一種化合物。

Figure 02_image031
式(5)至式(7)中, R13 為碳數1至10的烷基或碳數2至10的烯基,所述R13 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; X11 為氟、氯、-OCF3 、-OCHF2 、-CF3 、-CHF2 、-CH2 F、-OCF2 CHF2 或-OCF2 CHFCF3 ; 環C1 、環C2 及環C3 獨立地為1,4-伸環己基、至少一個氫可經氟取代的1,4-伸苯基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基或嘧啶-2,5-二基; Z14 、Z15 及Z16 獨立地為單鍵、-(CH2 )2 -、-CH=CH-、-CH=CF-、-CF=CF-、-C≡C-、-COO-、-CF2 O-、-OCF2 -、-CH2 O-、-CH=CF-CF2 O-、-CF=CF-CF2 O-或-(CH2 )4 -; L11 及L12 獨立地為氫或氟。Item 11 The liquid crystal composition according to Item 9 or Item 10, which further contains at least one compound selected from the group of compounds represented by formula (5) to formula (7).
Figure 02_image031
In formulas (5) to (7), R 13 is an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 13 , at least one -CH 2 - may be substituted by -O- , at least one hydrogen can be substituted by fluorine; X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 or -OCF 2 CHFCF 3 ; ring C 1 , Ring C 2 and Ring C 3 are independently 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be substituted with fluorine, tetrahydropyran-2,5-diyl, 1 ,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl; Z 14 , Z 15 and Z 16 are independently a single bond, -(CH 2 ) 2 -, -CH=CH- , -CH=CF-, -CF=CF-, -C≡C-, -COO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -CH=CF-CF 2 O-, -CF=CF-CF 2 O- or -(CH 2 ) 4 -; L 11 and L 12 are independently hydrogen or fluorine.

項12 根據項9至項11中任一項所述的液晶組成物,其還含有選自式(8)所表示的化合物的群組中的至少一種化合物。

Figure 02_image033
式(8)中, R14 為碳數1至10的烷基或碳數2至10的烯基,所述R14 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; X12 為-C≡N或-C≡C-C≡N; 環D1 獨立地為1,4-伸環己基、至少一個氫可經氟取代的1,4-伸苯基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基或嘧啶-2,5-二基; Z17 獨立地為單鍵、-(CH2 )2 -、-C≡C-、-COO-、-CF2 O-、-OCF2 -或-CH2 O-; L13 及L14 獨立地為氫或氟; i為1、2、3或4。Item 12 The liquid crystal composition according to any one of Items 9 to 11, which further contains at least one compound selected from the group of compounds represented by formula (8).
Figure 02_image033
In formula (8), R 14 is an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 14 , at least one -CH 2 - may be substituted by -O-, and at least one hydrogen may be substituted by -O-. Substituted by fluorine; X 12 is -C≡N or -C≡CC≡N; Ring D 1 is independently 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen can be substituted by fluorine, tetrakis Hydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl; Z 17 is independently a single bond, -(CH 2 ) 2 - , -C≡C-, -COO-, -CF 2 O-, -OCF 2 - or -CH 2 O-; L 13 and L 14 are independently hydrogen or fluorine; i is 1, 2, 3 or 4.

項13 根據項9至項12中任一項所述的液晶組成物,其還含有選自式(9)至式(15)、式(DB-1)及式(DB-2)所表示的化合物的群組中的至少一種化合物。

Figure 02_image035
Figure 02_image037
式(9)至式(15)中, R15 及R16 獨立地為碳數1至10的烷基或碳數2至10的烯基,所述R15 及R16 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; R17 為氫、氟、碳數1至10的烷基或碳數2至10的烯基,所述R17 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代,但不存在R17 為氟的情況; 環E1 、環E2 、環E3 及環E4 獨立地為1,4-伸環己基、1,4-伸環己烯基、至少一個氫可經氟取代的1,4-伸苯基、四氫吡喃-2,5-二基或十氫萘-2,6-二基; 環E5 及環E6 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、四氫吡喃-2,5-二基或十氫萘-2,6-二基; Z18 、Z19 、Z20 及Z21 獨立地為單鍵、-(CH2 )2 -、-COO-、-CH2 O-、-OCF2 -或-OCF2 -(CH2 )2 -; L15 及L16 獨立地為氟或氯; S11 為氫或甲基; X獨立地為-CHF-或-CF2 -; j、k、m、n、p、q、r及s獨立地為0或1,k、m、n及p的和為0、1、2或3,q、r及s的和為0、1、2或3,t為1、2或3; 式(DB-1)及式(DB-2)中, X100 獨立地為-S-、-O-或-CH2 -; a100 及a200 獨立地為0、1或2,a100 及a200 的和為0、1、2或3; R100 及R200 獨立地為氫、碳數1至15的烷基或碳數2至10的烯基,所述R100 及R200 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代,但不存在R100 及R200 為氟的情況; A100 及A200 獨立地為1,2-伸環丙基、1,3-伸環丁基、1,3-伸環戊基、1,3-伸環戊烯基、1,4-伸環己基、1,4-伸環己烯基、1,4-伸環庚基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、2,6,7-三氧雜雙環[2.2.2]辛烷-1,4-二基、1,4-伸苯基、萘-2,6-二基、四氫吡喃-2,5-二基、二氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、吡啶-2,5-二基、嘧啶-2,5-二基、9,10-二氫菲-2,7-二基、9H-氧雜蒽-2,6-二基或9H-芴-2,7-二基,所述A100 及A200 中,至少一個氫可經氟、氯、-CF3 、-CHF2 、-CH2 F、-OCF3 、-OCHF2 、-OCH2 F或-C≡N取代; Z100 及Z200 獨立地為單鍵或碳數1至6的伸烷基,所述Z100 及Z200 中,至少一個-CH2 -可經-O-、-S-、-CO-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-(CH2 )3 O-、-O(CH2 )3 -、-CH=CH-CH2 O-、-OCH2 -CH=CH-或-SiH2 -取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代; L100 及L101 獨立地為氟、氯、-CF3 或-CHF2 ; L102 、L103 、L104 及L105 獨立地為氫、氟、氯、-CF3 、-CHF2 、-CH2 F、-OCF3 、-OCHF2 或-OCH2 F,不存在L102 、L103 、L104 及L105 全部為氫的情況,但L102 、L103 、L104 及L105 的任意一個或兩個可為氫。Item 13 The liquid crystal composition according to any one of Items 9 to 12, which further contains a compound selected from the group consisting of formula (9) to formula (15), formula (DB-1), and formula (DB-2) At least one compound of the group of compounds.
Figure 02_image035
Figure 02_image037
In formulas (9) to (15), R 15 and R 16 are independently an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 15 and R 16 , at least one -CH 2 - can be substituted by -O-, at least one hydrogen can be substituted by fluorine; R 17 is hydrogen, fluorine, alkyl with 1 to 10 carbons or alkenyl with 2 to 10 carbons, among the R 17 , at least one -CH 2 - can be substituted by -O-, at least one hydrogen can be substituted by fluorine, but there is no case where R 17 is fluorine; ring E 1 , ring E 2 , ring E 3 and ring E 4 are independently 1,4 - cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl or decahydronaphthalene-2,6 -diyl; Ring E 5 and Ring E 6 are independently 1,4-cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene, tetrahydropyran-2,5-di or decahydronaphthalene-2,6-diyl; Z 18 , Z 19 , Z 20 and Z 21 are independently a single bond, -(CH 2 ) 2 -, -COO-, -CH 2 O-, -OCF 2 - or -OCF 2 -(CH 2 ) 2 -; L 15 and L 16 are independently fluorine or chlorine; S 11 is hydrogen or methyl; X is independently -CHF- or -CF 2 -; j, k , m, n, p, q, r, and s are independently 0 or 1, the sum of k, m, n, and p is 0, 1, 2, or 3, and the sum of q, r, and s is 0, 1, 2 or 3, t is 1, 2 or 3; In formula (DB-1) and formula (DB-2), X 100 is independently -S-, -O- or -CH 2 -; a 100 and a 200 are independently R 100 and R 200 are independently hydrogen, alkyl having 1 to 15 carbons or alkene having 2 to 10 carbons group, in the R 100 and R 200 , at least one -CH 2 - can be substituted by -O-, and at least one hydrogen can be substituted by fluorine, but there is no case where R 100 and R 200 are fluorine; A 100 and A 200 independently 1,2-cyclopentylene, 1,3-cyclobutyl, 1,3-cyclopentylene, 1,3-cyclopentenyl, 1,4-cyclohexylene, 1, 4-cyclohexenyl, 1,4-cycloheptide, decalin-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, 2,6 ,7-Trioxabicyclo[2.2.2]octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, 9,10-diyl Dihydrophenanthrene-2,7-diyl, 9H-oxanthene-2,6-diyl or 9H-fluorene-2,7-diyl, in A 100 and A 200 , at least one hydrogen may be fluorine , chlorine, -C F 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F or -C≡N substituted; Z 100 and Z 200 are independently a single bond or an alkylene having 1 to 6 carbon atoms Base, in the Z 100 and Z 200 , at least one -CH 2 - can be via -O-, -S-, -CO-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -(CH 2 ) 3 O-, -O(CH 2 ) 3 -, -CH=CH-CH 2 O-, -OCH 2 -CH=CH- or -SiH 2 - substituted, at least one -(CH 2 ) 2- can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine; L 100 and L 101 are independently fluorine, chlorine, -CF 3 or -CHF 2 ; L 102 , L 103 , L 104 and L 105 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 or -OCH 2 F, L 102 , L 103 absent , L 104 and L 105 are all hydrogen, but any one or both of L 102 , L 103 , L 104 and L 105 may be hydrogen.

項14 根據項9至項13中任一項所述的液晶組成物,其含有選自式(16)所表示的化合物的群組中的至少一種聚合性化合物。

Figure 02_image039
式(16)中, 環F及環I獨立地為環己基、環己烯基、苯基、1-萘基、2-萘基、四氫吡喃-2-基、1,3-二噁烷-2-基、嘧啶-2-基或吡啶-2-基,這些環F及環I中,至少一個氫可經氟、氯、碳數1至12的烷基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代; 環G為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基或吡啶-2,5-二基,這些環G中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代; Z22 及Z23 獨立地為單鍵或碳數1至10的伸烷基,所述Z22 及Z23 中,至少一個-CH2 -可經-O-、-CO-、-COO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-或-C(CH3 )=C(CH3 )-取代,至少一個氫可經氟或氯取代; P11 、P12 及P13 獨立地為選自式(P-1)至式(P-5)所表示的基的群組中的聚合性基;
Figure 02_image041
M11 為氫、氟、氯或碳數1至5的烷基,所述M11 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代;M12 及M13 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基; Sp11 、Sp12 及Sp13 獨立地為單鍵或碳數1至10的伸烷基,所述Sp11 、Sp12 及Sp13 中,至少一個-CH2 -可經-O-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代; u為0、1或2; f、g及h獨立地為0、1、2、3或4,而且f、g及h的和為2以上。Item 14 The liquid crystal composition according to any one of Items 9 to 13, which contains at least one polymerizable compound selected from the group of compounds represented by formula (16).
Figure 02_image039
In formula (16), ring F and ring I are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxyl Alkyl-2-yl, pyrimidin-2-yl or pyridin-2-yl, in these ring F and ring I, at least one hydrogen can be fluorine, chlorine, alkyl having 1 to 12 carbon atoms, or at least one hydrogen can be fluorine Or chlorine-substituted alkyl group with 1 to 12 carbon atoms; Ring G is 1,4-cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-1,2-di base, naphthalene-1,3-diyl, naphthalene-1,4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1 ,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5-diyl, 1,3-diyl Oxane-2,5-diyl, pyrimidine-2,5-diyl or pyridine-2,5-diyl, in these rings G, at least one hydrogen can be through fluorine, chlorine, alkyl having 1 to 12 carbons , an alkoxy group having 1 to 12 carbon atoms, or at least one hydrogen is substituted by an alkyl group having 1 to 12 carbon atoms substituted by fluorine or chlorine; Z 22 and Z 23 are independently a single bond or an alkylene having 1 to 10 carbon atoms Base, in said Z 22 and Z 23 , at least one -CH 2 - can be substituted by -O-, -CO-, -COO- or -OCO-, and at least one -(CH 2 ) 2 - can be substituted by -CH= CH-, -C(CH 3 )=CH-, -CH=C(CH 3 )- or -C(CH 3 )=C(CH 3 )- substituted, at least one hydrogen may be substituted by fluorine or chlorine; P 11 , P 12 and P 13 are independently polymerizable groups selected from the group of groups represented by formula (P-1) to formula (P-5);
Figure 02_image041
M 11 is hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, in the M 11 , at least one hydrogen can be substituted by fluorine or chlorine, and at least one -CH 2 - can be substituted by -O-; M 12 and M 13 is independently hydrogen, fluorine, chlorine, an alkyl group having 1 to 5 carbon atoms, or an alkyl group having 1 to 5 carbon atoms in which at least one hydrogen is substituted by fluorine or chlorine; Sp 11 , Sp 12 and Sp 13 are independently A single bond or an alkylene group having 1 to 10 carbon atoms, in said Sp 11 , Sp 12 and Sp 13 , at least one -CH 2 - may be substituted by -O-, -COO-, -OCO- or -OCOO-, At least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C-, and at least one hydrogen may be substituted by fluorine or chlorine; u is 0, 1 or 2; f, g and h are independently 0, 1, 2, 3 or 4, and the sum of f, g and h is 2 or more.

項15 根據項9至項14中任一項所述的液晶組成物,其含有選自式(16-1)至式(16-28)所表示的化合物的群組中的至少一種聚合性化合物。

Figure 02_image043
Figure 02_image045
Figure 02_image047
式(16-1)至式(16-28)中, Sp11 、Sp12 及Sp13 獨立地為單鍵或碳數1至10的伸烷基,所述Sp11 、Sp12 及Sp13 中,至少一個-CH2 -可經-O-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,u為0、1或2,g及h獨立地為0、1、2、3或4, Z23 為單鍵或碳數1至10的伸烷基,所述Z23 中,至少一個-CH2 -可經-O-、-CO-、-COO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-或-C(CH3 )=C(CH3 )-取代,至少一個氫可經氟或氯取代, P11 、P12 及P13 獨立地為選自式(P-1)至式(P-3)所表示的基的群組中的聚合性基;
Figure 02_image049
式(P-1)至式(P-3)中, M11 為氫、氟、氯或碳數1至5的烷基,所述M11 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代;M12 及M13 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基。Item 15 The liquid crystal composition according to any one of Items 9 to 14, which contains at least one polymerizable compound selected from the group of compounds represented by Formula (16-1) to Formula (16-28) .
Figure 02_image043
Figure 02_image045
Figure 02_image047
In formula (16-1) to formula (16-28), Sp 11 , Sp 12 and Sp 13 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and among the Sp 11 , Sp 12 and Sp 13 , at least one -CH 2 - can be substituted by -O-, -COO-, -OCO- or -OCOO-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, At least one hydrogen can be substituted by fluorine or chlorine, u is 0, 1 or 2, g and h are independently 0, 1, 2, 3 or 4, Z 23 is a single bond or an alkylene group having 1 to 10 carbons, In the Z 23 , at least one -CH 2 - can be substituted by -O-, -CO-, -COO- or -OCO-, and at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, -C (CH 3 )=CH-, -CH=C(CH 3 )- or -C(CH 3 )=C(CH 3 )- substituted, at least one hydrogen may be substituted by fluorine or chlorine, P 11 , P 12 and P 13 is independently a polymerizable group selected from the group of groups represented by formula (P-1) to formula (P-3);
Figure 02_image049
In formula (P-1) to formula (P-3), M 11 is hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, and in said M 11 , at least one hydrogen may be substituted by fluorine or chlorine, at least One -CH 2 - may be substituted by -O-; M 12 and M 13 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbons, or at least one hydrogen with 1 to 5 carbons substituted with fluorine or chlorine the alkyl group.

項16 根據項9至項15中任一項所述的液晶組成物,其還含有根據項1所述的式(1)及根據項14所述的式(16)以外的聚合性化合物、聚合起始劑、聚合抑制劑、光學活性化合物、抗氧化劑、紫外線吸收劑、光穩定劑、熱穩定劑及消泡劑的至少一種。Item 16 The liquid crystal composition according to any one of Items 9 to 15, which further contains a polymerizable compound other than the formula (1) according to Item 1 and the formula (16) according to Item 14, a polymer At least one of an initiator, a polymerization inhibitor, an optically active compound, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, and an antifoaming agent.

項17 一種液晶顯示元件,含有根據項9至項16中任一項所述的液晶組成物。Item 17 A liquid crystal display element containing the liquid crystal composition according to any one of Items 9 to 16.

本發明也包含以下項。(a)所述液晶組成物,其還含有聚合性化合物、聚合起始劑、聚合抑制劑、光學活性化合物、抗氧化劑、紫外線吸收劑、光穩定劑、熱穩定劑、消泡劑之類的添加物的至少兩種。(b)一種聚合性組成物,其是通過在所述液晶組成物中添加與化合物(1)或化合物(16)不同的聚合性化合物而製備。(c)一種聚合性組成物,其是通過在所述液晶組成物中添加化合物(1)與化合物(16)而製備。(d)一種液晶複合體,其是通過使聚合性組成物聚合而製備。(e)一種聚合物穩定配向型元件,含有所述液晶複合體。(f)一種聚合物穩定配向型元件,其是通過使用聚合性組成物而製成,所述聚合性組成物是通過在所述液晶組成物中添加化合物(1)與化合物(16)、以及與化合物(1)或化合物(16)不同的聚合性化合物而製備。 依序對化合物(1)的形態、化合物(1)的合成、液晶組成物及液晶顯示元件進行說明。The present invention also includes the following items. (a) The liquid crystal composition, which further contains a polymerizable compound, a polymerization initiator, a polymerization inhibitor, an optically active compound, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, a defoaming agent, and the like; At least two of the additives. (b) A polymerizable composition prepared by adding a polymerizable compound different from the compound (1) or the compound (16) to the liquid crystal composition. (c) A polymerizable composition prepared by adding the compound (1) and the compound (16) to the liquid crystal composition. (d) A liquid crystal composite prepared by polymerizing a polymerizable composition. (e) A polymer-stabilized alignment-type element comprising the liquid crystal composite. (f) a polymer-stabilized alignment-type element produced by using a polymerizable composition obtained by adding Compound (1) and Compound (16), and It is prepared from a polymerizable compound different from compound (1) or compound (16). The form of the compound (1), the synthesis of the compound (1), the liquid crystal composition, and the liquid crystal display element will be described in this order.

1.化合物(1)的形態 本發明的實施方式的化合物(1)的特徵在於為具有至少一個式(A-1)或式(A-2)所表示的結構並且具有聚合性基的極性化合物。化合物(1)通過在分子內具有式(A-1)或式(A-2)等結構而顯現出所述效果。

Figure 02_image051
1. Form of Compound (1) The compound (1) according to an embodiment of the present invention is a polar compound having a structure represented by at least one formula (A-1) or formula (A-2) and having a polymerizable group. . The compound (1) exhibits the above effects by having a structure such as formula (A-1) or formula (A-2) in the molecule.
Figure 02_image051

化合物(1)的用途之一為液晶顯示元件中所使用的液晶組成物用的添加物。化合物(1)是出於水平控制液晶分子的配向的目的而添加。關於此種化合物應具有的優選特性,在密閉於元件的條件下化學性穩定,且具有高的在液晶組成物中的溶解度,而且用於液晶顯示元件時的電壓保持率大。化合物(1)以相當大的程度滿足此種特性。One of the uses of the compound (1) is an additive for liquid crystal compositions used in liquid crystal display elements. Compound (1) is added for the purpose of horizontally controlling the alignment of liquid crystal molecules. Preferable properties to be possessed by such a compound are chemical stability under the condition of being enclosed in an element, high solubility in a liquid crystal composition, and high voltage holding ratio when used in a liquid crystal display element. Compound (1) satisfies this property to a considerable extent.

對化合物(1)的優選例進行說明。化合物(1)中的R1 、Z1 至Z5 、A1 至A4 、Sp1 、Sp2 、P1 、P2 、a及b的優選例也適用於化合物(1)的下位式。化合物(1)中,通過將這些基的種類適當組合,可任意調整特性。由於化合物的特性不存在大的差異,因此化合物(1)也可包含較天然存在比的量更多的2 H(氘)、13 C等同位素。

Figure 02_image001
Preferred examples of compound (1) will be described. Preferred examples of R 1 , Z 1 to Z 5 , A 1 to A 4 , Sp 1 , Sp 2 , P 1 , P 2 , a and b in compound (1) also apply to the following formula of compound (1). In the compound (1), properties can be arbitrarily adjusted by appropriately combining the types of these groups. Compound (1) may also contain isotopes such as 2 H (deuterium), 13 C, and the like in greater amounts than naturally occurring ratios, since there is no large difference in the properties of the compounds.
Figure 02_image001

a及b獨立地為0、1或2,a及b的和為0、1、2或3; 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、式(A-1)或式(A-2),這些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些基中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2)所表示的基,式(A-1)及式(A-2)中,Q1 及Q2 獨立地為-CH2 -、-O-、-N(-R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,

Figure 02_image007
當a為2時,兩個環A1 可不同,當b為2時,兩個環A4 可不同。a and b are independently 0, 1 or 2, and the sum of a and b is 0, 1, 2 or 3; Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-ring-extended Hexyl, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-2,6-diyl, decalin-2,6-diyl, 1,2,3,4-tetrahydro Naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, pyridine-2,5 -diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta[a]phenanthrene-3,17-diyl, 2, 3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,17-diyl, formula (A-1) Or formula (A-2), in these rings, at least one hydrogen can be through fluorine, chlorine, alkyl with 1 to 12 carbons, alkenyl with 2 to 12 carbons, alkoxy with 1 to 11 carbons, carbon Alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 of numbers 2 to 11 are substituted, in these groups, at least one hydrogen may be substituted by fluorine or chlorine, wherein ring A 1 , ring A 2 , ring A At least one of 3 or ring A 4 is a group represented by formula (A-1) or formula (A-2), and in formula (A-1) and formula (A-2), Q 1 and Q 2 are independently -CH 2 -, -O-, -N(-R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C-, at least one hydrogen may be substituted by fluorine or chlorine, but no R is present 8 is fluorine or chlorine,
Figure 02_image007
When a is 2, the two rings A 1 may be different, and when b is 2, the two rings A 4 may be different.

優選的環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、式(A-1)所表示的基或式(A-2)所表示的基,優選的Q1 及Q2 為-CH2 -、-O-、-N(-R8 )-或-S-,進而優選的Q1 及Q2 為-CH2 -或-N(-R8 )-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況。這些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基或碳數2至11的烯氧基取代,這些基中,至少一個氫可經氟或氯取代。進而優選為1,4-伸環己基、1,4-伸苯基、全氫環戊并[a]菲-3,17-二基或2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基,這些環中,至少一個氫可經氟或碳數1至5的烷基取代。特優選為1,4-伸環己基、1,4-伸苯基或全氫環戊并[a]菲-3,17-二基,這些環中,至少一個氫可經氟、甲基或乙基取代。Preferred Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2, 6-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3 -Dioxane-2,5-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, perhydrocyclopenta[a]phenanthrene-3,17-diyl, 2,3 ,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,17-diyl, represented by formula (A-1) The group represented by the formula (A-2) or the group represented by the formula (A-2), preferably Q 1 and Q 2 are -CH 2 -, -O-, -N(-R 8 )- or -S-, more preferably Q 1 and Q 2 is -CH 2 - or -N(-R 8 )-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - may be through - O- or -S- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but no R 8 is fluorine or the case of chlorine. In these rings, at least one hydrogen may be fluorine, chlorine, alkyl having 1 to 12 carbons, alkenyl having 2 to 12 carbons, alkoxy having 1 to 11 carbons, or alkenyloxy having 2 to 11 carbons Substituted, in these groups, at least one hydrogen may be substituted with fluorine or chlorine. More preferably 1,4-cyclohexylene, 1,4-phenylene, perhydrocyclopenta[a]phenanthrene-3,17-diyl or 2,3,4,7,8,9,10, 11,12,13,14,15,16,17-Tetrahydrocyclopenta[a]phenanthrene-3,17-diyl, in these rings, at least one hydrogen can be through fluorine or alkane having 1 to 5 carbons base substitution. Especially preferred is 1,4-cyclohexylene, 1,4-phenylene or perhydrocyclopento[a]phenanthrene-3,17-diyl, in these rings, at least one hydrogen can be fluorine, methyl or Ethyl substitution.

Z1 、Z2 、Z3 、Z4 及Z5 獨立地為單鍵或碳數1至10的伸烷基,所述Z1 、Z2 、Z3 、Z4 及Z5 中,至少一個-CH2 -可經-O-、-S-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代。其中,Z2 、Z3 或Z4 中的至少一個為-COS-、-SCO-、-CH=CHCOS-、-SCOCH=CH-、-COO-、-OCO-、-CH=CH-、-CH=CHCO-或-COCH=CH-,當a為2時,兩個Z1 可不同,當b為2時,兩個Z5 可不同。優選的Z1 、Z2 、Z3 、Z4 及Z5 獨立地為單鍵、-(CH2 )2 -、-CH=CH-、-C≡C-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-CF=CF-、-COS-、-SCO-、-CH=CHCOS-、-SCOCH=CH-、-CH=CHCO-或-COCH=CH-。進而優選為單鍵、-(CH2 )2 -、-CH=CH-、-COO-、-OCO-、-CH=CHCO-或-COCH=CH-。特優選為單鍵、-COO-或-OCO-。Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and among the Z 1 , Z 2 , Z 3 , Z 4 and Z 5 , at least one -CH 2 - can be substituted by -O-, -S-, -CO-, -COO-, -OCO- or -OCOO-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C ≡C-substituted, at least one hydrogen may be replaced by fluorine or chlorine. Wherein, at least one of Z 2 , Z 3 or Z 4 is -COS-, -SCO-, -CH=CHCOS-, -SCOCH=CH-, -COO-, -OCO-, -CH=CH-, - CH=CHCO- or -COCH=CH-, when a is 2, the two Z 1 can be different, and when b is 2, the two Z 5 can be different. Preferred Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently a single bond, -(CH 2 ) 2 -, -CH=CH-, -C≡C-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -CF=CF-, -COS-, -SCO-, -CH=CHCOS-, -SCOCH=CH-, -CH =CHCO- or -COCH=CH-. More preferably, it is a single bond, -(CH 2 ) 2 -, -CH=CH-, -COO-, -OCO-, -CH=CHCO-, or -COCH=CH-. Particularly preferred is a single bond, -COO- or -OCO-.

Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,這些基中,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代。 優選的Sp1 及Sp2 獨立地為單鍵、碳數1至6的伸烷基或一個-CH2 -經-O-取代的碳數1至6的伸烷基、或-OCOO-。進而優選為碳數1至6的伸烷基或-OCOO-。Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and in the alkylene group, at least one -CH 2 - may be via -O-, -CO-, -COO-, -OCO - or -OCOO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, in these groups, at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 Or -Sp 2 -P 2 substituted. Preferred Sp 1 and Sp 2 are independently a single bond, an alkylene group having 1 to 6 carbon atoms or a -CH 2 - alkylene group having 1 to 6 carbon atoms substituted with -O-, or -OCOO-. Furthermore, it is preferably an alkylene group having 1 to 6 carbon atoms or -OCOO-.

P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基。P 1 and P 2 are independently a group represented by any one of Formula (1b) to (1h).

優選的P1 及P2 獨立地為式(1b)、式(1c)、式(1d)及式(1e)的任一者所表示的基。

Figure 02_image055
Preferable P 1 and P 2 are independently a group represented by any one of formula (1b), formula (1c), formula (1d), and formula (1e).
Figure 02_image055

M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基,優選的M1 、M2 、M3 及M4 獨立地為氫、氟、甲基、乙基或三氟甲基。進而優選為氫。M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, an alkyl group with 1 to 5 carbon atoms, or an alkyl group with 1 to 5 carbon atoms in which at least one hydrogen is substituted by fluorine or chlorine, preferably M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluoro, methyl, ethyl or trifluoromethyl. More preferably, it is hydrogen.

R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述烷基中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代。R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbons, in the alkyl group, at least one hydrogen may be substituted by fluorine or chlorine, and at least one -CH 2 - may be substituted by -O-.

優選的R2 及R6 為氫、氟、甲基、乙基、甲氧基甲基或三氟甲基。進而優選為氫。Preferred R2 and R6 are hydrogen , fluorine, methyl, ethyl, methoxymethyl or trifluoromethyl. More preferably, it is hydrogen.

R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbon atoms, and among said R 3 , R 4 , R 5 and R 7 , at least one -CH 2 - may be through -O - or -S-substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no R 5 and R 7 are In the case of fluorine or chlorine.

優選的R3 、R4 、R5 及R7 獨立地為氫、碳數1至10的直鏈狀烷基、碳數2至10的直鏈狀烯基、碳數1至10的直鏈狀烷氧基或碳數3至6的環狀烷基。進而優選為氫、碳數2至6的直鏈狀烷基、碳數2至6的直鏈狀烯基、碳數1至5的直鏈狀烷氧基或碳數4至6的環狀烷基。Preferred R 3 , R 4 , R 5 and R 7 are independently hydrogen, straight-chain alkyl having 1 to 10 carbons, straight-chain alkenyl having 2 to 10 carbons, straight-chain having 1 to 10 carbons alkoxy or cyclic alkyl having 3 to 6 carbon atoms. Further preferred is hydrogen, a linear alkyl group having 2 to 6 carbon atoms, a linear alkenyl group having 2 to 6 carbon atoms, a linear alkoxy group having 1 to 5 carbon atoms, or a cyclic group having 4 to 6 carbon atoms. alkyl.

X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況。X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 9 , at least one -CH 2 - can be Substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but no R 9 is present In the case of fluorine or chlorine.

進而優選的基為式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)所表示的基。

Figure 02_image057
式(1b)至式(1h)中,M1 及M2 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基,X2 、X3 、X4 、X5 及X6 獨立地為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況。Further preferred groups are formula (1b-1), formula (1b-2), formula (1b-3), formula (1b-4), formula (1b-5), formula (1c-1), formula (1d) -1), the group represented by the formula (1d-2) or the formula (1e-1).
Figure 02_image057
In formulas (1b) to (1h), M 1 and M 2 are independently hydrogen, fluorine, chlorine, an alkyl group having 1 to 5 carbon atoms, or an alkyl group having 1 to 5 carbon atoms in which at least one hydrogen is substituted by fluorine or chlorine. Alkyl, X 2 , X 3 , X 4 , X 5 and X 6 are independently -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or carbon number 1 to 15 The alkyl group, in the R 9 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C- , at least one hydrogen can be replaced by fluorine or chlorine, but there is no case where R 9 is fluorine or chlorine.

化合物(1)的優選例為式(1-1)至式(1-3)。

Figure 02_image013
式(1-1)至式(1-3)中, 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸苯基、萘-2,6-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、式(A-1)或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2),Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況;
Figure 02_image007
Z2 、Z3 及Z4 獨立地為單鍵、-(CH2 )2 -、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,這些基中,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 02_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。Preferred examples of compound (1) are formula (1-1) to formula (1-3).
Figure 02_image013
In formula (1-1) to formula (1-3), ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-cyclohexylene, 1,4-phenylene, naphthalene -2,6-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl In a diradical, a radical represented by formula (A-1) or formula (A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be replaced by fluorine, chlorine, carbon atoms Alkyl of 1 to 12, alkenyl of carbon number 2 to 12, alkoxy of carbon number of 1 to 11, alkenyloxy of carbon number of 2 to 11, -Sp 1 -P 1 or -Sp 2 -P 2 substituted , in these alkyl groups, alkenyl groups, alkoxy groups, alkenyloxy groups, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine, wherein ring A 1 , ring A 2 , at least one of ring A 3 or ring A 4 is formula (A-1) or formula (A-2), and Q 1 and Q 2 are independently -CH 2 -, -O-, -N(R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least one -(CH 2 ) 2- can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or chlorine, but there is no situation that R 8 is fluorine or chlorine;
Figure 02_image007
Z 2 , Z 3 and Z 4 are independently a single bond, -(CH 2 ) 2 -, -C≡C-, -C≡CC≡C-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -CF=CF-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH -, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, in the alkylene group, At least one -CH 2 - can be substituted by -O-, -COO-, -OCOO- or -OCO-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, among these groups, at least one hydrogen Can be substituted by fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 , in the presence of multiple Sp 1 or Sp 2 , any two can be different; P 1 and P 2 are independently of the formula ( 1b) to the group represented by any one of the formula (1h), in the case of a plurality of P 1 or P 2 , any two may be different;
Figure 02_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine Alkyl having 1 to 5 carbons; X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or alkyl having 1 to 15 carbons, and R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen can be Fluorine or chlorine substitution, at least one -CH 2 - may be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, the R 3 , R 4 , R 5 and R 7 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one One hydrogen can be replaced by fluorine or chlorine, but there is no case where R5 and R7 are fluorine or chlorine.

式(1-1)、式(1-2)或式(1-3)所表示的化合物中,Z2 、Z3 或Z4 的任一個優選為-COO-或-OCO-。In the compound represented by formula (1-1), formula (1-2) or formula (1-3), any one of Z 2 , Z 3 or Z 4 is preferably -COO- or -OCO-.

化合物(1)優選為以下式所表示的化合物。

Figure 02_image021
Figure 02_image023
Figure 02_image025
Figure 02_image027
這些式中, Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經-Sp1 -P1 或-Sp2 -P2 取代; P1 、P2 、Sp1 及Sp2 以外的部分結構中,至少一個氫可經氟、氯、甲基或乙基取代; Q1 為-CH2 -或-N(-R8 )-,Q2 為-N(-R8 )-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況, P1 及P2 獨立地為式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)所表示的基;
Figure 02_image019
式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)中,X2 、X3 、X4 、X5 及X6 獨立地為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況。Compound (1) is preferably a compound represented by the following formula.
Figure 02_image021
Figure 02_image023
Figure 02_image025
Figure 02_image027
In these formulas, Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and in the Sp 1 and Sp 2 , at least one -CH 2 - may be through -O-, -COO-, -OCOO- or -OCO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, at least one hydrogen can be substituted by -Sp 1 -P 1 or -Sp 2 -P 2 ; P 1 , In partial structures other than P 2 , Sp 1 and Sp 2 , at least one hydrogen may be substituted by fluorine, chlorine, methyl or ethyl; Q 1 is -CH 2 - or -N(-R 8 )-, Q 2 is -N(-R 8 )-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least One -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine, P 1 and P 2 independently formula (1b-1), formula (1b-2), formula (1b-3), formula (1b-4), formula (1b-5), formula (1c-1), formula (1d-1) ), the base represented by formula (1d-2) or formula (1e-1);
Figure 02_image019
Equation (1b-1), Equation (1b-2), Equation (1b-3), Equation (1b-4), Equation (1b-5), Equation (1c-1), Equation (1d-1), Equation In (1d-2) or formula (1e-1), X 2 , X 3 , X 4 , X 5 and X 6 are independently -N(-R 9 )-, -O- or -S-, where , R 9 is hydrogen or an alkyl group with 1 to 15 carbon atoms, in said R 9 , at least one -CH 2 - can be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 9 is fluorine or chlorine.

另外,化合物(1)的具體例將在後述的實施例中敘述。In addition, specific examples of the compound (1) will be described in Examples to be described later.

式(2)至式(15)示出液晶組成物的成分化合物。化合物(2)至化合物(4)具有小的介電各向異性。化合物(5)至化合物(7)具有大的正介電各向異性。化合物(8)由於具有氰基,因此具有更大的正介電各向異性。化合物(9)至化合物(16)具有大的負介電各向異性。這些化合物的具體例將在下文敘述。Formulas (2) to (15) show component compounds of the liquid crystal composition. Compounds (2) to (4) have small dielectric anisotropy. Compounds (5) to (7) have large positive dielectric anisotropy. Compound (8) has a larger positive dielectric anisotropy because it has a cyano group. Compounds (9) to (16) have large negative dielectric anisotropy. Specific examples of these compounds will be described below.

化合物(16)中,P11 、P12 及P13 獨立地為聚合性基。In compound (16), P 11 , P 12 and P 13 are independently polymerizable groups.

優選的P11 、P12 及P13 為選自式(P-1)至式(P-5)所表示的基的群組中的聚合性基。進而優選的P11 、P12 及P13 為式(P-1)、式(P-2)或式(P-3)。特優選的式(P-1)為-OCO-CH=CH2 或-OCO-C(CH3 )=CH2 。式(P-1)至式(P-5)的波形線表示進行鍵結的部位。

Figure 02_image066
Preferable P 11 , P 12 and P 13 are polymerizable groups selected from the group of groups represented by formula (P-1) to formula (P-5). Further preferable P 11 , P 12 and P 13 are formula (P-1), formula (P-2) or formula (P-3). A particularly preferred formula (P-1) is -OCO-CH=CH 2 or -OCO-C(CH 3 )=CH 2 . The wavy lines in the formula (P-1) to the formula (P-5) indicate the part to be bonded.
Figure 02_image066

式(P-1)至式(P-5)中,M11 為氫、氟、氯或碳數1至5的烷基,所述M11 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代;M12 及M13 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基。 為了提高反應性,優選的M11 、M12 及M13 為氫或甲基。進而優選的M11 為甲基,進而優選的M12 及M13 為氫。In formula (P-1) to formula (P-5), M 11 is hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbons, and in said M 11 , at least one hydrogen may be substituted by fluorine or chlorine, at least One -CH 2 - may be substituted by -O-; M 12 and M 13 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbons, or at least one hydrogen with 1 to 5 carbons substituted with fluorine or chlorine the alkyl group. In order to improve reactivity, preferable M 11 , M 12 and M 13 are hydrogen or methyl. More preferable M 11 is methyl, and more preferable M 12 and M 13 are hydrogen.

Sp11 、Sp12 及Sp13 獨立地為單鍵或碳數1至10的伸烷基,所述Sp11 、Sp12 及Sp13 中,至少一個-CH2 -可經-O-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代。Sp 11 , Sp 12 and Sp 13 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and among the Sp 11 , Sp 12 and Sp 13 , at least one -CH 2 - may be via -O-, -COO -, -OCO- or -OCOO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine.

優選的Sp11 、Sp12 及Sp13 為單鍵。Preferred Sp 11 , Sp 12 and Sp 13 are single bonds.

環F及環I獨立地為環己基、環己烯基、苯基、1-萘基、2-萘基、四氫吡喃-2-基、1,3-二噁烷-2-基、嘧啶-2-基或吡啶-2-基,這些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代。Ring F and Ring I are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxan-2-yl, Pyrimidine-2-yl or pyridin-2-yl, in these rings, at least one hydrogen can be fluorine, chlorine, alkyl with 1 to 12 carbons, alkoxy with 1 to 12 carbons, or at least one hydrogen with fluorine or chlorine-substituted alkyl group having 1 to 12 carbon atoms.

優選的環F及環I為苯基。環G為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基或吡啶-2,5-二基,這些環中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代。特優選的環G為1,4-伸苯基或2-氟-1,4-伸苯基。Preferred ring F and ring I are phenyl. Ring G is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-1,2-diyl, naphthalene-1,3-diyl, naphthalene-1 ,4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1,8-diyl, naphthalene-2,3-diyl , naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2, 5-diyl or pyridine-2,5-diyl, in these rings, at least one hydrogen can be replaced by fluorine, chlorine, alkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons, or at least one hydrogen Substituted with alkyl having 1 to 12 carbons substituted with fluorine or chlorine. Particularly preferred ring G is 1,4-phenylene or 2-fluoro-1,4-phenylene.

Z22 及Z23 獨立地為單鍵或碳數1至10的伸烷基,所述伸烷基中,至少一個-CH2 -可經-O-、-CO-、-COO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-或-C(CH3 )=C(CH3 )-取代,這些基中,至少一個氫可經氟或氯取代。Z 22 and Z 23 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and in the alkylene group, at least one -CH 2 - may be via -O-, -CO-, -COO- or -OCO -Substituted, at least one -(CH 2 ) 2 - may be via -CH=CH-, -C(CH 3 )=CH-, -CH=C(CH 3 )- or -C(CH 3 )=C(CH 3 )-Substituted, in these groups, at least one hydrogen may be replaced by fluorine or chlorine.

優選的Z7 及Z8 為單鍵、-(CH2 )2 -、-CH2 O-、-OCH2 -、-COO-或-OCO-。進而優選的Z22 及Z23 為單鍵。Preferred Z 7 and Z 8 are a single bond, -(CH 2 ) 2 -, -CH 2 O-, -OCH 2 -, -COO- or -OCO-. More preferable Z 22 and Z 23 are single bonds.

u為0、1或2。u is 0, 1 or 2.

優選的u為0或1。f、g及h獨立地為0、1、2、3或4,而且f、g及h的和為1以上。優選的f、g或h為1或2。Preferably u is 0 or 1. f, g and h are independently 0, 1, 2, 3 or 4, and the sum of f, g and h is 1 or more. Preferred f, g or h are 1 or 2.

2.化合物(1)的合成 對化合物(1)的合成法進行說明。化合物(1)可通過將有機合成化學的方法適當組合來合成。未記載合成法的化合物通過《有機合成》(Organic Syntheses,約翰威立父子出版公司(John Wiley & Sons, Inc))、《有機反應》(Organic Reactions,約翰威立父子出版公司(John Wiley & Sons, Inc))、《綜合有機合成》(Comprehensive Organic Synthesis,培格曼出版公司(Pergamon Press))、《新實驗化學講座》(丸善)等書籍中所記載的方法來合成。2. Synthesis of compound (1) The synthesis method of compound (1) is demonstrated. Compound (1) can be synthesized by appropriately combining methods of synthetic organic chemistry. Compounds with undocumented syntheses were identified by Organic Syntheses (John Wiley & Sons, Inc), Organic Reactions (John Wiley & Sons) , Inc)), "Comprehensive Organic Synthesis" (Pergamon Press), "New Experimental Chemistry Lectures" (Maruzen) and other books to synthesize.

2-1.鍵結基Z1 、鍵結基Z2 、鍵結基Z3 、鍵結基Z4 及鍵結基Z5 的生成 生成化合物(1)中的鍵結基的方法的例子如下述流程所述。所述流程中,MSG1 (或MSG2 )為具有至少一個環的一價有機基。多個MSG1 (或MSG2 )所表示的一價有機基可相同,或可不同。化合物(1A)至化合物(1L)相當於化合物(1)或化合物(1)的中間體。2-1. Generation of Bonding Group Z 1 , Bonding Group Z 2 , Bonding Group Z 3 , Bonding Group Z 4 and Bonding Group Z 5 Examples of the method for generating the bonding group in compound (1) are as follows described in the process. In the scheme, MSG 1 (or MSG 2 ) is a monovalent organic group having at least one ring. The monovalent organic groups represented by a plurality of MSG 1 (or MSG 2 ) may be the same, or may be different. Compound (1A) to compound (1L) correspond to compound (1) or an intermediate of compound (1).

Figure 02_image068
Figure 02_image068

Figure 02_image070
Figure 02_image070

Figure 02_image072
Figure 02_image072

Figure 02_image074
Figure 02_image074

Figure 02_image076
Figure 02_image076

Figure 02_image078
Figure 02_image080
Figure 02_image078
Figure 02_image080

(I)單鍵的生成 在碳酸鹽、四(三苯基膦)鈀催化劑的存在下,使芳基硼酸(21)與化合物(22)進行反應來合成化合物(1A)。所述化合物(1A)也可以如下方式來合成:使化合物(23)與正丁基鋰進行反應,繼而與氯化鋅進行反應,然後在二氯雙(三苯基膦)鈀催化劑的存在下與化合物(22)進行反應。(I) Generation of single bonds Compound (1A) is synthesized by reacting arylboronic acid (21) with compound (22) in the presence of a carbonate and a tetrakis(triphenylphosphine)palladium catalyst. The compound (1A) can also be synthesized by reacting the compound (23) with n-butyllithium, followed by a reaction with zinc chloride, and then in the presence of a dichlorobis(triphenylphosphine)palladium catalyst React with compound (22).

(II)-COO-與-OCO-的生成 使化合物(23)與正丁基鋰進行反應,繼而與二氧化碳進行反應而獲得羧酸(24)。使所述羧酸(24)與由化合物(21)衍生出的苯酚(25)在1,3-二環己基碳二醯亞胺(1,3-dicyclohexylcarbodiimide,DCC)與4-二甲基胺基吡啶(4-dimethylamino pyridine,DMAP)的存在下脫水來合成具有-COO-的化合物(1B)。具有-OCO-的化合物也利用所述方法來合成。(II) Generation of -COO- and -OCO- The carboxylic acid (24) is obtained by reacting compound (23) with n-butyllithium and then reacting with carbon dioxide. The carboxylic acid (24) is combined with the phenol (25) derived from compound (21) in 1,3-dicyclohexylcarbodiimide (1,3-dicyclohexylcarbodiimide, DCC) with 4-dimethylamine Compound (1B) with -COO- was synthesized by dehydration in the presence of 4-dimethylamino pyridine (DMAP). Compounds with -OCO- were also synthesized using the method.

(III)-CF2 O-與-OCF2 -的生成 利用勞森試劑(Lawesson's reagent)對化合物(1B)進行硫化而獲得化合物(26)。利用氟化氫吡啶錯合物與N-溴琥珀醯亞胺(N-bromosuccinimide,NBS)對化合物(26)進行氟化而合成具有-CF2 O-的化合物(1C)。參照M.黑星(M. Kuroboshi)等人的《化學快報(Chem.Lett.)》1992年第827期。也可利用(二乙基胺基)三氟化硫((diethylamino)sulphur trifluoride,DAST)對化合物(26)進行氟化來合成化合物(1C)。參照W.H.班尼爾(W. H. Bunnelle)等人的《有機化學期刊(J.Org.Chem.)》1990年第55期第768頁。具有-OCF2 -的化合物也利用所述方法來合成。(III) Production of -CF 2 O- and -OCF 2 - Compound ( 26 ) is obtained by sulfurizing compound ( 1B ) with Lawesson's reagent. Compound (1C) having -CF 2 O- was synthesized by fluorination of compound (26) with hydrogen fluoride pyridine complex and N-bromosuccinimide (NBS). See M. Kuroboshi et al., Chem. Lett., 1992, No. 827. Compound (1C) can also be synthesized by fluorination of compound (26) with (diethylamino)sulphur trifluoride (DAST). See WH Bunnelle et al., J. Org. Chem., 1990, vol. 55, p. 768. Compounds with -OCF2- were also synthesized using the method described.

(IV)-CH=CH-的生成 使化合物(22)與正丁基鋰進行反應,繼而與N,N-二甲基甲醯胺(N,N-Dimethyl Formamide,DMF)進行反應而獲得醛(27)。使鏻鹽(28)與叔丁醇鉀進行反應而產生磷葉立德(phosphorus ylide),並使所述磷葉立德與醛(27)進行反應來合成化合物(1D)。因反應條件而生成順式體,因此視需要利用公知的方法將順式體異構化成反式體。(IV) Generation of -CH=CH- The aldehyde (27) is obtained by reacting the compound (22) with n-butyllithium and then with N,N-Dimethylformamide (N,N-Dimethyl Formamide, DMF). Compound (1D) is synthesized by reacting a phosphonium salt (28) with potassium tert-butoxide to produce a phosphorus ylide, and reacting the phosphorous ylide with an aldehyde (27). Since a cis isomer is produced depending on the reaction conditions, the cis isomer is isomerized into a trans isomer by a known method if necessary.

(V)-(CH2 )2 -的生成 在鈀碳催化劑的存在下,對化合物(1D)進行氫化而合成化合物(1E)。Formation of (V)-(CH 2 ) 2 - Compound (1E) is synthesized by hydrogenating compound (1D) in the presence of a palladium-carbon catalyst.

(VI)-C≡C-的生成 在二氯鈀與碘化銅的催化劑存在下,使化合物(23)與2-甲基-3-丁炔-2-醇進行反應,然後在鹼性條件下進行脫保護而獲得化合物(29)。在二氯雙(三苯基膦)鈀與鹵化銅的催化劑存在下,使化合物(29)與化合物(22)進行反應而合成化合物(1F)。(VI) Generation of -C≡C- Compound (23) is reacted with 2-methyl-3-butyn-2-ol in the presence of a catalyst of dichloropalladium and copper iodide, followed by deprotection under basic conditions to obtain compound (29) . Compound (1F) is synthesized by reacting compound (29) with compound (22) in the presence of a catalyst of dichlorobis(triphenylphosphine)palladium and copper halide.

(VII)-CH2 O-與-OCH2 -的生成 利用硼氫化鈉將化合物(27)還原而獲得化合物(30)。利用氫溴酸對其進行溴化而獲得化合物(31)。在碳酸鉀的存在下,使化合物(25)與化合物(31)進行反應而合成化合物(1G)。具有-OCH2 -的化合物也利用所述方法來合成。(VII) Production of -CH 2 O- and -OCH 2 - Compound (30) is obtained by reducing compound (27) with sodium borohydride. It is brominated with hydrobromic acid to obtain compound (31). Compound (1G) is synthesized by reacting compound (25) with compound (31) in the presence of potassium carbonate. Compounds with -OCH 2 - were also synthesized using the method described.

(VIII)-CF=CF-的生成 利用正丁基鋰對化合物(23)進行處理,然後使四氟乙烯進行反應而獲得化合物(32)。利用正丁基鋰對化合物(22)進行處理,然後與化合物(32)進行反應而合成化合物(1H)。(VIII) Generation of -CF=CF- Compound (32) is obtained by treating compound (23) with n-butyllithium and then reacting tetrafluoroethylene. Compound (22) is treated with n-butyllithium and then reacted with compound (32) to synthesize compound (1H).

(IX)-CH=CHCO-與-COCH=CH-的生成 在NaOH的存在下,通過化合物(40)與化合物(27)的醇醛縮合反應來合成化合物(1I)。(IX) Generation of -CH=CHCO- and -COCH=CH- Compound (1I) is synthesized by aldol condensation of compound (40) with compound (27) in the presence of NaOH.

(X)-CH=CHCOO-與-OCOCH=CH-的生成 使肉桂酸(41)與化合物(25)在1,3-二環己基碳二醯亞胺(DCC)與4-二甲基胺基吡啶(DMAP)的存在下脫水來合成化合物(1J)。(X) Generation of -CH=CHCOO- and -OCOCH=CH- Compound (1J) is synthesized by dehydrating cinnamic acid (41) and compound (25) in the presence of 1,3-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP).

(X)-CH=CHCOS-與-SCOCH=CH-的生成 使肉桂酸(41)與化合物(26)在1,3-二環己基碳二醯亞胺(DCC)與4-二甲基胺基吡啶(DMAP)的存在下脫水來合成化合物(1K)。(X) Generation of -CH=CHCOS- and -SCOCH=CH- Compound (1K) is synthesized by dehydrating cinnamic acid (41) and compound (26) in the presence of 1,3-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP).

(XI)-COS-與-SCO-的生成 使羧酸(24)與化合物(26)在1,3-二環己基碳二醯亞胺(DCC)與4-二甲基胺基吡啶(DMAP)的存在下脫水來合成化合物(1L)。(XI) Generation of -COS- and -SCO- Compound (1L) is synthesized by dehydrating carboxylic acid (24) and compound (26) in the presence of 1,3-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP).

2-2.環A1 、環A2 、環A3 及環A4 的生成 關於1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、2-氟-1,4-伸苯基、2-甲基-1,4-伸苯基、2-乙基-1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、9,10-二氫菲-2,7-二基、5,6-二氫菲啶-3,8-二基、6(5H)-菲啶酮(phenanthridinone)-3,8-二基等環,起始物質有市售或合成法廣為人知。2-2. Generation of Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 Fluoro-1,4-phenylene, 2-methyl-1,4-phenylene, 2-ethyl-1,4-phenylene, naphthalene-2,6-diyl, decalin-2 ,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl base, pyrimidine-2,5-diyl, pyridine-2,5-diyl, perhydrocyclopento[a]phenanthrene-3,17-diyl, 2,3,4,7,8,9,10 ,11,12,13,14,15,16,17-Tetrahydrocyclopenta[a]phenanthrene-3,17-diyl, 9,10-dihydrophenanthrene-2,7-diyl, 5, Rings such as 6-dihydrophenanthridine-3,8-diyl and 6(5H)-phenanthridinone-3,8-diyl, starting materials are commercially available or synthetic methods are widely known.

2-3.連結基Sp1 或連結基Sp2 及聚合性基P1 或聚合性基P2 的生成 聚合性基P1 或聚合性基P2 的優選例為丙烯酸酯(1b)、順丁烯二醯亞胺(1c)、衣康酸酯(1d)、乙烯酯(1e)、式(1f)、氧雜環丙基(1g)或乙烯氧基(1h)。

Figure 02_image082
2-3. Formation of the linking group Sp 1 or the linking group Sp 2 and the polymerizable group P 1 or the polymerizable group P 2 Preferred examples of the polymerizable group P 1 or the polymerizable group P 2 are acrylate (1b), cis-butyl enediimide (1c), itaconate (1d), vinyl ester (1e), formula (1f), oxane (1g) or vinyloxy (1h).
Figure 02_image082

合成所述聚合性基通過連結基Sp1 或連結基Sp2 而鍵結於環上的化合物的方法的例子如下所述。首先,示出連結基Sp1 或連結基Sp2 為單鍵的例子。An example of a method for synthesizing a compound in which the polymerizable group is bonded to the ring via the linking group Sp 1 or the linking group Sp 2 is as follows. First, an example in which the linking group Sp 1 or the linking group Sp 2 is a single bond is shown.

(1)為單鍵的化合物的合成 Sp1 或Sp2 為單鍵的化合物的合成方法如下述流程所述。所述流程中,MSG1 為具有至少一個環的一價有機基。化合物(1S)至化合物(1X)相當於化合物(1)。在聚合性基為丙烯酸酯或丙烯醯胺衍生物的情況下,是通過相對應的丙烯酸與HO-MSG1 或HNR9 -MSG1 的酯化或醯胺化來合成。乙烯氧基是通過HO-MSG1 與溴乙烯的醚化來合成。氧雜環丙基是通過末端雙鍵的氧化來合成。順丁烯二醯亞胺基是通過胺基與順丁烯二酸酐的反應來合成。衣康酸酯是通過相對應的衣康酸與HO-MSG1 的酯化來合成。乙烯酯是通過乙酸乙烯酯與HOOC-MSG1 的酯交換反應來合成。(1) Synthesis of Compounds in which Sp 1 or Sp 2 are Single Bonds The methods for synthesizing compounds in which Sp 1 or Sp 2 are single bonds are as described in the following scheme. In the scheme, MSG 1 is a monovalent organic group having at least one ring. Compound (1S) to compound (1X) correspond to compound (1). When the polymerizable group is an acrylate or acrylamide derivative, it is synthesized by esterification or amidation of the corresponding acrylic acid with HO-MSG 1 or HNR 9 -MSG 1 . Ethyleneoxy was synthesized by etherification of HO-MSG 1 with vinyl bromide. The oxane group is synthesized by oxidation of the terminal double bond. The maleimide group is synthesized by the reaction of the amine group with maleic anhydride. Itaconic acid esters were synthesized by esterification of the corresponding itaconic acid with HO-MSG 1 . Vinyl esters were synthesized by transesterification of vinyl acetate with HOOC-MSG 1 .

Figure 02_image084
Figure 02_image084

Figure 02_image086
Figure 02_image086

Figure 02_image088
Figure 02_image088

以上敘述了連結基Sp1 或連結基Sp2 為單鍵的化合物的合成法。生成其他連結基的方法可參考鍵結基Z1 、鍵結基Z2 、鍵結基Z3 、鍵結基Z4 及鍵結基Z5 的合成法來合成。The synthesis method of the compound in which the linking group Sp 1 or the linking group Sp 2 is a single bond has been described above. The method for generating other linking groups can be synthesized by referring to the synthesis method of the bonding group Z 1 , the bonding group Z 2 , the bonding group Z 3 , the bonding group Z 4 , and the bonding group Z 5 .

2-4.合成例 合成化合物(1)的方法的例子如下所述。這些化合物中,MES為具有至少一個環的液晶原基。P1 、M1 、M2 、Sp1 及Sp2 的定義與所述相同。 化合物(51A)及化合物(51B)有市售或可將具有適當的環結構的液晶原(MES)作為起始物質並依據通常的有機合成法來合成。 在合成MES與Sp1 以醚鍵連結的化合物的情況下,通過將化合物(51A)作為起始物質並使用化合物(52)及氫氧化鉀等鹼來進行醚化,可獲得化合物(53A)。另外,在合成MES與Sp1 以單鍵連結的化合物的情況下,通過將化合物(51B)作為起始物質並使用化合物(52)、鈀等金屬催化劑及鹼來進行交叉偶合反應,可獲得化合物(53B)。化合物(53A)或化合物(53B)視需要而有時衍生為使三甲基矽烷基(Trimethylsilyl,TMS)、四氫吡喃基(Tetrahydropyranyl,THP)等保護基發揮作用的化合物(54A)或化合物(54B)。 其後,由化合物(53A)、化合物(53B)、化合物(54A)或化合物(54B)並在化合物(55)及氫氧化鉀等鹼的存在下再次進行醚化,由此可獲得化合物(57A)或化合物(57B)。此時,在於前階段使保護基發揮作用的情況下,通過脫保護反應來去除保護基。2-4. Synthesis Examples Examples of the method for synthesizing the compound (1) are as follows. Among these compounds, MES is a mesogen group having at least one ring. The definitions of P 1 , M 1 , M 2 , Sp 1 and Sp 2 are the same as described above. Compound (51A) and compound (51B) are commercially available or can be synthesized according to a usual organic synthesis method using mesogen (MES) having an appropriate ring structure as a starting material. When synthesizing a compound in which MES and Sp 1 are linked by an ether bond, compound (53A) can be obtained by etherifying compound (52) and a base such as potassium hydroxide using compound (51A) as a starting material. In addition, when synthesizing a compound in which MES and Sp 1 are linked by a single bond, a compound (51B) can be obtained by performing a cross-coupling reaction using compound (52), a metal catalyst such as palladium, and a base using compound (51B) as a starting material. (53B). The compound (53A) or the compound (53B) is sometimes derived as a compound (54A) or a compound in which a protecting group such as trimethylsilyl (TMS) and tetrahydropyranyl (THP) functions as necessary. (54B). Then, compound (57A) can be obtained by etherifying compound (53A), compound (53B), compound (54A) or compound (54B) again in the presence of compound (55) and a base such as potassium hydroxide. ) or compound (57B). At this time, when the protective group is made to function in the previous stage, the protective group is removed by a deprotection reaction.

Figure 02_image090
P2 例如為式(1b-3)所表示的基的化合物(1)可由化合物(57)並利用以下方法來合成。由化合物(57)並在化合物(58)、DCC及DMAP的存在下進行酯化反應,由此可衍生為化合物(1Y)。
Figure 02_image092
Figure 02_image090
Compound (1) in which P 2 is, for example, a group represented by formula (1b-3) can be synthesized from compound (57) by the following method. Compound (1Y) can be derived from compound (57) by performing an esterification reaction in the presence of compound (58), DCC and DMAP.
Figure 02_image092

3.液晶組成物 本發明的實施方式的液晶組成物包含化合物(1)作為成分A。化合物(1)可通過與元件的基板的非共價鍵結方式的相互作用來有助於液晶分子的配向的控制。所述組成物優選為包含化合物(1)作為成分A,且還包含選自以下所示的成分B、成分C、成分D及成分E中的液晶性化合物。成分B為化合物(2)至化合物(4)。成分C為化合物(5)至化合物(7)。成分D為化合物(8)。成分E為化合物(9)至化合物(16)。所述組成物也可包含與化合物(2)至化合物(16)不同的其他液晶性化合物。當製備所述組成物時,優選為考慮到正或負的介電各向異性的大小等來選擇成分B、成分C、成分D及成分E。適當選擇了成分的組成物具有高的上限溫度、低的下限溫度、小的黏度、適當的光學各向異性(即,大的光學各向異性或小的光學各向異性)、大的正或負介電各向異性、大的比電阻、對熱或紫外線的穩定性及適當的彈性常數(即,大的彈性常數或小的彈性常數)。3. Liquid crystal composition The liquid crystal composition of the embodiment of the present invention contains the compound (1) as the component A. The compound (1) contributes to the control of the alignment of the liquid crystal molecules by the interaction with the substrate of the element in a non-covalent bonding manner. The composition preferably contains the compound (1) as the component A, and further contains a liquid crystal compound selected from the group consisting of the component B, the component C, the component D, and the component E shown below. Ingredient B is compound (2) to compound (4). Ingredient C is compound (5) to compound (7). Ingredient D is compound (8). Ingredient E is compound (9) to compound (16). The composition may also contain other liquid crystal compounds other than the compounds (2) to (16). When preparing the composition, it is preferable to select Component B, Component C, Component D, and Component E in consideration of the magnitude of positive or negative dielectric anisotropy and the like. A composition with appropriately selected components has a high upper limit temperature, a low lower limit temperature, a small viscosity, an appropriate optical anisotropy (ie, a large optical anisotropy or a small optical anisotropy), a large positive or Negative dielectric anisotropy, large specific resistance, stability to heat or ultraviolet light, and appropriate elastic constant (ie, large elastic constant or small elastic constant).

為了維持對紫外線的高穩定性,基於液晶組成物的重量,化合物(1)的優選比例通常為約0.01重量%以上,為了溶解於液晶組成物中,化合物(1)的優選比例通常為約10重量%以下。基於液晶組成物的重量,進而優選的比例為約0.1重量%至約5重量%的範圍。基於液晶組成物的重量,最優選的比例為約0.5重量%至約3重量%的範圍。In order to maintain high stability to ultraviolet rays, the preferred ratio of compound (1) is usually about 0.01% by weight or more based on the weight of the liquid crystal composition, and the preferred ratio of compound (1) is usually about 10% in order to dissolve in the liquid crystal composition. % by weight or less. A further preferred ratio is in the range of about 0.1% by weight to about 5% by weight based on the weight of the liquid crystal composition. The most preferred ratio is in the range of about 0.5 wt % to about 3 wt % based on the weight of the liquid crystal composition.

成分B是兩個末端基為烷基等的化合物。作為成分B的優選例,可列舉:化合物(2-1)至化合物(2-11)、化合物(3-1)至化合物(3-19)及化合物(4-1)至化合物(4-7)。成分B的化合物中,R11 及R12 獨立地為碳數1至10的烷基或碳數2至10的烯基,所述烷基或烯基中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代。Component B is a compound whose two terminal groups are alkyl groups or the like. Preferred examples of component B include compound (2-1) to compound (2-11), compound (3-1) to compound (3-19), and compound (4-1) to compound (4-7) ). In the compound of component B, R 11 and R 12 are independently an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in the alkyl or alkenyl group, at least one -CH 2 - may be through - O-substituted, at least one hydrogen may be replaced by fluorine.

Figure 02_image094
Figure 02_image094

成分B由於介電各向異性的絕對值小,因此為接近中性的化合物。化合物(2)主要在減少黏度或調整光學各向異性的方面有效果。化合物(3)及化合物(4)具有通過提高上限溫度而擴大向列相的溫度範圍的效果,或在調整光學各向異性的方面有效果。Component B is a nearly neutral compound because the absolute value of the dielectric anisotropy is small. Compound (2) is mainly effective in reducing viscosity or adjusting optical anisotropy. Compound (3) and compound (4) have the effect of expanding the temperature range of the nematic phase by increasing the upper limit temperature, or have the effect of adjusting the optical anisotropy.

隨著使成分B的含量增加,組成物的介電各向異性變小,但黏度變小。因此,只要滿足元件的閾電壓的要求值,則含量以多為宜。在製備IPS、VA等模式用的組成物的情況下,基於液晶組成物的重量,成分B的含量優選為30重量%以上,進而優選為40重量%以上。As the content of component B is increased, the dielectric anisotropy of the composition decreases, but the viscosity decreases. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content should be large. When preparing compositions for modes such as IPS and VA, the content of component B is preferably 30% by weight or more, and more preferably 40% by weight or more, based on the weight of the liquid crystal composition.

成分C是在右末端具有氟、氯或含氟基的化合物(5)至化合物(7)。作為成分C的優選例,可列舉:化合物(5-1)至化合物(5-16)、化合物(6-1)至化合物(6-120)、化合物(7-1)至化合物(7-62)。成分C的化合物中,R13 為碳數1至10的烷基或碳數2至10的烯基,所述烷基及烯基中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代;X11 為氟、氯、-OCF3 、-OCHF2 、-CF3 、-CHF2 、-CH2 F、-OCF2 CHF2 或-OCF2 CHFCF3Component C is compound (5) to compound (7) having fluorine, chlorine or a fluorine-containing group at the right terminal. Preferred examples of component C include compound (5-1) to compound (5-16), compound (6-1) to compound (6-120), compound (7-1) to compound (7-62) ). In the compound of component C, R 13 is an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms. One hydrogen may be substituted with fluorine ; X11 is fluorine, chlorine, -OCF3 , -OCHF2 , -CF3 , -CHF2 , -CH2F , -OCF2CHF2 or -OCF2CHFCF3 .

Figure 02_image096
Figure 02_image096

Figure 02_image098
Figure 02_image098

Figure 02_image100
Figure 02_image100

Figure 02_image102
Figure 02_image104
Figure 02_image102
Figure 02_image104

Figure 02_image106
Figure 02_image106

Figure 02_image108
Figure 02_image110
Figure 02_image108
Figure 02_image110

成分C由於介電各向異性為正,且對熱、光等的穩定性非常優異,因此用於製備IPS、FFS、OCB等模式用的組成物的情況。基於液晶組成物的重量,成分C的含量合適的是1重量%至99重量%的範圍,優選為10重量%至97重量%的範圍,進而優選為40重量%至95重量%的範圍。在將成分C添加至介電各向異性為負的組成物中的情況下,基於液晶組成物的重量,成分C的含量優選為30重量%以下。通過添加成分C,可調整組成物的彈性常數,並可調整元件的電壓-透過率曲線。Component C has positive dielectric anisotropy and is very excellent in stability to heat, light, and the like, so it is used in the preparation of compositions for modes such as IPS, FFS, and OCB. The content of Component C is suitably in the range of 1 to 99% by weight, preferably in the range of 10 to 97% by weight, and more preferably in the range of 40 to 95% by weight, based on the weight of the liquid crystal composition. When Component C is added to a composition having a negative dielectric anisotropy, the content of Component C is preferably 30% by weight or less based on the weight of the liquid crystal composition. By adding component C, the elastic constant of the composition can be adjusted, and the voltage-transmittance curve of the element can be adjusted.

成分D是右末端基為-C≡N或-C≡C-C≡N的化合物(8)。作為成分D的優選例,可列舉化合物(8-1)至化合物(8-64)。成分D的化合物中,R14 為碳數1至10的烷基或碳數2至10的烯基,所述烷基及烯基中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代;X12 為-C≡N或-C≡C-C≡N。Component D is a compound (8) whose right terminal group is -C≡N or -C≡CC≡N. Preferable examples of component D include compound (8-1) to compound (8-64). In the compound of component D, R 14 is an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms. One hydrogen may be replaced by fluorine; X 12 is -C≡N or -C≡CC≡N.

Figure 02_image112
Figure 02_image112

Figure 02_image114
Figure 02_image114

成分D由於介電各向異性為正,且其值大,因此主要用於製備TN等模式用的組成物的情況。通過添加所述成分D,可增大組成物的介電各向異性。成分D帶來擴大液晶相的溫度範圍、調整黏度或調整光學各向異性的效果。成分D對於調整元件的電壓-透過率曲線而言也有用。Since the dielectric anisotropy of component D is positive and its value is large, it is mainly used when preparing a composition for modes such as TN. By adding the component D, the dielectric anisotropy of the composition can be increased. Component D brings about the effect of expanding the temperature range of the liquid crystal phase, adjusting the viscosity, or adjusting the optical anisotropy. Component D is also useful for adjusting the voltage-transmittance curve of the element.

在製備TN等模式用的組成物的情況下,基於液晶組成物的重量,成分D的含量合適的是1重量%至99重量%的範圍,優選為10重量%至97重量%的範圍,進而優選為40重量%至95重量%的範圍。在將成分D添加至介電各向異性為負的組成物中的情況下,基於液晶組成物的重量,成分D的含量優選30重量%以下。通過添加成分D,可調整組成物的彈性常數,並可調整元件的電壓-透過率曲線。In the case of preparing a composition for modes such as TN, the content of the component D is suitably in the range of 1% by weight to 99% by weight, preferably in the range of 10% by weight to 97% by weight, based on the weight of the liquid crystal composition, and further It is preferably in the range of 40% by weight to 95% by weight. When Component D is added to a composition having a negative dielectric anisotropy, the content of Component D is preferably 30% by weight or less based on the weight of the liquid crystal composition. By adding component D, the elastic constant of the composition can be adjusted, and the voltage-transmittance curve of the element can be adjusted.

成分E為化合物(9)至化合物(16)。這些化合物具有如2,3-二氟-1,4-伸苯基那樣側位(lateral position)經兩個氟或氯取代的伸苯基。Ingredient E is compound (9) to compound (16). These compounds have phenylene substituted with two fluorine or chlorine in the lateral position like 2,3-difluoro-1,4-phenylene.

作為成分E的優選例,可列舉:化合物(9-1)至化合物(9-8)、化合物(10-1)至化合物(10-17)、化合物(11-1)、化合物(12-1)至化合物(12-3)、化合物(13-1)至化合物(13-11)、化合物(14-1)至化合物(14-3)、化合物(15-1)至化合物(15-3)及化合物(16-1)至化合物(16-3)。成分E的化合物中,R15 及R16 獨立地為碳數1至10的烷基或碳數2至10的烯基,所述烷基及烯基中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代;R17 為氫、氟、碳數1至10的烷基或碳數2至10的烯基,所述烷基及烯基中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代。Preferred examples of component E include compound (9-1) to compound (9-8), compound (10-1) to compound (10-17), compound (11-1), compound (12-1) ) to compound (12-3), compound (13-1) to compound (13-11), compound (14-1) to compound (14-3), compound (15-1) to compound (15-3) and compound (16-1) to compound (16-3). In the compound of component E, R 15 and R 16 are independently an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms. O-substituted, at least one hydrogen can be substituted by fluorine; R 17 is hydrogen, fluorine, alkyl with 1 to 10 carbons or alkenyl with 2 to 10 carbons, among the alkyl and alkenyl, at least one -CH 2 - may be substituted with -O-, at least one hydrogen may be substituted with fluorine.

Figure 02_image116
Figure 02_image116

Figure 02_image118
Figure 02_image118

成分E的介電各向異性為負且大。成分E用於製備IPS、VA、PSA等模式用的組成物的情況。隨著使成分E的含量增加,組成物的介電各向異性為負且變大,但黏度變大。因此,只要滿足元件的閾電壓的要求值,則含量以少為宜。當考慮到介電各向異性為-5左右時,為了進行充分的電壓驅動,基於液晶組成物的重量,成分E的含量優選為40重量%以上。The dielectric anisotropy of the component E is negative and large. Component E is used in the preparation of modal compositions such as IPS, VA, and PSA. As the content of the component E is increased, the dielectric anisotropy of the composition becomes negative and increases, but the viscosity increases. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content should be small. Considering that the dielectric anisotropy is about -5, the content of Component E is preferably 40% by weight or more based on the weight of the liquid crystal composition in order to perform sufficient voltage driving.

成分E中,化合物(9)為二環化合物,因此主要在減少黏度、調整光學各向異性或增加介電各向異性的方面有效果。化合物(10)及化合物(11)為三環化合物,因此具有提高上限溫度、增大光學各向異性或增大介電各向異性的效果。化合物(12)至化合物(16)具有增大介電各向異性的效果。Among the components E, since the compound (9) is a bicyclic compound, it is mainly effective in reducing the viscosity, adjusting the optical anisotropy, or increasing the dielectric anisotropy. Since compound (10) and compound (11) are tricyclic compounds, they have the effect of increasing the upper limit temperature, increasing the optical anisotropy, or increasing the dielectric anisotropy. Compounds (12) to (16) have an effect of increasing the dielectric anisotropy.

成分F為化合物(DB-1)及化合物(DB-2)。這些化合物具有如1,8-二氟-2,7-二苯并噻吩那樣側位經兩個氟或氯取代的二苯并噻吩結構、1,8-二氟-2,7-二苯并呋喃結構等。作為成分F的優選例,可列舉化合物(DB-1-1)至化合物(DB-1-14)及化合物(DB-2-1)至化合物(DB-2-9)。作為成分F的進而優選的例子,可列舉化合物(DB-1-1)至化合物(DB-1-14)。 成分F的化合物中,R100 獨立地為氫、碳數1至10的直鏈烷基、碳數3至10的分支鏈烷基或碳數2至10的烯基,所述R100 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代,R200 獨立地為碳數1至10的直鏈烷基、碳數3至10的分支鏈烷基或碳數2至10的烯基,所述R200 中,至少一個-CH2 -可經-O-或-S-取代,至少一個氫可經氟取代。Component F is compound (DB-1) and compound (DB-2). These compounds have the structure of dibenzothiophene substituted with two fluorines or chlorines on the side like 1,8-difluoro-2,7-dibenzothiophene, 1,8-difluoro-2,7-dibenzothiophene Furan structure, etc. Preferred examples of Component F include Compound (DB-1-1) to Compound (DB-1-14) and Compound (DB-2-1) to Compound (DB-2-9). Further preferable examples of Component F include compound (DB-1-1) to compound (DB-1-14). In the compound of component F, R 100 is independently hydrogen, straight-chain alkyl having 1 to 10 carbons, branched alkyl having 3 to 10 carbons, or alkenyl having 2 to 10 carbons, and in said R 100 , At least one -CH 2 - can be substituted by -O-, at least one hydrogen can be substituted by fluorine, R 200 is independently a straight chain alkyl group with 1 to 10 carbons, a branched chain alkyl group with 3 to 10 carbons or a carbon number The alkenyl group of 2 to 10, in the R 200 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one hydrogen may be substituted by fluorine.

Figure 02_image120
Figure 02_image120

Figure 02_image122
Figure 02_image122

Figure 02_image124
Figure 02_image124

成分E及成分F的介電各向異性為負且大。成分E及成分F可用於製備IPS、FFS、VA、PSA等模式用的組成物的情況。隨著使成分E及成分F的合計含量增加,組成物的介電各向異性為負且變大,但黏度變大。因此,只要滿足元件的閾電壓的要求值,則含量以少為宜。當考慮到介電各向異性為-5左右時,為了進行充分的電壓驅動,基於液晶組成物的重量,成分E及成分F的合計含量優選為40重量%以上。 成分F具有二苯并噻吩、二苯并呋喃、二苯并芴等縮合環結構。主要有提高上限溫度、增大光學各向異性或增大介電各向異性的效果。另外,由於為縮合環結構且也可具有雜原子,因此認為有較其他液晶性化合物而言極性變高的傾向,因此推斷與配向控制層形成單體的相容性相對變高。基於液晶組成物的重量,優選的成分F的含量為1重量%至20重量%的範圍。基於液晶組成物的重量,更優選的成分F的含量為3重量%至20重量%的範圍。進而優選的成分F的含量為3重量%至15重量%的範圍。The dielectric anisotropy of Component E and Component F is negative and large. Component E and Component F can be used in the preparation of modal compositions such as IPS, FFS, VA, and PSA. As the total content of Component E and Component F is increased, the dielectric anisotropy of the composition becomes negative and increases, but the viscosity increases. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content should be small. Considering that the dielectric anisotropy is about -5, the total content of Component E and Component F is preferably 40% by weight or more based on the weight of the liquid crystal composition in order to perform sufficient voltage driving. Component F has a condensed ring structure such as dibenzothiophene, dibenzofuran, and dibenzofluorene. It mainly has the effect of increasing the upper limit temperature, increasing the optical anisotropy or increasing the dielectric anisotropy. In addition, since it is a condensed ring structure and may have a hetero atom, it is considered that the polarity tends to be higher than that of other liquid crystal compounds, so it is estimated that the compatibility with the alignment control layer-forming monomer is relatively higher. The preferable content of Component F is in the range of 1% by weight to 20% by weight based on the weight of the liquid crystal composition. A more preferable content of the component F is in the range of 3% by weight to 20% by weight based on the weight of the liquid crystal composition. A more preferable content of the component F is in the range of 3% by weight to 15% by weight.

成分E中,化合物(9)為二環化合物,因此主要在減小黏度、調整光學各向異性或增加介電各向異性的方面有效果。化合物(10)及化合物(11)為三環化合物,因此有提高上限溫度、增大光學各向異性或增大介電各向異性的效果。化合物(12)至化合物(15)有增大介電各向異性的效果。Among the components E, since the compound (9) is a bicyclic compound, it is mainly effective in reducing the viscosity, adjusting the optical anisotropy, or increasing the dielectric anisotropy. The compound (10) and the compound (11) are tricyclic compounds, and therefore have the effect of increasing the upper limit temperature, increasing the optical anisotropy, or increasing the dielectric anisotropy. Compounds (12) to (15) have the effect of increasing the dielectric anisotropy.

在製備IPS、VA、PSA等模式用的組成物的情況下,基於液晶組成物的重量,成分E及成分F的合計含量優選為40重量%以上,進而優選為50重量%至95重量%的範圍。在將成分E及成分F添加至介電各向異性為正的組成物中的情況下,基於液晶組成物的重量,成分E及成分F的合計含量優選為30重量%以下。通過添加成分E及成分F,可調整組成物的彈性常數,並可調整元件的電壓-透過率曲線。When preparing compositions for modes such as IPS, VA, and PSA, the total content of component E and component F is preferably 40% by weight or more, and more preferably 50% by weight to 95% by weight, based on the weight of the liquid crystal composition. scope. When Component E and Component F are added to a composition having positive dielectric anisotropy, the total content of Component E and Component F is preferably 30% by weight or less based on the weight of the liquid crystal composition. By adding component E and component F, the elastic constant of the composition can be adjusted, and the voltage-transmittance curve of the element can be adjusted.

通過適當組合以上所述的成分B、成分C、成分D及成分E,可製備滿足上限溫度高、下限溫度低、黏度小、光學各向異性適當、正或負的介電各向異性大、比電阻大、對紫外線的穩定性高、對熱的穩定性高、彈性常數大等特性的至少一種的液晶組成物。視需要也可添加與成分B、成分C、成分D及成分E不同的液晶性化合物。By properly combining the components B, C, D, and E described above, it is possible to prepare materials that satisfy the requirements of high upper limit temperature, low minimum temperature, low viscosity, appropriate optical anisotropy, large positive or negative dielectric anisotropy, A liquid crystal composition having at least one of characteristics such as high specific resistance, high stability to ultraviolet rays, high thermal stability, and high elastic constant. A liquid crystal compound different from the component B, the component C, the component D, and the component E may be added as necessary.

液晶組成物可利用公知的方法來製備。例如,將成分化合物混合,然後通過加熱而使其相互溶解。也可根據用途而在所述組成物中添加添加物。添加物的例子為式(1)及式(16)以外的聚合性化合物、聚合起始劑、聚合抑制劑、光學活性化合物、抗氧化劑、紫外線吸收劑、光穩定劑、熱穩定劑、消泡劑等。此種添加物已為本技術領域具通常知識者所熟知,並在文獻中有記載。The liquid crystal composition can be prepared by a known method. For example, the component compounds are mixed and then heated to dissolve each other. Additives may be added to the composition according to the application. Examples of additives are polymerizable compounds other than formula (1) and formula (16), polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, ultraviolet absorbers, light stabilizers, heat stabilizers, antifoaming agents agent, etc. Such additives are well known to those of ordinary skill in the art and are documented in the literature.

聚合性化合物是出於在液晶組成物中生成聚合物的目的而添加。在對電極間施加電壓的狀態下照射紫外線,而使聚合性化合物與化合物(1)進行共聚,由此在液晶組成物中生成聚合物。此時,化合物(1)在極性基與玻璃(或金屬氧化物)的基板表面以非共價鍵結的方式相互作用的狀態下加以固定。由此,控制液晶分子的配向的能力進一步提高,同時化合物(1)不會漏出至液晶組成物中。另外,在玻璃(或金屬氧化物)的基板表面上也可獲得適當的預傾,因此可獲得響應時間縮短且電壓保持率大的液晶顯示元件。The polymerizable compound is added for the purpose of generating a polymer in the liquid crystal composition. A polymer is formed in the liquid crystal composition by irradiating ultraviolet rays in a state where a voltage is applied between the electrodes to copolymerize the polymerizable compound and the compound (1). At this time, the compound (1) is immobilized in a state in which the polar group interacts with the substrate surface of the glass (or metal oxide) in a non-covalent bond manner. Thereby, the ability to control the alignment of the liquid crystal molecules is further improved, and the compound (1) does not leak into the liquid crystal composition. In addition, an appropriate pretilt can be obtained also on the surface of the glass (or metal oxide) substrate, so that a liquid crystal display element with a shortened response time and a large voltage holding ratio can be obtained.

聚合性化合物的優選例為丙烯酸酯、甲基丙烯酸酯、乙烯基化合物、乙烯氧基化合物、丙烯基醚、環氧化合物(氧雜環丙烷、氧雜環丁烷)及乙烯基酮。進而優選的例子為具有至少一個丙烯醯氧基的化合物及具有至少一個甲基丙烯醯氧基的化合物。進而優選的例子中也包含具有丙烯醯氧基與甲基丙烯醯氧基這兩者的化合物。Preferable examples of the polymerizable compound are acrylates, methacrylates, vinyl compounds, vinyloxy compounds, propenyl ethers, epoxy compounds (oxiranes, oxetanes), and vinyl ketones. Further preferred examples are compounds having at least one acryloxy group and compounds having at least one methacryloyloxy group. Further preferred examples include compounds having both acryloxy and methacryloyloxy groups.

聚合性化合物的進而優選的例子為化合物(M-1)至化合物(M-17)。化合物(M-1)至化合物(M-17)中,R25 至R31 獨立地為氫或甲基;s、v及x獨立地為0或1;t及u獨立地為1至10的整數;L21 至L26 獨立地為氫或氟,L27 及L28 獨立地為氫、氟或甲基。Further preferred examples of the polymerizable compound are compound (M-1) to compound (M-17). In compounds (M-1) to (M-17), R 25 to R 31 are independently hydrogen or methyl; s, v and x are independently 0 or 1; t and u are independently 1 to 10 Integer; L 21 to L 26 are independently hydrogen or fluorine, and L 27 and L 28 are independently hydrogen, fluorine or methyl.

Figure 02_image126
Figure 02_image126

聚合性化合物可通過添加聚合起始劑而迅速聚合。通過使反應溫度最佳化,可減少殘存的聚合性化合物的量。光自由基聚合起始劑的例子為巴斯夫(BASF)公司的達羅固(Darocure)系列中的TPO、1173及4265;豔佳固(Irgacure)系列中的184、369、500、651、784、819、907、1300、1700、1800、1850及2959。The polymerizable compound can be rapidly polymerized by adding a polymerization initiator. By optimizing the reaction temperature, the amount of the remaining polymerizable compound can be reduced. Examples of photo-radical polymerization initiators are TPO, 1173 and 4265 in the Darocure series of BASF; 184, 369, 500, 651, 784, 819, 907, 1300, 1700, 1800, 1850 and 2959.

光自由基聚合起始劑的追加例為4-甲氧基苯基-2,4-雙(三氯甲基)三嗪、2-(4-丁氧基苯乙烯基)-5-三氯甲基-1,3,4-噁二唑、9-苯基吖啶、9,10-苯并吩嗪、二苯甲酮/米其勒酮混合物、六芳基聯咪唑/巰基苯并咪唑混合物、1-(4-異丙基苯基)-2-羥基-2-甲基丙烷-1-酮、苄基二甲基縮酮、2-甲基-1-[4-(甲硫基)苯基]-2-嗎啉基丙烷-1-酮、2,4-二乙基氧雜蒽酮/對二甲基胺基苯甲酸甲酯混合物、二苯甲酮/甲基三乙醇胺混合物。Additional examples of photo-radical polymerization initiators are 4-methoxyphenyl-2,4-bis(trichloromethyl)triazine, 2-(4-butoxystyryl)-5-trichloro Methyl-1,3,4-oxadiazole, 9-phenylacridine, 9,10-benzophenazine, benzophenone/Michel's ketone mixture, hexaarylbiimidazole/mercaptobenzimidazole Mixture, 1-(4-Isopropylphenyl)-2-hydroxy-2-methylpropan-1-one, Benzyldimethylketal, 2-methyl-1-[4-(methylthio ) Phenyl]-2-morpholinopropan-1-one, 2,4-diethylxanthone/p-dimethylaminobenzoic acid methyl ester mixture, benzophenone/methyltriethanolamine mixture .

在液晶組成物中添加光自由基聚合起始劑,然後在施加電場的狀態下照射紫外線,由此可進行聚合。但是,未反應的聚合起始劑或聚合起始劑的分解產物可能對元件引起圖像的燒痕等顯示不良。為了防止所述情況,也可在不添加聚合起始劑的狀態下進行光聚合。所照射的光的優選波長為150 nm至500 nm的範圍。進而優選的波長為250 nm至450 nm的範圍,最優選的波長為300 nm至400 nm的範圍。Polymerization can be carried out by adding a photoradical polymerization initiator to the liquid crystal composition, and then irradiating ultraviolet rays in a state where an electric field is applied. However, the unreacted polymerization initiator or the decomposition product of the polymerization initiator may cause poor display of images such as burn marks on the element. In order to prevent such a situation, photopolymerization may be performed without adding a polymerization initiator. The preferred wavelength of the irradiated light is in the range of 150 nm to 500 nm. A further preferred wavelength is in the range of 250 nm to 450 nm, and the most preferred wavelength is in the range of 300 nm to 400 nm.

在將具有酯(-COO-、-OCO-)作為鍵結基的化合物(1)混合至組成物中的情況下,作為成分A的化合物(1)給組成物的特性帶來的主要效果如下所述。所述化合物(1)在通過偏光而產生弗裡斯重排(Fries rearrangement)或光二聚化時,以分子水平在一定方向上進行排列。因此,由極性化合物製備的薄膜與聚醯亞胺之類的配向膜同樣地使液晶分子配向。When the compound (1) having an ester (-COO-, -OCO-) as a bonding group is mixed into the composition, the main effects of the compound (1) as the component A on the properties of the composition are as follows said. When the compound (1) undergoes Fries rearrangement or photodimerization by polarized light, it is arranged in a certain direction at the molecular level. Therefore, a thin film prepared from a polar compound aligns liquid crystal molecules in the same manner as an alignment film such as polyimide.

在具有芳香族酯且具有聚合性基的化合物(1)的情況下,通過照射紫外光而芳香族酯部位進行光分解,由此形成自由基而產生光弗裡斯重排。 光弗裡斯重排中,在偏光紫外光的偏光方向與芳香族酯部位的長軸方向為相同方向的情況下產生芳香族酯部位的光分解。在光分解後,進行再鍵結並通過互變異構化而在分子內產生羥基。認為通過所述羥基而產生基板界面的相互作用,極性化合物具有各向異性而容易吸附於基板界面側。另外,由於具有聚合性基,因此通過聚合而沿偏光的朝向進行反應的化合物(1)不會失去其方向性地加以固定。可利用所述性質來製備能夠使液晶分子配向的薄膜。為了製備所述薄膜,所照射的紫外線合適的是直線偏光。首先,在液晶組成物中以0.1重量%至10重量%的範圍添加作為極性化合物的化合物(1),為了使極性化合物溶解而對組成物進行加溫。將所述組成物注入至不具有配向膜的元件中。繼而,一邊對元件進行加溫,一邊照射直線偏光,由此使極性化合物進行光弗裡斯重排並加以聚合。 經光弗裡斯重排的極性化合物在一定方向上進行排列,且聚合後所形成的薄膜具有作為液晶配向膜的功能。In the case of the compound (1) having an aromatic ester and a polymerizable group, by irradiation with ultraviolet light, the aromatic ester moiety undergoes photolysis, thereby forming a radical and generating a photo-Friesian rearrangement. In the photofries rearrangement, when the polarization direction of the polarized ultraviolet light is the same as the long axis direction of the aromatic ester moiety, photodecomposition of the aromatic ester moiety occurs. After photolysis, rebonding proceeds and intramolecular hydroxyl groups are generated by tautomerization. It is considered that the interaction of the substrate interface occurs due to the hydroxyl group, and the polar compound has anisotropy and is easily adsorbed on the substrate interface side. Moreover, since it has a polymerizable group, the compound (1) which reacts in the direction of polarized light by polymerization is fixed without losing the directionality. Such properties can be exploited to prepare thin films capable of aligning liquid crystal molecules. In order to prepare the film, the irradiated ultraviolet rays are suitably linearly polarized light. First, the compound (1), which is a polar compound, is added in a range of 0.1% by weight to 10% by weight to the liquid crystal composition, and the composition is heated in order to dissolve the polar compound. The composition is injected into an element without an alignment film. Next, while heating the element, linearly polarized light is irradiated, whereby the polar compound undergoes photofrisian rearrangement and is polymerized. The polar compounds rearranged by photofries are arranged in a certain direction, and the thin film formed after polymerization has a function as a liquid crystal alignment film.

當保管聚合性化合物時,為了防止聚合,也可添加聚合抑制劑。聚合性化合物通常是在不去除聚合抑制劑的狀態下添加至組成物中。聚合抑制劑的例子為對苯二酚、甲基對苯二酚之類的對苯二酚衍生物、4-叔丁基鄰苯二酚、4-甲氧基苯酚、吩噻嗪等。When storing the polymerizable compound, a polymerization inhibitor may be added in order to prevent polymerization. The polymerizable compound is usually added to the composition without removing the polymerization inhibitor. Examples of polymerization inhibitors are hydroquinone, hydroquinone derivatives such as methyl hydroquinone, 4-tert-butylcatechol, 4-methoxyphenol, phenothiazine, and the like.

光學活性化合物帶來通過在液晶分子中誘發螺旋結構而賦予所需的扭轉角來防止逆扭轉的效果。通過添加光學活性化合物,可調整螺旋節距。出於調整螺旋節距的溫度依存性的目的而也可添加兩種以上的光學活性化合物。作為光學活性化合物的優選例,可列舉下述的化合物(Op-1)至化合物(Op-18)。化合物(Op-18)中,環J為1,4-伸環己基或1,4-伸苯基,R28 為碳數1至10的烷基。The optically active compound brings about the effect of preventing reverse twist by inducing a helical structure in the liquid crystal molecule to impart a desired twist angle. By adding optically active compounds, the pitch of the helix can be adjusted. Two or more optically active compounds may be added for the purpose of adjusting the temperature dependence of the helical pitch. Preferred examples of the optically active compound include the following compounds (Op-1) to (Op-18). In compound (Op-18), ring J is 1,4-cyclohexylene or 1,4-phenylene, and R 28 is an alkyl group having 1 to 10 carbon atoms.

Figure 02_image128
Figure 02_image128

為了維持大的電壓保持率,有效的是抗氧化劑。作為抗氧化劑的優選例,可列舉:下述的化合物(AO-1)及化合物(AO-2);豔佳諾(IRGANOX)415、豔佳諾(IRGANOX)565、豔佳諾(IRGANOX)1010、豔佳諾(IRGANOX)1035、豔佳諾(IRGANOX)3114及豔佳諾(IRGANOX)1098(商品名:巴斯夫(BASF)公司)。為了防止上限溫度的降低,有效的是紫外線吸收劑。紫外線吸收劑的優選例為二苯甲酮衍生物、苯甲酸酯衍生物、三唑衍生物等。作為具體例,可列舉:下述的化合物(AO-3)及化合物(AO-4);帝奴彬(TINUVIN)329、帝奴彬(TINUVIN)P、帝奴彬(TINUVIN)326、帝奴彬(TINUVIN)234、帝奴彬(TINUVIN)213、帝奴彬(TINUVIN)400、帝奴彬(TINUVIN)328及帝奴彬(TINUVIN)99-2(商品名:巴斯夫(BASF)公司);及1,4-二氮雜雙環[2.2.2]辛烷(1,4-Diazabicyclo[2.2.2]octane,DABCO)。In order to maintain a large voltage holding ratio, antioxidants are effective. Preferable examples of antioxidants include the following compound (AO-1) and compound (AO-2); IRGANOX 415, IRGANOX 565, and IRGANOX 1010 , Yan Jianuo (IRGANOX) 1035, Yan Jianuo (IRGANOX) 3114 and Yan Jianuo (IRGANOX) 1098 (trade name: BASF (BASF) company). In order to prevent the lowering of the upper limit temperature, an ultraviolet absorber is effective. Preferable examples of the ultraviolet absorber are benzophenone derivatives, benzoate derivatives, triazole derivatives, and the like. Specific examples include the following compounds (AO-3) and compounds (AO-4); TINUVIN 329, TINUVIN P, TINUVIN 326, TINUVIN 326 TINUVIN 234, TINUVIN 213, TINUVIN 400, TINUVIN 328 and TINUVIN 99-2 (trade name: BASF); And 1,4-diazabicyclo[2.2.2]octane (1,4-Diazabicyclo[2.2.2]octane, DABCO).

為了維持大的電壓保持率,優選為具有立體阻礙的胺之類的光穩定劑。作為光穩定劑的優選例,可列舉:下述的化合物(AO-5)及化合物(AO-6);帝奴彬(TINUVIN)144、帝奴彬(TINUVIN)765及帝奴彬(TINUVIN)770DF(商品名:巴斯夫(BASF)公司)。為了維持大的電壓保持率,熱穩定劑也有效,作為優選例,可列舉易璐佛斯(IRGAFOS)168(商品名:巴斯夫(BASF)公司)。為了防止起泡,有效的是消泡劑。消泡劑的優選例為二甲基矽油、甲基苯基矽油等。In order to maintain a large voltage holding ratio, a light stabilizer such as an amine having steric hindrance is preferable. Preferred examples of light stabilizers include the following compounds (AO-5) and compounds (AO-6); TINUVIN 144, TINUVIN 765, and TINUVIN 770DF (trade name: BASF Corporation). In order to maintain a large voltage holding ratio, a thermal stabilizer is also effective, and as a preferable example, IRGAFOS 168 (trade name: BASF) can be mentioned. To prevent foaming, antifoaming agents are effective. Preferable examples of the defoaming agent are dimethyl silicone oil, methyl phenyl silicone oil, and the like.

Figure 02_image130
Figure 02_image130

化合物(AO-1)中,R40 為碳數1至20的烷基、碳數1至20的烷氧基、-COOR41 或-CH2 CH2 COOR41 ,此處,R41 為碳數1至20的烷基。化合物(AO-2)及化合物(AO-5)中,R42 為碳數1至20的烷基。化合物(AO-5)中,R43 為氫、甲基或O· (氧自由基),環G為1,4-伸環己基或1,4-伸苯基,z為1、2或3。In compound (AO-1), R 40 is an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, -COOR 41 or -CH 2 CH 2 COOR 41 , where R 41 is a carbon number 1 to 20 alkyl groups. In compound (AO-2) and compound (AO-5), R 42 is an alkyl group having 1 to 20 carbon atoms. In compound (AO-5), R 43 is hydrogen, methyl or O ( oxygen radical), ring G is 1,4-cyclohexylene or 1,4-phenylene, z is 1, 2 or 3 .

4.液晶顯示元件 液晶組成物可用於具有PC、TN、STN、OCB、PSA等運行模式且以主動矩陣方式驅動的液晶顯示元件。所述組成物也可用於具有PC、TN、STN、OCB、VA、IPS等運行模式且以被動矩陣方式驅動的液晶顯示元件。這些元件也可應用於反射型、透過型、半透過型的任一類型。4. Liquid crystal display element The liquid crystal composition can be used for liquid crystal display elements having operating modes such as PC, TN, STN, OCB, PSA, etc. and driven in an active matrix manner. The composition can also be used for liquid crystal display elements having operating modes such as PC, TN, STN, OCB, VA, IPS, etc. and driven in a passive matrix manner. These elements can also be applied to any type of reflection type, transmission type, and semi-transmission type.

所述組成物也可用於對向列液晶進行微膠囊化所製作的向列曲線排列相(nematic curvilinear aligned phase,NCAP)元件、在液晶中形成三維網狀高分子所製作的聚合物分散型液晶顯示元件(Polymer Dispersed Liquid Crystal Display,PDLCD)、以及聚合物網路液晶顯示元件(Polymer Network Liquid Crystal Display,PNLCD)。當聚合性化合物的添加量基於液晶組成物的重量而為約10重量%以下時,可製作PSA模式的液晶顯示元件。基於液晶組成物的重量,聚合性化合物的優選比例為約0.1重量%至約2重量%的範圍。基於液晶組成物的重量,進而優選的比例為約0.2重量%至約1.0重量%的範圍。PSA模式的元件可以主動矩陣、被動矩陣之類的驅動方式來驅動。此種元件也可應用於反射型、透過型、半透過型的任一類型。通過增加聚合性化合物的添加量,也可製作聚合物分散(polymer dispersed)模式的元件。The composition can also be used for nematic curvilinear aligned phase (NCAP) elements prepared by microencapsulating nematic liquid crystals, and polymer-dispersed liquid crystals prepared by forming three-dimensional network polymers in liquid crystals. Display element (Polymer Dispersed Liquid Crystal Display, PDLCD), and polymer network liquid crystal display element (Polymer Network Liquid Crystal Display, PNLCD). When the addition amount of the polymerizable compound is about 10% by weight or less based on the weight of the liquid crystal composition, a PSA mode liquid crystal display element can be produced. The preferred ratio of the polymerizable compound is in the range of about 0.1% by weight to about 2% by weight based on the weight of the liquid crystal composition. A further preferable ratio is in the range of about 0.2 wt % to about 1.0 wt % based on the weight of the liquid crystal composition. The elements in the PSA mode can be driven by active matrix, passive matrix and other driving methods. This type of element can also be applied to any type of reflection type, transmission type, and semi-transmission type. By increasing the addition amount of the polymerizable compound, a device of a polymer dispersed mode can also be produced.

聚合物穩定配向型元件中,組成物中所含的聚合物使液晶分子配向。作為極性化合物的化合物(1)幫助液晶分子進行排列。即,化合物(1)可代替配向膜來使用。製造此種元件的方法的一例如下所述。 準備具有被稱為陣列基板與彩色濾光片基板的兩個基板的元件。所述基板不具有配向膜。所述基板的至少一個具有電極層。將液晶性化合物混合來製備液晶組成物。在所述組成物中添加聚合性化合物及作為極性化合物的化合物(1)。視需要也可進而添加添加物。將所述組成物注入至元件中。對所述元件進行光照射。優選為紫外線。通過光照射來使聚合性化合物進行聚合。通過所述聚合而生成包含聚合物的組成物,從而可製作具有PSA模式的元件。In the polymer-stabilized alignment element, the polymer contained in the composition aligns the liquid crystal molecules. Compound (1), which is a polar compound, helps the liquid crystal molecules to align. That is, the compound (1) can be used instead of the alignment film. An example of a method of manufacturing such an element is described below. An element having two substrates called an array substrate and a color filter substrate is prepared. The substrate does not have an alignment film. At least one of the substrates has an electrode layer. The liquid crystal compound is mixed to prepare a liquid crystal composition. A polymerizable compound and compound (1) as a polar compound are added to the composition. Additives may be further added if necessary. The composition is injected into the element. The element is irradiated with light. Ultraviolet rays are preferred. The polymerizable compound is polymerized by light irradiation. By the polymerization, a polymer-containing composition can be produced, whereby a device having a PSA mode can be produced.

對製造元件的方法進行說明。第一步驟為將作為極性化合物的化合物(1)添加至液晶組成物中,並在高於上限溫度的溫度下對組成物進行加溫而使其溶解。第二步驟為將所述組成物注入至液晶顯示元件中。第三步驟為在將液晶組成物加溫至高於上限溫度的溫度的狀態下照射偏光紫外線。作為極性化合物的化合物(1)通過直線偏光而產生光弗裡斯重排或光二聚化,同時也進行聚合。化合物(1)的聚合物以薄膜的形式形成於基板上並加以固定。所述聚合物以分子水平在一定方向上進行排列,因此薄膜具有作為液晶配向膜的功能。可利用所述方法來製造不具有聚醯亞胺之類的配向膜的液晶顯示元件。A method of manufacturing the element will be described. The first step is to add the compound (1), which is a polar compound, to the liquid crystal composition, and to heat and dissolve the composition at a temperature higher than the upper limit temperature. The second step is to inject the composition into the liquid crystal display element. The third step is to irradiate polarized ultraviolet rays in a state where the liquid crystal composition is heated to a temperature higher than the upper limit temperature. The compound (1), which is a polar compound, undergoes photofrisian rearrangement or photodimerization by linear polarization, and also polymerizes at the same time. The polymer of compound (1) is formed on the substrate in the form of a thin film and fixed. The polymers are arranged in a certain direction at the molecular level, so the thin film has a function as a liquid crystal alignment film. This method can be used to manufacture a liquid crystal display element without an alignment film such as polyimide.

所述程序中,作為極性化合物的化合物(1)由於極性基與基板表面相互作用,因此偏向存在於基板上。所述化合物(1)通過偏光紫外線的照射而使液晶分子配向,同時聚合性化合物通過紫外線而進行聚合,因此生成維持所述配向的聚合物。通過所述聚合物的效果,液晶分子的配向追加性地穩定化,因此元件的響應時間縮短。圖像的燒痕為液晶分子的運行不良,因此通過所述聚合物的效果而也同時改善燒痕。特別是本發明的實施方式的化合物(1)為聚合性的極性化合物,因此使液晶分子配向,並且與其他聚合性化合物進行共聚。由此,極性化合物不會漏出至液晶組成物中,因此可獲得電壓保持率大的液晶顯示元件。 [實施例]In the above procedure, the compound (1), which is a polar compound, tends to exist on the substrate because the polar group interacts with the surface of the substrate. The compound (1) aligns liquid crystal molecules by irradiation with polarized ultraviolet rays, and at the same time, the polymerizable compound is polymerized by ultraviolet rays, thereby producing a polymer that maintains the alignment. By the effect of the polymer, the alignment of the liquid crystal molecules is additionally stabilized, so that the response time of the device is shortened. The burn marks of the image are caused by the poor functioning of the liquid crystal molecules, so the burn marks are also improved at the same time by the effect of the polymer. In particular, since the compound (1) according to the embodiment of the present invention is a polymerizable polar compound, it aligns liquid crystal molecules and copolymerizes with other polymerizable compounds. Thereby, since the polar compound does not leak into the liquid crystal composition, a liquid crystal display element having a large voltage holding ratio can be obtained. [Example]

通過實施例(包含合成例、元件的使用例)來對本發明進一步進行詳細說明。本發明並不受這些實施例的限制。本發明包含使用例1的組成物與使用例2的組成物的混合物。本發明也包含通過將使用例的組成物的至少兩種混合而製備的混合物。 1.化合物(1)的實施例The present invention will be further described in detail with reference to Examples (including synthesis examples and use examples of elements). The present invention is not limited by these examples. The present invention includes a mixture of the composition of Use Example 1 and the composition of Use Example 2. The present invention also includes mixtures prepared by mixing at least two of the compositions of the use examples. 1. Examples of compound (1)

化合物(1)是通過實施例1等中所示的程序來合成。只要無特別記載,則反應是在氮氣環境下進行。所合成的化合物是通過核磁共振(Nuclear Magnetic Resonance,NMR)分析等方法而鑒定。化合物(1)、液晶性化合物、組成物、元件的特性是利用下述方法來測定。Compound (1) was synthesized by the procedure shown in Example 1 and the like. Unless otherwise specified, the reaction is carried out in a nitrogen atmosphere. The synthesized compounds were identified by methods such as nuclear magnetic resonance (Nuclear Magnetic Resonance, NMR) analysis. The properties of the compound (1), the liquid crystal compound, the composition, and the device were measured by the following methods.

NMR分析:在測定時,使用布魯克拜厄斯賓(Bruker BioSpin)公司製造的DRX-500。1 H-NMR的測定中,使試樣溶解於CDCl3 等氘化溶媒中,在室溫下以500 MHz、累計次數16次的條件進行測定。使用四甲基矽烷作為內部標準。19 F-NMR的測定中,使用CFCl3 作為內部標準,以累計次數24次進行測定。核磁共振光譜的說明中,s是指單峰,d是指雙重峰,t是指三重峰,q是指四重峰,quin是指五重峰,sex是指六重峰,m是指多重峰,br是指寬峰。NMR analysis: In the measurement, DRX-500 manufactured by Bruker BioSpin was used. In the measurement of 1 H-NMR, the sample is dissolved in a deuterated solvent such as CDCl 3 , and the measurement is performed at room temperature under the conditions of 500 MHz and 16 cumulative times. Tetramethylsilane was used as an internal standard. In the measurement of 19 F-NMR, CFCl 3 was used as an internal standard, and the measurement was carried out in a cumulative number of 24 times. In the description of NMR spectra, s refers to singlet, d refers to doublet, t refers to triplet, q refers to quartet, quin refers to quintet, sex refers to sextet, and m refers to multiplet. Peak, br means broad peak.

氣相色譜分析:在測定時,使用島津製作所製造的GC-2010型氣相色譜儀。管柱是使用安捷倫科技公司(Agilent Technologies Inc.)製造的毛細管柱DB-1(長度60 m、內徑0.25 mm、膜厚0.25 μm)。作為載體氣體,使用氦氣(1 ml/min)。將試樣氣化室的溫度設定為300℃,將檢測器(火焰離子化檢測器(flame ionization detector,FID))部分的溫度設定為300℃。試樣是溶解於丙酮中並以成為1重量%的溶液的方式製備,將1 μl的所獲得的溶液注入至試樣氣化室中。記錄計是使用島津製作所製造的GC溶解(GC Solution)系統等。Gas chromatographic analysis: In the measurement, a GC-2010 gas chromatograph manufactured by Shimadzu Corporation was used. As the column, a capillary column DB-1 (length 60 m, inner diameter 0.25 mm, film thickness 0.25 μm) manufactured by Agilent Technologies Inc. was used. As carrier gas helium (1 ml/min) was used. The temperature of the sample vaporization chamber was set to 300°C, and the temperature of the detector (flame ionization detector (FID)) portion was set to 300°C. The sample was dissolved in acetone to prepare a 1 wt % solution, and 1 μl of the obtained solution was injected into the sample vaporization chamber. As the recorder, a GC solution (GC Solution) system manufactured by Shimadzu Corporation or the like was used.

高效液相色譜(High Performance Liquid Chromatography,HPLC)分析:在測定時,使用島津製作所製造的普羅米納斯(Prominence)(LC-20AD;SPD-20A)。管柱是使用維美希(YMC)製造的YMC-填充(YMC-Pack)ODS-A(長度150 mm、內徑4.6 mm、粒子徑5 μm)。溶出液是將乙腈與水適宜混合而使用。作為檢測器,適宜使用紫外線(Ultraviolet,UV)檢測器、折射率(Reflective Index,RI)檢測器、科羅娜(CORONA)檢測器等。在使用UV檢測器的情況下,將檢測波長設為254 nm。試樣是溶解於乙腈中並以成為0.1重量%的溶液的方式製備,將1 μL的所述溶液導入至試樣室中。作為記錄計,使用島津製作所製造的C-R7A plus。High Performance Liquid Chromatography (HPLC) analysis: Prominence (LC-20AD; SPD-20A) manufactured by Shimadzu Corporation was used for the measurement. The column was YMC-packed (YMC-Pack) ODS-A (length 150 mm, inner diameter 4.6 mm, particle diameter 5 μm) manufactured by Vemex (YMC). The eluate is used by appropriately mixing acetonitrile and water. As a detector, an ultraviolet (Ultraviolet, UV) detector, a refractive index (Reflective Index, RI) detector, a Corona (CORONA) detector, etc. are used suitably. In the case of using a UV detector, the detection wavelength was set to 254 nm. The sample was dissolved in acetonitrile to prepare a 0.1 wt % solution, and 1 μL of the solution was introduced into the sample chamber. As a recorder, C-R7A plus manufactured by Shimadzu Corporation was used.

紫外可見分光分析:在測定時,使用島津製作所製造的法碼思拜(PharmaSpec)UV-1700。將檢測波長設為190 nm至700 nm。試樣是溶解於乙腈中並以成為0.01 mmol/L的溶液的方式製備,並放入至石英槽(光程長度1 cm)中進行測定。UV-Vis Spectroscopic Analysis: PharmaSpec UV-1700 manufactured by Shimadzu Corporation was used for the measurement. Set the detection wavelength from 190 nm to 700 nm. The sample was dissolved in acetonitrile to prepare a solution of 0.01 mmol/L, and placed in a quartz cell (optical path length 1 cm) for measurement.

測定試樣:當測定相結構及轉變溫度(透明點、熔點、聚合起始溫度等)時,將化合物本身用作試樣。Measurement sample: When measuring the phase structure and transition temperature (clear point, melting point, polymerization initiation temperature, etc.), the compound itself is used as a sample.

測定方法:特性的測定是通過下述方法來進行。這些方法大多為社團法人電子信息技術產業協會(Japan Electronics and Information Technology Industries Association,JEITA)所審議制定的JEITA標準(JEITA·ED-2521B)中所記載的方法、或將其加以修飾的方法。用於測定的TN元件中,未安裝薄膜電晶體(TFT)。Measurement method: The measurement of the characteristic was carried out by the following method. Most of these methods are methods described in the JEITA standard (JEITA·ED-2521B) reviewed and formulated by the Japan Electronics and Information Technology Industries Association (JEITA), or methods that have been modified. Thin film transistors (TFTs) were not mounted on the TN elements used for the measurement.

(1)相結構 將試樣放置於包括偏光顯微鏡的熔點測定裝置的加熱板(梅特勒(Mettler)公司的FP-52型熱平台(hot stage))上。對所述試樣一邊以3℃/min的速度加熱一邊利用偏光顯微鏡觀察相狀態及其變化,確定相的種類。(1) Phase structure The sample was placed on a hot plate (hot stage, model FP-52 from Mettler) of a melting point determination apparatus including a polarizing microscope. The phase state and its change were observed with a polarizing microscope while heating the sample at a rate of 3°C/min, and the type of the phase was determined.

(2)轉變溫度(℃) 在測定時,使用珀金埃爾默(Perkin Elmer)公司製造的掃描熱量計、金剛石(Diamond)示差掃描熱量計(Differential Scanning Calorimeter,DSC)系統或SSI奈米科技(SSI Nanotechnology)公司製造的高感度示差掃描熱量計X-DSC7000。對試樣以3℃/min的速度進行升降溫,通過外推而求出伴隨著試樣的相變化的吸熱峰值或發熱峰值的起始點,決定轉變溫度。化合物的熔點、聚合起始溫度也是使用所述裝置來測定。有時將化合物自固體轉變為層列相、向列相等液晶相的溫度簡稱為“液晶相的下限溫度”。有時將化合物自液晶相轉變為液體的溫度簡稱為“透明點”。(2) Transformation temperature (℃) During the measurement, a scanning calorimeter, a Diamond Differential Scanning Calorimeter (DSC) system manufactured by Perkin Elmer, or a high-precision DSC system manufactured by SSI Nanotechnology was used. Sensitivity differential scanning calorimeter X-DSC7000. The temperature of the sample was raised and lowered at a rate of 3°C/min, and the starting point of the endothermic peak or the exothermic peak accompanying the phase change of the sample was obtained by extrapolation, and the transition temperature was determined. The melting point of the compound and the polymerization initiation temperature were also measured using the apparatus. The temperature at which the compound is transformed from a solid to a smectic phase or a nematic phase liquid crystal phase is sometimes simply referred to as "the lower limit temperature of the liquid crystal phase". The temperature at which a compound transitions from a liquid crystal phase to a liquid is sometimes simply referred to as the "clearing point".

將結晶表示為C。在區分結晶的種類的情況下,分別如C1 、C2 那樣表示。將層列相表示為S,將向列相表示為N。層列相中,在區分層列A相、層列B相、層列C相或層列F相的情況下,分別表示為SA 、SB 、SC 或SF 。將液體(各向同性)表示為I。轉變溫度例如是如“C 50.0 N 100.0 I”那樣表述。其表示自結晶轉變為向列相的溫度為50.0℃,自向列相轉變為液體的溫度為100.0℃。The crystal is represented as C. When distinguishing the type of crystals, they are represented as C 1 and C 2 , respectively. Denote the smectic phase as S and the nematic phase as N. Among the smectic phases, when the smectic A phase, the smectic B phase, the smectic C phase, or the smectic F phase are distinguished, they are represented as S A , S B , S C or SF , respectively. Denote the liquid (isotropic) as I. The transition temperature is expressed as, for example, "C 50.0 N 100.0 I". It indicates that the temperature at which the self-crystal transitions to the nematic phase is 50.0°C, and the temperature at which the transition from the nematic phase to the liquid is 100.0°C.

(3)向列相的上限溫度(TNI 或NI;℃) 將試樣放置於包括偏光顯微鏡的熔點測定裝置的加熱板上,以1℃/min的速度進行加熱。對試樣的一部分自向列相變化為各向同性液體時的溫度進行測定。有時將向列相的上限溫度簡稱為“上限溫度”。當試樣為化合物(1)與母液晶的混合物時,以TNI 的記號來表示。當試樣為化合物(1)與成分B、成分C、成分D之類的化合物的混合物時,以NI的記號來表示。(3) Upper limit temperature of nematic phase (T NI or NI; °C) The sample was placed on a heating plate of a melting point measuring apparatus including a polarizing microscope, and heated at a rate of 1 °C/min. The temperature at which a part of the sample changes from the nematic phase to the isotropic liquid is measured. The upper limit temperature of the nematic phase is sometimes simply referred to as the "upper limit temperature". When the sample is a mixture of compound (1) and mother liquid crystal, it is represented by the symbol of TNI . When the sample is a mixture of compound (1) and compounds such as Component B, Component C, and Component D, it is represented by the symbol of NI.

(4)向列相的下限溫度(TC ;℃) 將具有向列相的試樣在0℃、-10℃、-20℃、-30℃及-40℃的冷凍器中保管10天後,觀察液晶相。例如當試樣在-20℃下保持向列相、且在-30℃下變化為結晶或層列相時,將TC 記載為≦-20℃。有時將向列相的下限溫度簡稱為“下限溫度”。(4) Lower limit temperature of nematic phase (T C ; °C) After storing the sample having a nematic phase in a freezer at 0°C, -10°C, -20°C, -30°C, and -40°C for 10 days , observe the liquid crystal phase. For example, when a sample maintains a nematic phase at -20°C and changes to a crystalline or smectic phase at -30°C, the T C is described as ≦-20°C. The lower limit temperature of the nematic phase is sometimes simply referred to as the "lower limit temperature".

(5)黏度(體積黏度(bulk viscosity);η;在20℃下測定;mPa·s) 在測定時,使用東京計器股份有限公司製造的E型旋轉黏度計。(5) Viscosity (bulk viscosity; η; measured at 20°C; mPa s) In the measurement, an E-type rotational viscometer manufactured by Tokyo Keiki Co., Ltd. was used.

(6)光學各向異性(折射率各向異性;在25℃下測定;Δn) 使用波長589 nm的光,通過在接目鏡上安裝有偏光板的阿貝折射計來進行測定。對主棱鏡的表面朝一個方向摩擦後,將試樣滴加至主棱鏡上。折射率(n∥)是在偏光的方向與摩擦的方向平行時測定。折射率(n⊥)是在偏光的方向與摩擦的方向垂直時測定。光學各向異性(Δn)的值是由Δn=n∥-n⊥的式子來計算。(6) Optical anisotropy (refractive index anisotropy; measured at 25°C; Δn) The measurement was performed with an Abbe refractometer with a polarizing plate attached to the eyepiece using light having a wavelength of 589 nm. After rubbing the surface of the main prism in one direction, the sample was dropped onto the main prism. The refractive index (n∥) was measured when the direction of polarized light was parallel to the direction of rubbing. The refractive index (n⊥) was measured when the direction of polarized light was perpendicular to the direction of rubbing. The value of optical anisotropy (Δn) is calculated by the formula Δn=n∥-n⊥.

(7)比電阻(ρ;在25℃下測定;Ωcm) 在包括電極的容器中注入1.0 mL試樣。對所述容器施加直流電壓(10 V),測定10秒後的直流電流。比電阻是由下式來算出。(比電阻)={(電壓)×(容器的電容)}/{(直流電流)×(真空的介電常數)}。(7) Specific resistance (ρ; measured at 25°C; Ωcm) Inject 1.0 mL of sample into the vessel including the electrode. A DC voltage (10 V) was applied to the container, and the DC current after 10 seconds was measured. The specific resistance is calculated by the following formula. (specific resistance)={(voltage)×(capacitance of container)}/{(direct current)×(dielectric constant of vacuum)}.

對於介電各向異性為正的試樣與介電各向異性為負的試樣,有時特性的測定法不同。介電各向異性為正時的測定法是記載於項(8a)至項(12a)中。在介電各向異性為負的情況下,記載於項(8b)至項(12b)中。The method for measuring properties may be different between a sample with positive dielectric anisotropy and a sample with negative dielectric anisotropy. The method of measuring when the dielectric anisotropy is positive is described in the items (8a) to (12a). When the dielectric anisotropy is negative, it is described in the items (8b) to (12b).

(8a)黏度(旋轉黏度;γ1;在25℃下測定;mPa·s) 正的介電各向異性:測定是依據M.今井(M. Imai)等人的《分子晶體與液晶(Molecular Crystals and Liquid Crystals)》(Vol. 259,37(1995))中所記載的方法。在扭轉角為0度、而且兩片玻璃基板的間隔(單元間隙)為5 μm的TN元件中放入試樣。對所述元件在16 V至19.5 V的範圍內以0.5 V為單位階段性地施加電壓。不施加電壓0.2秒後,以僅一個矩形波(矩形脈衝;0.2秒)與不施加(2秒)的條件反覆施加電壓。對因所述施加而產生的暫態電流(transient current)的峰值電流(peak current)與峰值時間(peak time)進行測定。根據這些測定值與M.今井(M. Imai)等人的論文40頁的計算式(8)而獲得旋轉黏度的值。所述計算所必需的介電各向異性的值是使用測定了所述旋轉黏度的元件並利用以下記載的方法而求出。(8a) Viscosity (rotational viscosity; γ1; measured at 25°C; mPa s) Positive dielectric anisotropy: measured according to the method described in "Molecular Crystals and Liquid Crystals" by M. Imai et al. (Vol. 259, 37 (1995)) . A sample was placed in a TN device with a twist angle of 0 degrees and a gap (cell gap) between two glass substrates of 5 μm. A voltage in the range of 16 V to 19.5 V was applied stepwise in units of 0.5 V to the element. After the voltage was not applied for 0.2 seconds, the voltage was repeatedly applied under conditions of only one rectangular wave (rectangular pulse; 0.2 seconds) and no application (2 seconds). The peak current (peak current) and peak time (peak time) of the transient current (transient current) generated by the application were measured. The value of rotational viscosity was obtained from these measured values and the calculation formula (8) on page 40 of the paper by M. Imai et al. The value of the dielectric anisotropy necessary for the above calculation was obtained by the method described below using the element that measured the rotational viscosity.

(8b)黏度(旋轉黏度;γ1;在25℃下測定;mPa·s) 負的介電各向異性:測定是依據M.今井(M. Imai)等人的《分子晶體與液晶(Molecular Crystals and Liquid Crystals)》(Vol. 259,37(1995))中所記載的方法。在兩片玻璃基板的間隔(單元間隙)為20 μm的VA元件中放入試樣。對所述元件在39伏特至50伏特的範圍內以1伏特為單位階段性地施加電壓。不施加電壓0.2秒後,以僅一個矩形波(矩形脈衝;0.2秒)與不施加(2秒)的條件反覆施加電壓。對因所述施加而產生的暫態電流(transient current)的峰值電流(peak current)與峰值時間(peak time)進行測定。根據這些測定值與M.今井(M. Imai)等人的論文40頁的計算式(8)而獲得旋轉黏度的值。所述計算所必需的介電各向異性是使用下述介電各向異性的項中測定的值。(8b) Viscosity (rotational viscosity; γ1; measured at 25°C; mPa s) Negative dielectric anisotropy: measured according to the method described in "Molecular Crystals and Liquid Crystals" by M. Imai et al. (Vol. 259, 37 (1995)) . A sample was placed in a VA element with a gap (cell gap) between two glass substrates of 20 μm. A voltage was applied to the element in steps of 1 volt in the range of 39 volts to 50 volts. After the voltage was not applied for 0.2 seconds, the voltage was repeatedly applied under conditions of only one rectangular wave (rectangular pulse; 0.2 seconds) and no application (2 seconds). The peak current (peak current) and peak time (peak time) of the transient current (transient current) generated by the application were measured. The value of rotational viscosity was obtained from these measured values and the calculation formula (8) on page 40 of the paper by M. Imai et al. The dielectric anisotropy necessary for the calculation is the value measured using the term of the dielectric anisotropy described below.

(9a)介電各向異性(Δε;在25℃下測定) 正的介電各向異性:在兩片玻璃基板的間隔(單元間隙)為9 μm、而且扭轉角為80度的TN元件中放入試樣。對所述元件施加正弦波(10 V、1 kHz),2秒後測定液晶分子的長軸方向上的介電常數(ε∥)。對所述元件施加正弦波(0.5 V、1 kHz),2秒後測定液晶分子的短軸方向上的介電常數(ε⊥)。介電各向異性的值是由Δε=ε∥-ε⊥的式子來計算。(9a) Dielectric anisotropy (Δε; measured at 25°C) Positive dielectric anisotropy: A sample was placed in a TN device with a gap (cell gap) between two glass substrates of 9 μm and a twist angle of 80 degrees. A sine wave (10 V, 1 kHz) was applied to the element, and after 2 seconds, the dielectric constant (ε∥) in the long axis direction of the liquid crystal molecules was measured. A sine wave (0.5 V, 1 kHz) was applied to the element, and the dielectric constant (ε⊥) in the short axis direction of the liquid crystal molecules was measured after 2 seconds. The value of dielectric anisotropy is calculated by the formula Δε=ε∥-ε⊥.

(9b)介電各向異性(Δε;在25℃下測定) 負的介電各向異性:介電各向異性的值是由Δε=ε∥-ε⊥的式子來計算。介電常數(ε∥及ε⊥)是如下那樣測定。 1)介電常數(ε∥)的測定:在經充分清洗的玻璃基板上塗佈十八烷基三乙氧基矽烷(0.16 mL)的乙醇(20 mL)溶液。利用旋轉器使玻璃基板旋轉後,在150℃下加熱1小時。在兩片玻璃基板的間隔(單元間隙)為4 μm的VA元件中放入試樣,通過利用紫外線進行硬化的接著劑將所述元件密閉。對所述元件施加正弦波(0.5 V、1 kHz),2秒後測定液晶分子的長軸方向上的介電常數(ε∥)。 2)介電常數(ε⊥)的測定:在經充分清洗的玻璃基板上塗佈聚醯亞胺溶液。將所述玻璃基板煆燒後,對所獲得的配向膜實施摩擦處理。在兩片玻璃基板的間隔(單元間隙)為9 μm、扭轉角為80度的TN元件中放入試樣。對所述元件施加正弦波(0.5 V、1 kHz),2秒後測定液晶分子的短軸方向上的介電常數(ε⊥)。(9b) Dielectric anisotropy (Δε; measured at 25°C) Negative dielectric anisotropy: The value of dielectric anisotropy is calculated by the formula Δε=ε∥-ε⊥. The dielectric constants (ε∥ and ε⊥) were measured as follows. 1) Determination of dielectric constant (ε∥): A solution of octadecyltriethoxysilane (0.16 mL) in ethanol (20 mL) was coated on a fully cleaned glass substrate. After the glass substrate was rotated with a spinner, it was heated at 150° C. for 1 hour. A sample was placed in a VA element having a distance (cell gap) between two glass substrates of 4 μm, and the element was hermetically sealed with an adhesive cured by ultraviolet rays. A sine wave (0.5 V, 1 kHz) was applied to the element, and after 2 seconds, the dielectric constant (ε∥) in the long axis direction of the liquid crystal molecules was measured. 2) Determination of dielectric constant (ε⊥): The polyimide solution was coated on the fully cleaned glass substrate. After sintering the glass substrate, a rubbing treatment is performed on the obtained alignment film. A sample was placed in a TN device with a gap (cell gap) between two glass substrates of 9 μm and a twist angle of 80 degrees. A sine wave (0.5 V, 1 kHz) was applied to the element, and the dielectric constant (ε⊥) in the short axis direction of the liquid crystal molecules was measured after 2 seconds.

(10a)彈性常數(K;在25℃下測定;pN) 正的介電各向異性:在測定時使用橫河惠普(Yokogawa-Hewlett Packard)股份有限公司製造的HP4284A型LCR計。在兩片玻璃基板的間隔(單元間隙)為20 μm的水平配向元件中放入試樣。對所述元件施加0伏特至20伏特的電荷,測定靜電電容及施加電壓。使用《液晶器件手冊》(日刊工業報社)75頁中的式(2.98)、式(2.101)對所測定的靜電電容(C)與施加電壓(V)的值進行擬合,由式(2.99)獲得K11 及K33 的值。繼而,在171頁中的式(3.18)中,使用之前求出的K11 及K33 的值來算出K22 。彈性常數K是以如上所述那樣求出的K11 、K22 及K33 的平均值來表示。(10a) Elastic constant (K; measured at 25° C.; pN) Positive dielectric anisotropy: An LCR meter HP4284A manufactured by Yokogawa-Hewlett Packard Co., Ltd. was used for the measurement. A sample was placed in a horizontal alignment element with a gap (cell gap) between two glass substrates of 20 μm. A charge of 0 V to 20 V was applied to the element, and the electrostatic capacitance and the applied voltage were measured. Using equations (2.98) and (2.101) in the "Handbook of Liquid Crystal Devices" (Nikkan Kogyo Shimbun) on page 75, the measured electrostatic capacitance (C) and the value of the applied voltage (V) were fitted, and the equation (2.99) The values of K 11 and K 33 were obtained. Next, in the formula (3.18) on page 171, K 22 is calculated using the values of K 11 and K 33 previously obtained. The elastic constant K is represented by the average value of K 11 , K 22 and K 33 obtained as described above.

(10b)彈性常數(K11 及K33 ;在25℃下測定;pN) 負的介電各向異性:在測定時使用東陽技術(TOYO Technica)股份有限公司製造的EC-1型彈性常數測定器。在兩片玻璃基板的間隔(單元間隙)為20 μm的垂直配向元件中放入試樣。對所述元件施加20伏特至0伏特的電荷,測定靜電電容及施加電壓。使用《液晶器件手冊》(日刊工業報社)75頁中的式(2.98)、式(2.101)對靜電電容(C)與施加電壓(V)的值進行擬合,由式(2.100)獲得彈性常數的值。(10b) Elastic constants (K 11 and K 33 ; measured at 25° C.; pN) Negative dielectric anisotropy: measured using an EC-1 type elastic constant manufactured by TOYO Technica Co., Ltd. device. A sample was placed in a vertical alignment element with a gap (cell gap) between two glass substrates of 20 μm. A charge of 20 volts to 0 volts was applied to the element, and the electrostatic capacitance and the applied voltage were measured. Use the equations (2.98) and (2.101) in the "Handbook of Liquid Crystal Devices" (Nikkan Kogyo Shimbun) on page 75 to fit the values of the electrostatic capacitance (C) and the applied voltage (V), and obtain the elastic constant from the equation (2.100) value of .

(11a)閾電壓(Vth;在25℃下測定;V) 正的介電各向異性:在測定時使用大塚電子股份有限公司製造的LCD5100型亮度計。光源為鹵素燈。在兩片玻璃基板的間隔(單元間隙)為0.45/Δn(μm)、扭轉角為80度的常白模式(normally white mode)的TN元件中放入試樣。對所述元件施加的電壓(32 Hz、矩形波)是自0 V起以0.02 V為單位階段性地增加至10 V。此時,對元件自垂直方向照射光,對透過元件的光量進行測定。製成所述光量達到最大時為透過率100%、所述光量最小時為透過率0%的電壓-透過率曲線。閾電壓是以透過率成為90%時的電壓來表示。(11a) Threshold voltage (Vth; measured at 25°C; V) Positive dielectric anisotropy: LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source is a halogen lamp. A sample was placed in a normally white mode TN element with an interval (cell gap) of two glass substrates of 0.45/Δn (μm) and a twist angle of 80 degrees. The voltage (32 Hz, rectangular wave) applied to the element was increased from 0 V to 10 V in steps of 0.02 V. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. A voltage-transmittance curve was created in which the transmittance was 100% when the light amount reached the maximum, and the transmittance was 0% when the light amount was the smallest. The threshold voltage is represented by the voltage at which the transmittance becomes 90%.

(11b)閾電壓(Vth;在25℃下測定;V) 負的介電各向異性:在測定時使用大塚電子股份有限公司製造的LCD5100型亮度計。光源為鹵素燈。在兩片玻璃基板的間隔(單元間隙)為4 μm、摩擦方向為反平行的常黑模式(normally black mode)的VA元件中放入試樣,使用利用紫外線進行硬化的接著劑將所述元件密閉。對所述元件施加的電壓(60 Hz、矩形波)是自0 V起以0.02 V為單位階段性地增加至20 V。此時,對元件自垂直方向照射光,測定透過元件的光量。製成所述光量達到最大時為透過率100%、所述光量最小時為透過率0%的電壓-透過率曲線。閾電壓是以透過率成為10%時的電壓來表示。(11b) Threshold voltage (Vth; measured at 25°C; V) Negative dielectric anisotropy: LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source is a halogen lamp. A sample was placed in a normally black mode VA element in which the distance between two glass substrates (cell gap) was 4 μm and the rubbing direction was anti-parallel, and the element was adhered with an adhesive cured by ultraviolet rays. airtight. The voltage (60 Hz, rectangular wave) applied to the element was increased from 0 V to 20 V in steps of 0.02 V. At this time, the element was irradiated with light from a vertical direction, and the amount of light transmitted through the element was measured. A voltage-transmittance curve was created in which the transmittance was 100% when the light amount reached the maximum, and the transmittance was 0% when the light amount was the smallest. The threshold voltage is represented by the voltage at which the transmittance becomes 10%.

(12a)響應時間(τ;在25℃下測定;ms) 正的介電各向異性:在測定時使用大塚電子股份有限公司製造的LCD5100型亮度計。光源為鹵素燈。低通濾波器(Low-pass filter)是設定為5 kHz。在兩片玻璃基板的間隔(單元間隙)為5.0 μm、扭轉角為80度的常白模式(normally white mode)的TN元件中放入試樣。對所述元件施加矩形波(60 Hz、5 V、0.5秒)。此時,對元件自垂直方向照射光,測定透過元件的光量。將所述光量達到最大時視為透過率100%,所述光量最小時視為透過率0%。上升時間(τr:rise time;毫秒)為透過率自90%變化為10%所需要的時間。下降時間(τf:fall time;毫秒)為透過率自10%變化為90%所需要的時間。響應時間是以如上所述那樣求出的上升時間與下降時間的和來表示。(12a) Response time (τ; measured at 25°C; ms) Positive dielectric anisotropy: LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source is a halogen lamp. The low-pass filter is set to 5 kHz. A sample was placed in a normally white mode TN element with a gap (cell gap) between two glass substrates of 5.0 μm and a twist angle of 80 degrees. A rectangular wave (60 Hz, 5 V, 0.5 sec) was applied to the element. At this time, the element was irradiated with light from a vertical direction, and the amount of light transmitted through the element was measured. When the light amount reached the maximum, the transmittance was regarded as 100%, and when the light amount was the minimum, the transmittance was regarded as 0%. The rise time (τr: rise time; milliseconds) is the time required for the transmittance to change from 90% to 10%. The fall time (τf: fall time; milliseconds) is the time required for the transmittance to change from 10% to 90%. The response time is represented by the sum of the rise time and the fall time obtained as described above.

(12b)響應時間(τ;在25℃下測定;ms) 負的介電各向異性:在測定時使用大塚電子股份有限公司製造的LCD5100型亮度計。光源為鹵素燈。低通濾波器(Low-pass filter)是設定為5 kHz。在兩片玻璃基板的間隔(單元間隙)為3.2 μm、摩擦方向為反平行的常黑模式(normally black mode)的PVA元件中放入試樣。使用利用紫外線進行硬化的接著劑將所述元件密閉。對所述元件施加稍許超過閾電壓的程度的電壓1分鐘,繼而,一邊施加5.6 V的電壓,一邊照射23.5 mW/cm2 的紫外線8分鐘。對所述元件施加矩形波(60 Hz、10 V、0.5秒)。此時,對元件自垂直方向照射光,測定透過元件的光量。將所述光量達到最大時視為透過率100%,所述光量最小時視為透過率0%。響應時間是以透過率自90%變化為10%所需要的時間(下降時間;fall time;毫秒)來表示。(12b) Response time (τ; measured at 25° C.; ms) Negative dielectric anisotropy: An LCD5100 luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source is a halogen lamp. The low-pass filter is set to 5 kHz. A sample was placed in a normally black mode PVA element in which the distance (cell gap) between two glass substrates was 3.2 μm and the rubbing direction was antiparallel. The element is hermetically sealed with an adhesive that cures with ultraviolet light. A voltage slightly exceeding the threshold voltage was applied to the element for 1 minute, and then 23.5 mW/cm 2 of ultraviolet rays were irradiated for 8 minutes while applying a voltage of 5.6 V. A rectangular wave (60 Hz, 10 V, 0.5 sec) was applied to the element. At this time, the element was irradiated with light from a vertical direction, and the amount of light transmitted through the element was measured. When the light amount reached the maximum, the transmittance was regarded as 100%, and when the light amount was the minimum, the transmittance was regarded as 0%. The response time is expressed as the time (fall time; fall time; milliseconds) required for the transmittance to change from 90% to 10%.

(13)AC殘像(亮度變化率) 對後述的液晶顯示元件的亮度-電壓特性(B-V特性)進行測定。設為應力施加前的亮度-電壓特性:B(前(before))。另外,將此處所測定的可獲得最大亮度的電壓設為Vmax。繼而,以Vmax對元件施加120 Hz的交流電20分鐘後,短路1秒,並再次測定亮度-電壓特性(B-V特性)。將其設為應力施加後的亮度-電壓特性:B(後(after))。基於這些值,使用下式來估計亮度變化率ΔB(%)。 ΔB(%)=[B(後(after))-B(前(before))]/B(前(before))(式1) 這些測定是參考國際公開2000/43833號來進行。本發明中,可以說相對亮度成為21.6%的電壓下的ΔB(%)的值越小,越可防止AC殘像的產生。(13) AC afterimage (brightness change rate) The luminance-voltage characteristics (B-V characteristics) of the liquid crystal display element described later were measured. Let it be the luminance-voltage characteristic before stress application: B (before). In addition, the voltage at which the maximum luminance measured here can be obtained is set as Vmax. Next, after applying an alternating current of 120 Hz to the element for 20 minutes at Vmax, it was short-circuited for 1 second, and the luminance-voltage characteristic (B-V characteristic) was measured again. Let this be the luminance-voltage characteristic after stress application: B (after). Based on these values, the luminance change rate ΔB (%) is estimated using the following equation. ΔB(%)=[B(after)-B(before)]/B(before) (Formula 1) These measurements were performed with reference to International Publication No. 2000/43833. In the present invention, it can be said that the smaller the value of ΔB (%) at the voltage at which the relative luminance becomes 21.6%, the more the generation of AC afterimages can be prevented.

原料 索爾米克斯(solmix)(註冊商標)A-11為乙醇(85.5%)、甲醇(13.4%)及異丙醇(1.1%)的混合物,是自日本醇銷售(股)獲取。raw material Solmix (registered trademark) A-11 is a mixture of ethanol (85.5%), methanol (13.4%) and isopropanol (1.1%), and was obtained from Nippon Alcohol Sales Co., Ltd.

[合成例1] 化合物(No.2)的合成

Figure 02_image132
[Synthesis Example 1] Synthesis of Compound (No. 2)
Figure 02_image132

第一步驟 將化合物(T-1)(12.6 g)、碳酸鉀(9.5 g)、化合物(T-2)(11.5 g)及DMF(100 ml)放入至反應器中,並在60℃下攪拌2小時。將反應混合物注入至水中,利用乙酸乙酯對水層進行提取。利用水對有機層進行清洗,並利用無水硫酸鎂進行乾燥。在減壓下對所述溶液進行濃縮,並利用矽膠色譜法(體積比,乙酸乙酯:甲苯=1:9)對殘渣進行純化而獲得化合物(T-3)(12.0 g;65%)。再者,化合物(T-1)為已知物質,化合物(T-2)為市售品。first step Compound (T-1) (12.6 g), potassium carbonate (9.5 g), compound (T-2) (11.5 g) and DMF (100 ml) were put into a reactor and stirred at 60°C for 2 hours . The reaction mixture was poured into water, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with water and dried with anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate:toluene=1:9) to obtain Compound (T-3) (12.0 g; 65%). In addition, compound (T-1) is a known substance, and compound (T-2) is a commercial item.

第二步驟 將化合物(T-3)(12.0 g)及四氫呋喃(Tetrahydrofuran,THF)(150 ml)放入至反應器中,並冷卻至-60℃以下。一邊保持-60℃以下一邊向其中滴加正丁基鋰(n-BuLi)(1.6 M己烷溶液(hexane solution))(20.5 ml),其後,攪拌1小時。向其中吹入CO2 氣體,直至溫度不上升,攪拌30分鐘後,恢復至室溫,進而攪拌1小時。將反應混合物注入至水中,利用鹽酸將PH調整為6至5之間,並利用乙酸乙酯進行提取。利用水對有機層進行清洗,並利用無水硫酸鎂進行乾燥。在減壓下對所述溶液進行濃縮,並利用甲苯/庚烷混合溶媒進行清洗,獲得化合物(T-4)(6.5 g;59%)。The second step The compound (T-3) (12.0 g) and tetrahydrofuran (Tetrahydrofuran, THF) (150 ml) were put into the reactor and cooled to below -60°C. n-BuLi (n-BuLi) (1.6 M hexane solution) (20.5 ml) was added dropwise thereto while maintaining -60° C. or lower, followed by stirring for 1 hour. CO 2 gas was blown into it until the temperature did not rise, and after stirring for 30 minutes, the temperature was returned to room temperature, and the mixture was further stirred for 1 hour. The reaction mixture was poured into water, the pH was adjusted to between 6 and 5 with hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with water and dried with anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and washed with a toluene/heptane mixed solvent to obtain Compound (T-4) (6.5 g; 59%).

第三步驟 將化合物(T-4)(1.89 g)、化合物(T-5)(1.5 g)、DMAP(0.13 g)及二氯甲烷(100 ml)放入至反應器中,並冷卻至0℃。向其中添加DCC(1.08 g),恢復至室溫並攪拌12小時。對不溶物進行過濾分離,然後將反應混合物注入至水中,利用二氯甲烷對水層進行提取。利用水對有機層進行清洗,並利用無水硫酸鎂進行乾燥。在減壓下對所述溶液進行濃縮,利用矽膠色譜法(體積比,乙酸乙酯:甲苯=1:9)對殘渣進行純化,並利用庚烷進行再沉澱,由此獲得化合物(T-6)(3.7 g;112%)。再者,若為本技術領域具通常知識者,則可容易合成化合物(T-5)。third step Compound (T-4) (1.89 g), compound (T-5) (1.5 g), DMAP (0.13 g) and dichloromethane (100 ml) were put into a reactor, and cooled to 0°C. Thereto was added DCC (1.08 g), returned to room temperature and stirred for 12 hours. After the insoluble matter was separated by filtration, the reaction mixture was poured into water, and the aqueous layer was extracted with dichloromethane. The organic layer was washed with water and dried with anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, the residue was purified by silica gel chromatography (volume ratio, ethyl acetate:toluene=1:9), and reprecipitated with heptane to obtain compound (T-6 ) (3.7 g; 112%). In addition, the compound (T-5) can be easily synthesized by a person with ordinary knowledge in the technical field.

第四步驟 將化合物(T-6)(3.7 g)、對甲苯磺酸吡啶鹽(Pyridinium p-toluenesulfonate,PPTS)(2.2 g)、THF(50 ml)及甲醇(50 ml)放入至反應器中,並在50℃下攪拌2小時。將反應混合物注入至水中,利用甲苯對水層進行提取。利用水對有機層進行清洗,利用無水硫酸鎂進行乾燥。在減壓下對所述溶液進行濃縮,並利用矽膠色譜法(體積比,乙酸乙酯:甲苯=1:4)對殘渣進行純化而獲得化合物(T-7)(3.24 g;100%)。Fourth step Compound (T-6) (3.7 g), Pyridinium p-toluenesulfonate (PPTS) (2.2 g), THF (50 ml) and methanol (50 ml) were put into the reactor, and Stir at 50°C for 2 hours. The reaction mixture was poured into water, and the aqueous layer was extracted with toluene. The organic layer was washed with water and dried with anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate:toluene=1:4) to obtain Compound (T-7) (3.24 g; 100%).

第五步驟 將化合物(T-7)(3.24 g)、化合物(T-8)(0.78 g)、DMAP(0.14 g)及二氯甲烷(100 ml)放入至反應器中,並冷卻至0℃。向其中添加DCC(1.08 g),恢復至室溫並攪拌12小時。對不溶物進行過濾分離,然後將反應混合物注入至水中,利用二氯甲烷對水層進行提取。利用水對有機層進行清洗,並利用無水硫酸鎂進行乾燥。在減壓下對所述溶液進行濃縮,利用矽膠色譜法(體積比,乙酸乙酯:甲苯=1:9)對殘渣進行純化,並利用庚烷進行再沉澱,由此獲得化合物(No.2)(2.83 g;77%)。Fifth step Compound (T-7) (3.24 g), compound (T-8) (0.78 g), DMAP (0.14 g) and dichloromethane (100 ml) were put into a reactor, and cooled to 0°C. Thereto was added DCC (1.08 g), returned to room temperature and stirred for 12 hours. After the insoluble matter was separated by filtration, the reaction mixture was poured into water, and the aqueous layer was extracted with dichloromethane. The organic layer was washed with water and dried with anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate:toluene=1:9), and reprecipitated with heptane to obtain the compound (No. 2). ) (2.83 g; 77%).

所獲得的化合物(No.2)的NMR分析值如下所述。1 H-NMR:化學位移δ(ppm;CDCl3 ):8.11 (dd, 1H), 8.04 (s, 1H), 7.77 (d, 1H), 7.74 (d, 1H), 7.02 (d, 1H), 6.89 (dd, 1H), 6.83 (d, 1H), 6.79 (d, 1H), 6.76 (dd, 1H), 6.09 (s, 1H), 5.72 (dd, 1H), 5.54 (d, 1H), 5.36 (dd, 1H), 4.61 (t, 2H), 4.29 (t, 3H), 4.15 (t, 2H), 3.94 (t, 2H), 2.95-2.86 (m, 4H), 2.19 (s, 2H), 1.94 (s, 3H), 1.79 (quint, 2H), 1.70 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).The NMR analysis value of the obtained compound (No. 2) is as follows. 1 H-NMR: chemical shift δ (ppm; CDCl 3 ): 8.11 (dd, 1H), 8.04 (s, 1H), 7.77 (d, 1H), 7.74 (d, 1H), 7.02 (d, 1H), 6.89 (dd, 1H), 6.83 (d, 1H), 6.79 (d, 1H), 6.76 (dd, 1H), 6.09 (s, 1H), 5.72 (dd, 1H), 5.54 (d, 1H), 5.36 (dd, 1H), 4.61 (t, 2H), 4.29 (t, 3H), 4.15 (t, 2H), 3.94 (t, 2H), 2.95-2.86 (m, 4H), 2.19 (s, 2H), 1.94 (s, 3H), 1.79 (quint, 2H), 1.70 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).

化合物(No.2)的物性如下所述。 轉變溫度(℃):C 63.9 I 聚合溫度(℃):118.8The physical properties of compound (No. 2) are as follows. Transition temperature (°C): C 63.9 I Polymerization temperature (°C): 118.8

[合成例2] 化合物(No.5)的合成 將合成例1中的化合物(T-1)置換為化合物(T-9),並進行相同的操作,由此可合成化合物(No.5)。

Figure 02_image134
[Synthesis Example 2] Synthesis of Compound (No. 5) Compound (No. 5) can be synthesized by substituting Compound (T-1) in Synthesis Example 1 with Compound (T-9) and performing the same operation. .
Figure 02_image134

所獲得的化合物(No.5)的NMR分析值如下所述。1 H-NMR:化學位移δ(ppm;CDCl3 ):8.15 (dd, 1H), 8.09 (s, 1H), 7.88 (d, 1H), 7.87 (d, 1H), 7.59 (d, 2H), 7.54 (dd, 1H), 7.47 (s, 1H), 7.04 (d, 1H), 7.01 (d, 2H), 6.81 (d, 1H), 6.77 (dd, 1H), 6.11 (s, 1H), 5.73 (dd, 1H), 5.54 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.30 (t, 2H), 4.16 (t, 2H), 3.96 (t, 2H), 3.02-2.96 (m, 4H), 1.79 (quint, 2H), 1.70 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).The NMR analysis value of the obtained compound (No. 5) is as follows. 1 H-NMR: chemical shift δ (ppm; CDCl 3 ): 8.15 (dd, 1H), 8.09 (s, 1H), 7.88 (d, 1H), 7.87 (d, 1H), 7.59 (d, 2H), 7.54 (dd, 1H), 7.47 (s, 1H), 7.04 (d, 1H), 7.01 (d, 2H), 6.81 (d, 1H), 6.77 (dd, 1H), 6.11 (s, 1H), 5.73 (dd, 1H), 5.54 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.30 (t, 2H), 4.16 (t, 2H), 3.96 (t, 2H), 3.02- 2.96 (m, 4H), 1.79 (quint, 2H), 1.70 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).

化合物(No.5)的物性如下所述。 轉變溫度(℃):C 79.49 I 聚合溫度(℃):145.6The physical properties of compound (No. 5) are as follows. Transition temperature (°C): C 79.49 I Polymerization temperature (°C): 145.6

化合物(T-9)的合成

Figure 02_image136
使化合物(T-10)(7.1 g)、4-碘苯酚(4-iodophenol)(20 g)溶解於甲苯(100 ml)中,加入水(100 ml)、乙醇(100 ml)、Pd(PPh3 )4 (0.54 g)、四丁基溴化銨(tetrabutylammonium bromide,TBAB)(0.76 g)及碳酸鉀(9.72 g),並加熱回流6小時。反應結束後,利用乙酸乙酯進行提取,利用水進行清洗,然後利用無水硫酸鎂進行乾燥,並進行減壓濃縮而獲得淡茶色固體。將所述固體製成溶液,實施矽膠管柱色譜法(體積比,乙酸乙酯:甲苯=9:1)及再結晶(甲醇),由此獲得化合物(T-9)(3.7 g;45%)。再者,化合物(T-10)為已知物質。Synthesis of Compound (T-9)
Figure 02_image136
Compound (T-10) (7.1 g), 4-iodophenol (20 g) were dissolved in toluene (100 ml), water (100 ml), ethanol (100 ml), Pd (PPh) were added 3 ) 4 (0.54 g), tetrabutylammonium bromide (TBAB) (0.76 g) and potassium carbonate (9.72 g), and heated to reflux for 6 hours. After completion of the reaction, extraction was performed with ethyl acetate, washed with water, dried with anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain a light brown solid. The solid was made into a solution and subjected to silica gel column chromatography (volume ratio, ethyl acetate:toluene=9:1) and recrystallization (methanol) to obtain compound (T-9) (3.7 g; 45%) ). In addition, compound (T-10) is a known substance.

[合成例3] 化合物(No.3)的合成 將合成例1中的化合物(T-5)置換為化合物(T-11),並進行相同的操作,由此可合成化合物(No.3)。

Figure 02_image138
[Synthesis Example 3] Synthesis of Compound (No. 3) Compound (No. 3) can be synthesized by substituting Compound (T-5) in Synthesis Example 1 with Compound (T-11) and performing the same operation .
Figure 02_image138

所獲得的化合物(No.3)的NMR分析值如下所述。1 H-NMR:化學位移δ(ppm;CDCl3 ):8.15 (dd, 1H), 8.08 (s, 1H), 7.80 (d, 1H), 7.76 (d, 1H), 7.51 (d, 2H), 7.45 (s, 1H), 7.42 (dd, 1H), 7.18 (d, 1H), 6.96 (d, 2H), 6.90 (dd, 1H), 6.85 (d, 1H), 6.11 (s, 1H), 5.78 (dd, 1H), 5.55 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.31 (t, 2H), 4.17 (t, 2H), 4.01 (t, 2H), 2.98-2.89 (m, 4H), 2.30 (s, 3H), 1.95 (s, 3H), 1.83 (quint, 2H), 1.73 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).The NMR analysis value of the obtained compound (No. 3) is as follows. 1 H-NMR: chemical shift δ (ppm; CDCl 3 ): 8.15 (dd, 1H), 8.08 (s, 1H), 7.80 (d, 1H), 7.76 (d, 1H), 7.51 (d, 2H), 7.45 (s, 1H), 7.42 (dd, 1H), 7.18 (d, 1H), 6.96 (d, 2H), 6.90 (dd, 1H), 6.85 (d, 1H), 6.11 (s, 1H), 5.78 (dd, 1H), 5.55 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.31 (t, 2H), 4.17 (t, 2H), 4.01 (t, 2H), 2.98- 2.89 (m, 4H), 2.30 (s, 3H), 1.95 (s, 3H), 1.83 (quint, 2H), 1.73 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).

化合物(No.3)的物性如下所述。 轉變溫度(℃):C 76.2 I 聚合溫度(℃):110.7The physical properties of compound (No. 3) are as follows. Transition temperature (°C): C 76.2 I Polymerization temperature (°C): 110.7

化合物(T-11)的合成

Figure 02_image140
第一步驟 使化合物(T-12)(18 g)、4-碘酚(16.7 g)溶解於甲苯(150 ml)中,加入水(70 ml)、乙醇(70 ml)、Pd(PPh3 )4 (0.88 g)、TBAB(2.5 g)及碳酸鉀(21 g),並加熱回流6小時。反應結束後,利用乙酸乙酯進行提取,利用水進行清洗,然後利用無水硫酸鎂進行乾燥,並進行減壓濃縮而獲得淡茶色固體。利用甲苯對所述固體進行加熱清洗,獲得化合物(T-13)(13 g;60%)。再者,化合物(T-12)為已知物質。Synthesis of Compound (T-11)
Figure 02_image140
In the first step, compound (T-12) (18 g) and 4-iodophenol (16.7 g) were dissolved in toluene (150 ml), water (70 ml), ethanol (70 ml), Pd(PPh 3 ) were added 4 (0.88 g), TBAB (2.5 g) and potassium carbonate (21 g) and heated to reflux for 6 hours. After completion of the reaction, extraction was performed with ethyl acetate, washed with water, dried with anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain a light brown solid. The solid was heated and washed with toluene to obtain Compound (T-13) (13 g; 60%). In addition, compound (T-12) is a known substance.

第二步驟 將化合物(T-13)(5 g)、碳酸鉀(4.9 g)、化合物(T-14)(5.26 g)及DMF(100 ml)放入至反應器中,並在60℃下攪拌2小時。將反應混合物注入至水中,利用乙酸乙酯對水層進行提取。利用水對有機層進行清洗,並利用無水硫酸鎂進行乾燥。在減壓下對所述溶液進行濃縮,並利用矽膠色譜法(體積比,乙酸乙酯:甲苯=1:9)對殘渣進行純化而獲得化合物(T-15)(7.5 g;94%)。再者,化合物(T-14)為已知物質。second step Compound (T-13) (5 g), potassium carbonate (4.9 g), compound (T-14) (5.26 g) and DMF (100 ml) were put into a reactor and stirred at 60°C for 2 hours . The reaction mixture was poured into water, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with water and dried with anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate:toluene=1:9) to obtain Compound (T-15) (7.5 g; 94%). In addition, compound (T-14) is a known substance.

第三步驟 將化合物(T-15)(7.5 g)、對甲苯磺酸吡啶鹽(PPTS)(6.2 g)、THF(50 ml)及甲醇(50 ml)放入至反應器中,並在50℃下攪拌2小時。將反應混合物注入至水中,利用乙酸乙酯對水層進行提取。利用水對有機層進行清洗,並利用無水硫酸鎂進行乾燥。在減壓下對所述溶液進行濃縮,利用矽膠色譜法(體積比,乙酸乙酯:甲苯=1:9)對殘渣進行純化而獲得化合物(T-11)(5.6 g;92%)。third step Compound (T-15) (7.5 g), pyridinium p-toluenesulfonate (PPTS) (6.2 g), THF (50 ml) and methanol (50 ml) were put into a reactor and stirred at 50°C 2 hours. The reaction mixture was poured into water, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with water and dried with anhydrous magnesium sulfate. The solution was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (volume ratio, ethyl acetate:toluene=1:9) to obtain Compound (T-11) (5.6 g; 92%).

[合成例4] 化合物(No.46)的合成 將合成例1中的化合物(T-5)置換為化合物(T-16),並進行相同的操作,由此可合成化合物(No.46)。

Figure 02_image142
[Synthesis Example 4] Synthesis of Compound (No. 46) Compound (No. 46) can be synthesized by substituting Compound (T-5) in Synthesis Example 1 with Compound (T-16) and performing the same operation .
Figure 02_image142

所獲得的化合物(No.46)的NMR分析值如下所述。1 H-NMR:化學位移δ(ppm;CDCl3 ):8.14 (dd, 1H), 8.08 (s, 1H), 7.80 (d, 1H), 7.76 (d, 1H), 7.50 (d, 2H), 7.45 (s, 1H), 7.42 (dd, 1H), 7.18 (d, 1H), 6.96 (d, 2H), 6.90 (dd, 1H), 6.84 (d, 1H), 6.10 (s, 1H), 5.73 (dd, 1H), 5.55 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.31 (t, 2H), 4.03 (t, 2H), 3.97 (d, 2H), 3.48 (t, 2H), 3.25 (d, 2H), 2.98-2.89 (m, 4H), 2.30 (s, 3H), 1.95-1.5 (m, 10H), 1.1-0.9 (m, 4H)The NMR analysis value of the obtained compound (No. 46) is as follows. 1 H-NMR: chemical shift δ (ppm; CDCl 3 ): 8.14 (dd, 1H), 8.08 (s, 1H), 7.80 (d, 1H), 7.76 (d, 1H), 7.50 (d, 2H), 7.45 (s, 1H), 7.42 (dd, 1H), 7.18 (d, 1H), 6.96 (d, 2H), 6.90 (dd, 1H), 6.84 (d, 1H), 6.10 (s, 1H), 5.73 (dd, 1H), 5.55 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.31 (t, 2H), 4.03 (t, 2H), 3.97 (d, 2H), 3.48 ( t, 2H), 3.25 (d, 2H), 2.98-2.89 (m, 4H), 2.30 (s, 3H), 1.95-1.5 (m, 10H), 1.1-0.9 (m, 4H)

化合物(No.46)的物性如下所述。 轉變溫度(℃):C 115.5 I 聚合溫度(℃):147.9The physical properties of compound (No. 46) are as follows. Transition temperature (°C): C 115.5 I Polymerization temperature (°C): 147.9

化合物(T-16)的合成 化合物(T-11)的合成中,使用化合物(T-17)代替化合物(T-14),由此合成化合物(T-16)。

Figure 02_image144
Synthesis of Compound (T-16) In the synthesis of Compound (T-11), Compound (T-16) was synthesized by using Compound (T-17) instead of Compound (T-14).
Figure 02_image144

[合成例5] 化合物(No.47)的合成 將合成例1中的化合物(T-5)置換為化合物(T-18),並進行相同的操作,由此可合成化合物(No.47)。再者,若為本技術領域具通常知識者,則可使用作為已知物質的2,7-二氫-2,7-菲二醇來容易地合成化合物(T-18)。

Figure 02_image146
[Synthesis Example 5] Synthesis of Compound (No. 47) Compound (No. 47) can be synthesized by substituting Compound (T-5) in Synthesis Example 1 with Compound (T-18) and performing the same operation . In addition, a compound (T-18) can be easily synthesized using 2,7-dihydro-2,7-phenanthrenediol, which is a known substance, for those skilled in the art.
Figure 02_image146

所獲得的化合物(No.47)的NMR分析值如下所述。1 H-NMR:化學位移δ(ppm;CDCl3 ):8.11 (dd, 1H), 8.05 (s, 1H), 7.78 (d, 1H), 7.76 (d, 1H), 7.71 (d, 2H), 7.65 (d, 1H), 7.12 (dd, 1H), 7.09 (s, 1H), 6.90 (dd, 2H), 6.83 (s, 1H), 6.82 (dd, 1H), 6.78 (s, 1H), 6.10 (s, 1H), 5.73 (dd, 1H), 5.55 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.30 (t, 2H), 4.17 (t, 2H), 4.00 (t, 2H), 2.98-2.85 (m, 8H), 1.81 (quint, 2H), 1.73 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).The NMR analysis value of the obtained compound (No. 47) is as follows. 1 H-NMR: chemical shift δ (ppm; CDCl 3 ): 8.11 (dd, 1H), 8.05 (s, 1H), 7.78 (d, 1H), 7.76 (d, 1H), 7.71 (d, 2H), 7.65 (d, 1H), 7.12 (dd, 1H), 7.09 (s, 1H), 6.90 (dd, 2H), 6.83 (s, 1H), 6.82 (dd, 1H), 6.78 (s, 1H), 6.10 (s, 1H), 5.73 (dd, 1H), 5.55 (d, 1H), 5.37 (dd, 1H), 4.62 (t, 2H), 4.30 (t, 2H), 4.17 (t, 2H), 4.00 ( t, 2H), 2.98-2.85 (m, 8H), 1.81 (quint, 2H), 1.73 (quint, 2H), 1.55 (quint, 2H), 1.49 (quint, 2H).

化合物(No.47)的物性如下所述。 轉變溫度(℃):C 105.2 I 聚合溫度(℃):146.8The physical properties of compound (No. 47) are as follows. Transition temperature (°C): C 105.2 I Polymerization temperature (°C): 146.8

可依據合成例中記載的合成法來合成以下的化合物(No.1)至化合物(No.47)作為化合物(1)的具體例。The following compounds (No. 1) to (No. 47) can be synthesized as specific examples of the compound (1) according to the synthesis methods described in the synthesis examples.

Figure 02_image148
Figure 02_image148

Figure 02_image150
Figure 02_image150

Figure 02_image152
Figure 02_image152

Figure 02_image154
Figure 02_image154

Figure 02_image156
Figure 02_image156

Figure 02_image158
Figure 02_image158

2.元件的使用例 使用例中的化合物基於下述的表2的1)至5)的定義而以記號來表示。表2中,與1,4-伸環己基相關的立體構型為反式構型。位於記號後的括弧內的編號與化合物的編號相對應。記號(-)是指其他液晶性化合物。液晶性化合物的比例(百分率)是基於液晶組成物的重量的重量百分率(重量%)。最後,歸納組成物的特性值。

Figure 02_image160
Figure 02_image162
Figure 02_image164
Figure 02_image166
Figure 02_image168
2. Use examples of elements The compounds in the use examples are represented by symbols based on the definitions of 1) to 5) in Table 2 below. In Table 2, the steric configuration related to the 1,4-cyclohexylene group is the trans configuration. The number in parentheses after the symbol corresponds to the number of the compound. The symbol (-) refers to other liquid crystal compounds. The ratio (percentage) of the liquid crystal compound is the weight percentage (% by weight) based on the weight of the liquid crystal composition. Finally, the characteristic values of the composition are summarized.
Figure 02_image160
Figure 02_image162
Figure 02_image164
Figure 02_image166
Figure 02_image168

1.原料 在不具有配向膜的元件中注入添加有極性化合物的組成物。在照射直線偏光後,確認所述元件中的液晶分子的配向。首先對原料進行說明。原料是自組成物(M1)至組成物(M8)之類的組成物、化合物(No.1)至化合物(No.47)之類的化合物(1)中適宜選擇。組成物如下所述。1. Raw materials A composition to which a polar compound is added is injected into a device without an alignment film. After the linearly polarized light was irradiated, the alignment of the liquid crystal molecules in the element was confirmed. First, the raw material will be described. The raw material is appropriately selected from the composition such as the composition (M1) to the composition (M8) and the compound (1) such as the compound (No. 1) to the compound (No. 47). The composition is as follows.

[組成物(M1)] 2-HH-3         (2-1)          21% 3-HH-4         (2-1)          5% 3-HB-O2      (2-5)          2.5% 1-BB-3         (2-8)          4% 3-HHB-1      (3-1)          1.5% 3-HBB-2      (3-4)          9.5% 2-H1OB(2F,3F)-O2  (9-5)          7% 3-H1OB(2F,3F)-O2  (9-5)          11% 3-HDhB(2F,3F)-O2  (10-3)        3.5% 3-HH1OB(2F,3F)-O2     (10-5)        8% 2-HBB(2F,3F)-O2    (10-7)        3% 3-HBB(2F,3F)-O2    (10-7)        9% 5-HBB(2F,3F)-O2    (10-7)        7% V-HBB(2F,3F)-O2   (10-7)        8% NI=80.8℃;Tc<-20℃;Δn=0.108;Δε=-3.8;Vth=2.02 V;η=19.8 mPa·s;γ1=115.0 mPa·s.[Composition (M1)] 2-HH-3 (2-1) 21% 3-HH-4 (2-1) 5% 3-HB-O2 (2-5) 2.5% 1-BB-3 (2-8) 4% 3-HHB-1 (3-1) 1.5% 3-HBB-2 (3-4) 9.5% 2-H1OB(2F,3F)-O2 (9-5) 7% 3-H1OB(2F,3F)-O2 (9-5) 11% 3-HDhB(2F,3F)-O2 (10-3) 3.5% 3-HH1OB(2F,3F)-O2 (10-5) 8% 2-HBB(2F,3F)-O2 (10-7) 3% 3-HBB(2F,3F)-O2 (10-7) 9% 5-HBB(2F,3F)-O2 (10-7) 7% V-HBB(2F,3F)-O2 (10-7) 8% NI=80.8℃; Tc<-20℃; Δn=0.108; Δε=-3.8; Vth=2.02 V; η=19.8 mPa·s; γ1=115.0 mPa·s.

[組成物(M2)] 2-HH-3         (2-1)          21% 3-HH-4         (2-1)          5% 3-HBB-2      (3-4)          9% 3-HHB-3      (3-1)          8% 5-HBB(F,F)-F          (6-24)        20% 3-HBB(F,F)-F          (6-24)        30% 2-HHBB(F,F)-F       (7-6)          3% 3-HHBB(F,F)-F       (7-6)          4% NI=85.1℃;Tc<-20℃;Δn=0.109;Δε=5.3;Vth=1.83 V;η=20.1 mPa·s;γ1=82.4 mPa·s.[Composition (M2)] 2-HH-3 (2-1) 21% 3-HH-4 (2-1) 5% 3-HBB-2 (3-4) 9% 3-HHB-3 (3-1) 8% 5-HBB(F,F)-F (6-24) 20% 3-HBB(F,F)-F (6-24) 30% 2-HHBB(F,F)-F (7-6) 3% 3-HHBB(F,F)-F (7-6) 4% NI=85.1℃; Tc<-20℃; Δn=0.109; Δε=5.3; Vth=1.83 V; η=20.1 mPa·s; γ1=82.4 mPa·s.

[組成物(M3)] 3-HH-V        (2-1)          18% 3-HH-4         (2-1)          11% 5-HB-O2      (2-5)          2% 3-HHB-1      (3-1)          5% 3-HHB-3      (3-1)          5% 3-HHB-O1         (3-1)          6% 3-HHB(F,F)-F          (6-3)          10% 3-BB(F)B(F,F)-F (6-69)        7% 3-BB(F,F)XB(F,F)-F (6-97)        14% 3-HHXB(F,F)-F       (6-100) 2% 3-GHB(F,F)-F          (6-109) 4% 4-BB(F)B(F,F)XB(F,F)-F    (7-47)        10% 5-BB(F)B(F,F)XB(F,F)-F    (7-47)        6% NI=78.4℃;Tc<-20℃;Δn=0.108;Δε=10.4;Vth=1.35 V;η=17.8 mPa·s;γ1=79.9 mPa·s.[Composition (M3)] 3-HH-V (2-1) 18% 3-HH-4 (2-1) 11% 5-HB-O2 (2-5) 2% 3-HHB-1 (3-1) 5% 3-HHB-3 (3-1) 5% 3-HHB-O1 (3-1) 6% 3-HHB(F,F)-F (6-3) 10% 3-BB(F)B(F,F)-F (6-69) 7% 3-BB(F,F)XB(F,F)-F (6-97) 14% 3-HHXB(F,F)-F (6-100) 2% 3-GHB(F,F)-F (6-109) 4% 4-BB(F)B(F,F)XB(F,F)-F (7-47) 10% 5-BB(F)B(F,F)XB(F,F)-F (7-47) 6% NI=78.4℃; Tc<-20℃; Δn=0.108; Δε=10.4; Vth=1.35 V; η=17.8 mPa·s; γ1=79.9 mPa·s.

[組成物(M4)] 3-HH-V        (2-1)          34% V-HHB-1      (3-1)          12% V-HBB-2      (3-4)          5% 3-HBB-2      (3-4)          5% 3-BB(F,F)XB(F,F)-F (6-97)        15% 3-GB(F,F)XB(F,F)-F (6-113)      4% 3-HHB(F,F)XB(F,F)-F   (7-29)        8% 3-HBBXB(F,F)-F     (7-32)        5% 3-BB(F,F)XB(F)B(F,F)-F    (7-56)        4% 4-GB(F)B(F,F)XB(F,F)-F    (7-57)        4% 5-GB(F)B(F,F)XB(F,F)-F    (7-57)        4% NI=77.4℃;Tc<-20℃;Δn=0.108;Δε=10.2;Vth=1.35 V;η=13.2 mPa·s;γ1=69.0 mPa·s.[Composition (M4)] 3-HH-V (2-1) 34% V-HHB-1 (3-1) 12% V-HBB-2 (3-4) 5% 3-HBB-2 (3-4) 5% 3-BB(F,F)XB(F,F)-F (6-97) 15% 3-GB(F,F)XB(F,F)-F (6-113) 4% 3-HHB(F,F)XB(F,F)-F (7-29) 8% 3-HBBXB(F,F)-F (7-32) 5% 3-BB(F,F)XB(F)B(F,F)-F (7-56) 4% 4-GB(F)B(F,F)XB(F,F)-F (7-57) 4% 5-GB(F)B(F,F)XB(F,F)-F (7-57) 4% NI=77.4℃; Tc<-20℃; Δn=0.108; Δε=10.2; Vth=1.35 V; η=13.2 mPa·s; γ1=69.0 mPa·s.

[組成物(M5)] 3-HH-V        (2-1)          29% 3-HH-V1      (2-1)          2% V-HHB-1      (3-1)          5% 2-BB(2F,3F)-O2 (9-3)          3% 3-BB(2F,3F)-O2 (9-3)          10.5% 3-H2B(2F,3F)-O2    (9-4)          5% V2-HHB(2F,3F)-O2 (10-1)        12% V-HHB(2F,3F)-O2   (10-1)        11.5% 3-HH2B(2F,3F)-O2  (10-4)        9% V-HBB(2F,3F)-O2   (10-7)        11% V-HBB(2F,3F)-O4   (10-7)        2% NI=89.1℃;Tc<-20℃;Δn=0.107;Δε=-3.7;Vth=2.32 V;γ1=129.7 mPa·s.[Composition (M5)] 3-HH-V (2-1) 29% 3-HH-V1 (2-1) 2% V-HHB-1 (3-1) 5% 2-BB(2F,3F)-O2 (9-3) 3% 3-BB(2F,3F)-O2 (9-3) 10.5% 3-H2B(2F,3F)-O2 (9-4) 5% V2-HHB(2F,3F)-O2 (10-1) 12% V-HHB(2F,3F)-O2 (10-1) 11.5% 3-HH2B(2F,3F)-O2 (10-4) 9% V-HBB(2F,3F)-O2 (10-7) 11% V-HBB(2F,3F)-O4 (10-7) 2% NI=89.1℃; Tc<-20℃; Δn=0.107; Δε=-3.7; Vth=2.32 V; γ1=129.7 mPa·s.

[組成物(M6)] 2-HH-3         (2-1)          20% 3-HH-VFF         (2-1)          6% V-HBB-2      (3-4)          10% 3-HB(2F,3F)-O2 (9-1)          12% 5-HB(2F,3F)-O2 (9-1)          11% 3-HHB(2F,3F)-O2    (10-1)        9% V-HHB(2F,3F)-O1   (10-1)        3% V-HHB(2F,3F)-O2   (10-1)        8% 2-HBB(2F,3F)-O2    (10-7)       3% 3-HBB(2F,3F)-O2    (10-7)        9% 4-HBB(2F,3F)-O2    (10-7)        9% NI=85.7℃;Tc<-20℃;Δn=0.104;Δε=-3.5;Vth=2.12 V;γ1=102 mPa·s.[Composition (M6)] 2-HH-3 (2-1) 20% 3-HH-VFF (2-1) 6% V-HBB-2 (3-4) 10% 3-HB(2F,3F)-O2 (9-1) 12% 5-HB(2F,3F)-O2 (9-1) 11% 3-HHB(2F,3F)-O2 (10-1) 9% V-HHB(2F,3F)-O1 (10-1) 3% V-HHB(2F,3F)-O2 (10-1) 8% 2-HBB(2F,3F)-O2 (10-7) 3% 3-HBB(2F,3F)-O2 (10-7) 9% 4-HBB(2F,3F)-O2 (10-7) 9% NI=85.7℃; Tc<-20℃; Δn=0.104; Δε=-3.5; Vth=2.12 V; γ1=102 mPa·s.

[組成物(M7)] 2-HH-3         (2-1)          9% 3-HH-5         (2-1)          11% 5-HH-O1      (2-1)          5% 5-HB-3         (2-5)          12% V-HHB-1      (3-1)          4% 3-HB(2F,3F)-O4 (9-1)          4% 5-HB(2F,3F)-O4 (9-1)          5% 2-HHB(2F,3F)-1 (10-1)        9% 3-HHB(2F,3F)-1 (10-1)        10% 3-HHB(2F,3F)-O2    (10-1)        10% 5-HHB(2F,3F)-O2    (10-1)        9% 2-HBB(2F,3F)-O2    (10-7)        2% 2O-DBTF2-O4        (DB-1-1)    5% 2O-DBTF2-O5        (DB-1-1)    5% NI=81.3℃;Δn=0.091;Δε=-3.4;Vth=2.25 V.[Composition (M7)] 2-HH-3 (2-1) 9% 3-HH-5 (2-1) 11% 5-HH-O1 (2-1) 5% 5-HB-3 (2-5) 12% V-HHB-1 (3-1) 4% 3-HB(2F,3F)-O4 (9-1) 4% 5-HB(2F,3F)-O4 (9-1) 5% 2-HHB(2F,3F)-1 (10-1) 9% 3-HHB(2F,3F)-1 (10-1) 10% 3-HHB(2F,3F)-O2 (10-1) 10% 5-HHB(2F,3F)-O2 (10-1) 9% 2-HBB(2F,3F)-O2 (10-7) 2% 2O-DBTF2-O4 (DB-1-1) 5% 2O-DBTF2-O5 (DB-1-1) 5% NI=81.3℃; Δn=0.091; Δε=-3.4; Vth=2.25 V.

[組成物(M8)] 3-HH-V        (2-1)          29% 1-BB-3         (2-8)          5% 3-HBB-2      (3-4)          5% V-HBB-2      (3-4)          4% 3-HB(2F,3F)-O2 (9-1)          15% 5-HB(2F,3F)-O2 (9-1)          3% 3-HHB(2F,3F)-O2    (10-1)        9% 5-HHB(2F,3F)-O2    (10-1)        4% V-HHB(2F,3F)-O1   (10-1)        4% V-HHB(2F,3F)-O2   (10-1)        10% 3-HBB(2F,3F)-O2    (10-7)        6% 2O-DBTF2-O4        (DB-1-1)    2% 3-HDBTF2-O4        (DB-1-2)    4% NI=83.4℃;Δn=0.104;Δε=-3.4;Vth=2.26 V.[Composition (M8)] 3-HH-V (2-1) 29% 1-BB-3 (2-8) 5% 3-HBB-2 (3-4) 5% V-HBB-2 (3-4) 4% 3-HB(2F,3F)-O2 (9-1) 15% 5-HB(2F,3F)-O2 (9-1) 3% 3-HHB(2F,3F)-O2 (10-1) 9% 5-HHB(2F,3F)-O2 (10-1) 4% V-HHB(2F,3F)-O1 (10-1) 4% V-HHB(2F,3F)-O2 (10-1) 10% 3-HBB(2F,3F)-O2 (10-7) 6% 2O-DBTF2-O4 (DB-1-1) 2% 3-HDBTF2-O4 (DB-1-2) 4% NI=83.4℃; Δn=0.104; Δε=-3.4; Vth=2.26 V.

2.液晶分子的配向 使用例1至使用例7 (試樣的製備) 在組成物(M1)中,以0.1重量%、0.3重量%、0.5重量%、1.0重量%、3.0重量%、5.0重量%、10.0重量%的比例添加作為化合物(1)的化合物(No.2)來作為可使液晶分子水平配向的化合物,並以150 ppm的比例添加作為抗氧化劑的R40 為正庚基的化合物(AO-1)。在100℃下進行加熱攪拌,其後,恢復至室溫並放置一周,結果這些混合物無結晶等的析出而完全溶解。2. Alignment of Liquid Crystal Molecules Use Examples 1 to 7 (Preparation of Samples) In the composition (M1), 0.1 wt %, 0.3 wt %, 0.5 wt %, 1.0 wt %, 3.0 wt %, 5.0 wt % %, 10.0% by weight, as compound (1), compound (No. 2) as a compound that can align liquid crystal molecules horizontally, and as an antioxidant, a compound in which R 40 is n-heptyl is added at a ratio of 150 ppm (AO-1). After heating and stirring at 100°C, the mixture was returned to room temperature and allowed to stand for one week. As a result, these mixtures were completely dissolved without precipitation of crystals or the like.

(元件的製作) 在90℃下將這些混合物注入至不具有配向膜的IPS元件中。這些混合物在90℃下示出各向同性相,因此在向列相的上限溫度以上的溫度下注入這些混合物。一邊在90℃下對IPS元件進行加熱,一邊自法線方向對元件照射一定時間的在波長313 nm、波長335 nm及波長365 nm下具有峰值的偏光紫外線,由此進行配向處理,並持續進行照射,直至配向變得良好。(Production of components) These mixtures were injected into IPS elements without alignment films at 90°C. These mixtures showed an isotropic phase at 90°C, so these mixtures were injected at temperatures above the upper temperature limit of the nematic phase. While heating the IPS element at 90°C, the element is irradiated with polarized ultraviolet rays having peaks at wavelengths of 313 nm, 335 nm, and 365 nm from the normal direction for a certain period of time, thereby performing the alignment treatment, which is continued. Irradiate until the alignment becomes good.

(偏光紫外線的照射條件) 波長313 nm時的照度為3 mW/cm2 。使用牛尾(Ushio)電機公司製造的UIT-150及UVD-S313來測定。 紫外線的照射燈使用牛尾(Ushio)電機股份有限公司製造的USH-250BY。 曝光機單元使用牛尾(Ushio)電機股份有限公司製造的ML-251A/B。 偏光紫外線是使用線柵(wire grid)偏光元件(寶萊(Polatechno)(股)公司製造的ProFlux UVT260A)來形成。(Irradiation conditions of polarized ultraviolet rays) The illuminance at a wavelength of 313 nm was 3 mW/cm 2 . Measured using UIT-150 and UVD-S313 manufactured by Ushio Electric Co., Ltd. As the ultraviolet irradiation lamp, USH-250BY manufactured by Ushio Electric Co., Ltd. was used. The exposure machine unit used ML-251A/B manufactured by Ushio Electric Co., Ltd. The polarized ultraviolet rays were formed using a wire grid polarizing element (ProFlux UVT260A manufactured by Polatechno Co., Ltd.).

(配向的確認方法) 相對於直線偏光的偏光軸而使元件平行,並設置於偏光元件與檢偏器正交配置的偏光顯微鏡上,自下方對所述元件照射光來觀察有無漏光。在光未通過元件的情況下,判斷為配向“良好”。在觀察到通過元件的光的情況下,判斷為配向“不良”且照射不充分。(How to check the alignment) The elements were parallel to the polarization axis of linearly polarized light, and were installed on a polarizing microscope in which the polarizing element and the analyzer were arranged orthogonally, and the element was irradiated with light from below to observe whether there was light leakage. When light did not pass through the element, the alignment was determined to be "good". When the light passing through the element was observed, it was judged that the alignment was "defective" and the irradiation was insufficient.

(AC殘像) 使用所述單元來測定AC殘像,並歸納於下述表3中。(AC afterimage) AC afterimages were determined using the unit and are summarized in Table 3 below.

使用例8至使用例42 使用組成物(M1),以150 ppm的比例添加作為抗氧化劑的R40 為正庚基的化合物(AO-1),並以下述表3中所示的比例混合化合物(1)作為可使液晶分子水平配向的化合物。此外,與使用例1同樣地進行操作。利用與使用例1相同的方法來測定AC殘像。將結果歸納於下述表3中。使用例8至使用例14的混合物在90℃下也示出各向同性相。再者,以下,有時將可使液晶分子水平配向的化合物稱為“水平配向用的化合物”等。Use Example 8 to Use Example 42 Using the composition (M1), a compound (AO-1) in which R 40 is an n-heptyl group as an antioxidant was added at a ratio of 150 ppm, and the compounds were mixed at a ratio shown in Table 3 below (1) As a compound that can align liquid crystal molecules horizontally. In addition, it carried out similarly to the use example 1. AC afterimages were measured in the same manner as in Use Example 1. The results are summarized in Table 3 below. The mixtures of Use Example 8 to Use Example 14 also showed an isotropic phase at 90°C. In addition, the compound which can align liquid crystal molecules horizontally may be called "the compound for horizontal alignment" etc. below.

表3 使用例 組成物 水平配向用的化合物(1) 添加濃度 (wt%) AC殘像(%) 1 M1 No.2 0.1 5 2 M1 No.2 0.3 6 3 M1 No.2 0.5 7 4 M1 No.2 1 6 5 M1 No.2 3 8 6 M1 No.2 5 9 7 M1 No.2 10 5 8 M1 No.3 0.1 7 9 M1 No.3 0.3 8 10 M1 No.3 0.5 3 11 M1 No.3 1 9 12 M1 No.3 3 5 13 M1 No.3 5 4 14 M1 No.3 10 6 15 M1 No.3 0.1 7 16 M1 No.3 0.3 9 17 M1 No.3 0.5 8 18 M1 No.3 1 5 19 M1 No.3 3 7 20 M1 No.3 5 7 21 M1 No.3 10 6 22 M1 No.46 0.1 5 23 M1 No.46 0.3 6 24 M1 No.46 0.5 7 25 M1 No.46 1 6 26 M1 No.46 3 8 27 M1 No.46 5 9 28 M1 No.46 10 5 29 M1 No.47 0.1 7 30 M1 No.47 0.3 8 31 M1 No.47 0.5 5 32 M1 No.47 1 9 33 M1 No.47 3 5 34 M1 No.47 5 4 35 M1 No.47 10 6 36 M1 No.47 0.1 7 37 M1 No.47 0.3 9 38 M1 No.47 0.5 8 39 M1 No.47 1 5 40 M1 No.47 3 7 41 M1 No.47 5 7 42 M1 No.47 10 6 table 3 use case composition Compounds for Horizontal Alignment (1) Additive concentration (wt%) AC afterimage (%) 1 M1 No.2 0.1 5 2 M1 No.2 0.3 6 3 M1 No.2 0.5 7 4 M1 No.2 1 6 5 M1 No.2 3 8 6 M1 No.2 5 9 7 M1 No.2 10 5 8 M1 No.3 0.1 7 9 M1 No.3 0.3 8 10 M1 No.3 0.5 3 11 M1 No.3 1 9 12 M1 No.3 3 5 13 M1 No.3 5 4 14 M1 No.3 10 6 15 M1 No.3 0.1 7 16 M1 No.3 0.3 9 17 M1 No.3 0.5 8 18 M1 No.3 1 5 19 M1 No.3 3 7 20 M1 No.3 5 7 twenty one M1 No.3 10 6 twenty two M1 No.46 0.1 5 twenty three M1 No.46 0.3 6 twenty four M1 No.46 0.5 7 25 M1 No.46 1 6 26 M1 No.46 3 8 27 M1 No.46 5 9 28 M1 No.46 10 5 29 M1 No.47 0.1 7 30 M1 No.47 0.3 8 31 M1 No.47 0.5 5 32 M1 No.47 1 9 33 M1 No.47 3 5 34 M1 No.47 5 4 35 M1 No.47 10 6 36 M1 No.47 0.1 7 37 M1 No.47 0.3 9 38 M1 No.47 0.5 8 39 M1 No.47 1 5 40 M1 No.47 3 7 41 M1 No.47 5 7 42 M1 No.47 10 6

將使用例1至使用例42中所使用的組成物M1變更為M2至M8,並分別進行相同的操作,結果任一者中,AC殘像均無大變化。The composition M1 used in Use Example 1 to Use Example 42 was changed to M2 to M8, and the same operations were performed, respectively. As a result, AC afterimages did not change significantly in any of them.

自組成物(M1)至組成物(M8)的組成物,化合物(No.1)至化合物(No.45)的化合物(1)中適當選擇,並進行相同的操作,結果任一者中,AC殘像均為15%以下。From the composition (M1) to the composition (M8), the compound (1) from the compound (No.1) to the compound (No.45) was appropriately selected, and the same operation was performed. As a result, in any one, AC afterimages are all below 15%.

比較例1至比較例14 將專利文獻3中記載的化合物(S-1)及專利文獻2中記載的化合物(S-2)作為可使液晶分子水平配向的化合物而以下述表4中所示的比例混合於組成物(M1)中,通過與使用例相同的操作來評價AC殘像。比較例1至比較例21的混合物在90℃下也示出各向同性相。 其結果,與本發明的實施方式的化合物相比,任一化合物中,使用例中的AC殘像的值均為20%以上。另外,使用組成物(M2)至組成物(M8)來進行相同的評價,結果均為與使用組成物(M1)的情況相同的傾向。

Figure 02_image170
Comparative Examples 1 to 14 The compound (S-1) described in Patent Document 3 and the compound (S-2) described in Patent Document 2 are shown in Table 4 below as compounds capable of horizontal alignment of liquid crystal molecules. The ratio of 1 was mixed in the composition (M1), and the AC afterimage was evaluated by the same operation as in the use example. The mixtures of Comparative Examples 1 to 21 also showed an isotropic phase at 90°C. As a result, compared with the compound of the embodiment of the present invention, in any compound, the value of the AC afterimage in the use example was 20% or more. In addition, when the same evaluation was performed using the composition (M2) to the composition (M8), all of the results showed the same tendency as the case where the composition (M1) was used.
Figure 02_image170

表4 比較例 組成物 水平配向用的化合物 添加濃度 (wt%) AC殘像(%) 1 M1 S-1 0.1 25 2 M1 S-1 0.3 28 3 M1 S-1 0.5 22 4 M1 S-1 1 29 5 M1 S-1 3 21 6 M1 S-1 5 27 7 M1 S-1 10 26 8 M1 S-2 0.1 31 9 M1 S-2 0.3 34 10 M1 S-2 0.5 38 11 M1 S-2 1 39 12 M1 S-2 3 36 13 M1 S-2 5 33 14 M1 S-2 10 37 Table 4 Comparative example composition Compounds for Horizontal Alignment Additive concentration (wt%) AC afterimage (%) 1 M1 S-1 0.1 25 2 M1 S-1 0.3 28 3 M1 S-1 0.5 twenty two 4 M1 S-1 1 29 5 M1 S-1 3 twenty one 6 M1 S-1 5 27 7 M1 S-1 10 26 8 M1 S-2 0.1 31 9 M1 S-2 0.3 34 10 M1 S-2 0.5 38 11 M1 S-2 1 39 12 M1 S-2 3 36 13 M1 S-2 5 33 14 M1 S-2 10 37

關於照射時間,使用例中為10分鐘~30分鐘,比較例中為30分鐘~60分鐘,使用例的感度基本良好。 使用例中,雖改變組成物或極性化合物即作為可使液晶分子水平配向的化合物的化合物(1)的種類、量,但無溶解殘留或析出,AC殘像的值無大變化。另一方面,比較例中,AC殘像的值為20%以上。因此,可知:只要使用本發明的實施方式的化合物(1),則可將AC殘像抑制得低,可獲得可靠性優異的水平配向型液晶顯示元件。另外,只要使用本發明的實施方式的液晶組成物,則可獲得具有可使用元件的溫度範圍廣、響應時間短、電壓保持率高、閾電壓低、對比度比大、壽命長的至少一種特性的液晶顯示元件。進而,可獲得具有如下液晶組成物的液晶顯示元件,所述液晶組成物在向列相的上限溫度高、向列相的下限溫度低、黏度小、光學各向異性適當、負的介電各向異性大、比電阻大、對紫外線的穩定性高、對熱的穩定性高之類的特性中,滿足至少一種。 [產業上的可利用性]The irradiation time is 10 minutes to 30 minutes in the use examples and 30 minutes to 60 minutes in the comparative examples, and the sensitivity of the use examples is basically good. In the use example, although the type and amount of compound (1), which is a compound capable of horizontally aligning liquid crystal molecules, were changed in composition or polar compound, there was no residual dissolution or precipitation, and the value of AC afterimage did not change significantly. On the other hand, in the comparative example, the value of the AC afterimage was 20% or more. Therefore, it turned out that if the compound (1) of embodiment of this invention is used, AC afterimages can be suppressed low, and the horizontal alignment type liquid crystal display element excellent in reliability can be obtained. In addition, by using the liquid crystal composition according to the embodiment of the present invention, it is possible to obtain a device having at least one of the characteristics of a wide usable element temperature range, a short response time, a high voltage holding ratio, a low threshold voltage, a large contrast ratio, and a long life. Liquid crystal display element. Furthermore, a liquid crystal display element having a liquid crystal composition having a high upper limit temperature of a nematic phase, a low lower limit temperature of a nematic phase, a small viscosity, a suitable optical anisotropy, and a negative dielectric property can be obtained. At least one of properties such as high anisotropy, high specific resistance, high stability to ultraviolet rays, and high thermal stability are satisfied. [Industrial Availability]

本發明的實施方式的液晶組成物可用於液晶監視器、液晶電視等中。The liquid crystal composition of the embodiment of the present invention can be used for a liquid crystal monitor, a liquid crystal television, and the like.

without

Claims (17)

一種化合物,由式(1)表示;
Figure 03_image001
式(1)中, a及b獨立地為0、1或2,a及b的和為0、1、2或3; 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、式(A-1)所表示的基或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)所表示的基或式(A-2)所表示的基,式(A-1)及式(A-2)中,Q1 及Q2 獨立地為-CH2 -、-O-、-N(-R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況;
Figure 03_image007
當a為2時,兩個環A1 可不同,當b為2時,兩個環A4 可不同; Z1 、Z2 、Z3 、Z4 及Z5 獨立地為單鍵或碳數1至10的伸烷基,所述Z1 、Z2 、Z3 、Z4 及Z5 中,至少一個-CH2 -可經-O-、-S-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但Z2 、Z3 或Z4 中的至少一個為-COS-、-SCO-、-CH=CHCOS-、-SCOCH=CH-、-COO-、-OCO-、-CH=CH-、-CH=CHCO-或-COCH=CH-,當a為2時,兩個Z1 可不同,當b為2時,兩個Z5 可不同; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-CO-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代; 在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 03_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 獨立地為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。
a compound represented by formula (1);
Figure 03_image001
In formula (1), a and b are independently 0, 1 or 2, and the sum of a and b is 0, 1, 2 or 3; Ring A 1 , Ring A 2 , Ring A 3 and Ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl, 1,2, 3,4-Tetrahydronaphthalene-2,6-diyl, Tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, Pyrimidine-2,5-diyl , pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopenta[a]phenanthrene-3,17 -diyl, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecylhydrocyclopenta[a]phenanthrene-3,17-diyl, In the group represented by the formula (A-1) or the group represented by the formula (A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be replaced by fluorine, chlorine, carbon Alkyl having 1 to 12 carbons, alkenyl having 2 to 12 carbons, alkoxy having 1 to 11 carbons, alkenyloxy having 2 to 11 carbons, -Sp 1 -P 1 or -Sp 2 -P 2 Substituted, in these alkyl, alkenyl, alkoxy, alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine, wherein ring A 1 , ring A 2. At least one of ring A 3 or ring A 4 is a group represented by formula (A-1) or a group represented by formula (A-2), in formula (A-1) and formula (A-2), Q 1 and Q 2 are independently -CH 2 -, -O-, -N(-R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbons, the R In 8 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or chlorine substitution, but there is no case where R 8 is fluorine or chlorine;
Figure 03_image007
When a is 2, the two rings A 1 may be different, and when b is 2, the two rings A 4 may be different; Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single bonds or carbon numbers 1 to 10 alkylene groups, in said Z 1 , Z 2 , Z 3 , Z 4 and Z 5 , at least one -CH 2 - may be through -O-, -S-, -CO-, -COO-, -OCO- or -OCOO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but Z 2 , Z 3 or At least one of Z 4 is -COS-, -SCO-, -CH=CHCOS-, -SCOCH=CH-, -COO-, -OCO-, -CH=CH-, -CH=CHCO-, or -COCH= CH-, when a is 2, the two Z 1 can be different, when b is 2, the two Z 5 can be different; Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbons, In the Sp 1 and Sp 2 , at least one -CH 2 - can be substituted by -O-, -CO-, -COO-, -OCO- or -OCOO-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 ; In the presence of multiple Sp 1 or Sp 2 , any Two may be different; P 1 and P 2 are independently a base represented by any one of formulas (1b) to (1h), and when there are multiple P 1 or P 2 , any two may be different;
Figure 03_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine Alkyl having 1 to 5 carbons; X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or alkyl having 1 to 15 carbons, and R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are independently hydrogen, fluorine, chlorine or an alkyl group with 1 to 5 carbons, and in said R 2 and R 6 , at least one hydrogen Can be substituted by fluorine or chlorine, at least one -CH 2 - can be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, the R 3 , Among R 4 , R 5 and R 7 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C- , at least one hydrogen can be replaced by fluorine or chlorine, but there is no case where R 5 and R 7 are fluorine or chlorine.
如請求項1所述的化合物,其中,式(1)中, a及b獨立地為0、1或2,a及b的和為0、1或2; 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-2,6-二基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、全氫環戊并[a]菲-3,17-二基、2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氫環戊并[a]菲-3,17-二基、式(A-1)所表示的基或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)所表示的基或式(A-2)所表示的基,Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,
Figure 03_image007
當a為2時,兩個環A1 可不同,當b為2時,兩個環A4 可不同; Z1 、Z2 、Z3 、Z4 及Z5 獨立地為單鍵、-(CH2 )2 -、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-;當a為2時,兩個Z1 可不同,當b為2時,兩個Z5 可不同; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 03_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基,X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。
The compound according to claim 1, wherein, in formula (1), a and b are independently 0, 1 or 2, and the sum of a and b is 0, 1 or 2; ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, decahydronaphthalene-2, 6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl , pyrimidine-2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl, perhydrocyclopentane [a]phenanthrene-3,17-diyl, 2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a] A phenanthrene-3,17-diyl group, a group represented by the formula (A-1), or a group represented by the formula (A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least One hydrogen can be through fluorine, chlorine, alkyl group of carbon number 1 to 12, alkenyl group of carbon number 2 to 12, alkoxy group of carbon number 1 to 11, alkenyloxy group of carbon number 2 to 11, -Sp 1 - P 1 or -Sp 2 -P 2 is substituted, and in these alkyl, alkenyl, alkoxy, alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine , wherein at least one of ring A 1 , ring A 2 , ring A 3 or ring A 4 is a group represented by formula (A-1) or a group represented by formula (A-2), and Q 1 and Q 2 are independent is -CH 2 -, -O-, -N(R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but is absent When R 8 is fluorine or chlorine,
Figure 03_image007
When a is 2, the two rings A 1 may be different, and when b is 2, the two rings A 4 may be different; Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently single bonds, -( CH 2 ) 2 -, -C≡C-, -C≡CC≡C-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -CF=CF-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH-, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; when a is 2, the two Z 1 can be different, when b is 2, the two Z 5 can be different; Sp 1 and Sp 2 are independently a single bond or an extension of carbon number 1 to 10 Alkyl, among the Sp 1 and Sp 2 , at least one -CH 2 - can be substituted by -O-, -COO- or -OCO-, and at least one -(CH 2 ) 2 - can be substituted by -CH=CH- , at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 , when there are multiple Sp 1 or Sp 2 , any two can be different; P 1 and P 2 are independent ground is a base represented by any one of formula (1b) to formula (1h), and in the case of a plurality of P 1 or P 2 , any two may be different;
Figure 03_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine an alkyl group having 1 to 5 carbon atoms, X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and the R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen can be Fluorine or chlorine substitution, at least one -CH 2 - may be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, the R 3 , R 4 , R 5 and R 7 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one One hydrogen can be replaced by fluorine or chlorine, but there is no case where R5 and R7 are fluorine or chlorine.
如請求項1或請求項2所述的化合物,其由式(1-1)至式(1-3)的任一者表示;
Figure 03_image013
式(1-1)至式(1-3)中, 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸苯基、萘-2,6-二基、嘧啶-2,5-二基、吡啶-2,5-二基、芴-2,7-二基、菲-2,7-二基、蒽-2,6-二基、式(A-1)或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,這些烷基、烯基、烷氧基、烯氧基、-Sp1 -P1 或-Sp2 -P2 中,至少一個氫可經氟或氯取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2),Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況;
Figure 03_image007
Z2 、Z3 及Z4 獨立地為單鍵、-(CH2 )2 -、-C≡C-、-C≡C-C≡C-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-CF=CF-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b)至式(1h)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 03_image009
式(1b)至式(1h)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基;X1 為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 、R5 及R7 獨立地為氫或碳數1至15的烷基,所述R3 、R4 、R5 及R7 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 及R7 為氟或氯的情況。
The compound of claim 1 or claim 2, which is represented by any one of formula (1-1) to formula (1-3);
Figure 03_image013
In formula (1-1) to formula (1-3), ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-cyclohexylene, 1,4-phenylene, naphthalene -2,6-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, anthracene-2,6-diyl In a diradical, a radical represented by formula (A-1) or formula (A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be replaced by fluorine, chlorine, carbon number Alkyl of 1 to 12, alkenyl of carbon number 2 to 12, alkoxy of carbon number of 1 to 11, alkenyloxy of carbon number of 2 to 11, -Sp 1 -P 1 or -Sp 2 -P 2 substituted , in these alkyl, alkenyl, alkoxy, alkenyloxy, -Sp 1 -P 1 or -Sp 2 -P 2 , at least one hydrogen may be substituted by fluorine or chlorine, wherein ring A 1 , ring A 2 , at least one of ring A 3 or ring A 4 is formula (A-1) or formula (A-2), and Q 1 and Q 2 are independently -CH 2 -, -O-, -N(R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least one -(CH 2 ) 2- can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or chlorine, but there is no situation that R 8 is fluorine or chlorine;
Figure 03_image007
Z 2 , Z 3 and Z 4 are independently a single bond, -(CH 2 ) 2 -, -C≡C-, -C≡CC≡C-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -CF=CF-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH -, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and the Sp 1 and Sp 2 Among them, at least one -CH 2 - can be substituted by -O-, -COO-, -OCOO- or -OCO-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, and at least one hydrogen can be substituted by -CH=CH- Fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 substitution, in the case of multiple Sp 1 or Sp 2 , any two can be different; P 1 and P 2 are independently formula (1b) To the group represented by any one of the formula (1h), when there are multiple P 1 or P 2 , any two may be different;
Figure 03_image009
In formula (1b) to formula (1h), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine Alkyl having 1 to 5 carbons; X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is hydrogen or alkyl having 1 to 15 carbons, and R 9 Among them, at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by fluorine or Chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group with 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen can be Fluorine or chlorine substitution, at least one -CH 2 - may be substituted by -O-; R 3 , R 4 , R 5 and R 7 are independently hydrogen or an alkyl group having 1 to 15 carbons, and said R 3 , R 4 , R 5 and R 7 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one One hydrogen can be replaced by fluorine or chlorine, but there is no case where R5 and R7 are fluorine or chlorine.
如請求項3所述的化合物,其中,式(1-1)至式(1-3)中, 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸苯基、萘-2,6-二基、芴-2,7-二基、菲-2,7-二基、式(A-1)所表示的基或式(A-2)所表示的基,這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數2至12的烯基、碳數1至11的烷氧基、碳數2至11的烯氧基、-Sp1 -P1 或-Sp2 -P2 取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)所表示的基或式(A-2)所表示的基,Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,
Figure 03_image007
Z2 、Z3 及Z4 獨立地為單鍵、-(CH2 )2 -、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b)、式(1c)、式(1d)或式(1e)的任一者所表示的基,在存在多個P1 或P2 的情況下,任意兩個可不同;
Figure 03_image017
式(1b)至式(1e)中, M1 、M2 、M3 及M4 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基,X1 為-N(-R9 )-、-O-或-S-,此處,R9 獨立地為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況; R2 及R6 為氫、氟、氯或碳數1至5的烷基,所述R2 及R6 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代; R3 、R4 及R5 獨立地為氫或碳數1至15的烷基,所述R3 、R4 及R5 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R5 為氟或氯的情況。
The compound according to claim 3, wherein, in formula (1-1) to formula (1-3), ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-ring-extended Hexyl, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, group represented by formula (A-1) or formula ( In the group represented by A-2), among these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be substituted by fluorine, chlorine, alkyl having 1 to 12 carbons, 2 to 12 carbons alkenyl, alkoxy with 1 to 11 carbons, alkenyl with 2 to 11 carbons, -Sp 1 -P 1 or -Sp 2 -P 2 substituted, wherein ring A 1 , ring A 2 , ring At least one of A 3 or ring A 4 is a group represented by formula (A-1) or a group represented by formula (A-2), and Q 1 and Q 2 are independently -CH 2 -, -O-, - N(R 8 )- or -S-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, and in said R 8 , at least one -CH 2 - may be substituted by -O- or -S- , at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine,
Figure 03_image007
Z 2 , Z 3 and Z 4 are independently a single bond, -(CH 2 ) 2 -, -C≡CC≡C-, -C≡C-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH-, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; Sp 1 and Sp 2 independent is a single bond or an alkylene group having 1 to 10 carbon atoms, in the Sp 1 and Sp 2 , at least one -CH 2 - may be substituted by -O-, -COO-, -OCOO- or -OCO-, at least One -(CH 2 ) 2 - can be substituted by -CH=CH-, at least one hydrogen can be substituted by -Sp 1 -P 1 or -Sp 2 -P 2 , in the presence of multiple Sp 1 or Sp 2 , Any two may be different; P 1 and P 2 are independently a group represented by any one of formula (1b), formula (1c), formula (1d) or formula (1e), when there are multiple P 1 or P In the case of 2 , any two can be different;
Figure 03_image017
In formula (1b) to formula (1e), M 1 , M 2 , M 3 and M 4 are independently hydrogen, fluorine, chlorine, alkyl having 1 to 5 carbon atoms, or at least one hydrogen substituted by fluorine or chlorine an alkyl group having 1 to 5 carbon atoms, X 1 is -N(-R 9 )-, -O- or -S-, where R 9 is independently hydrogen or an alkyl group having 1 to 15 carbon atoms, said In R 9 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by -CH=CH- or -C≡C- Fluorine or chlorine substitution, but there is no case where R 9 is fluorine or chlorine; R 2 and R 6 are hydrogen, fluorine, chlorine or an alkyl group with 1 to 5 carbon atoms, and among the R 2 and R 6 , at least one hydrogen Can be substituted by fluorine or chlorine, at least one -CH 2 - can be substituted by -O-; R 3 , R 4 and R 5 are independently hydrogen or an alkyl group having 1 to 15 carbons, the R 3 , R 4 and In R 5 , at least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, and at least one hydrogen can be substituted by -CH=CH- or -C≡C- Fluorine or chlorine substitution, but not where R5 is fluorine or chlorine.
如請求項3所述的化合物,其中,式(1-1)至式(1-3)中, 環A1 、環A2 、環A3 及環A4 獨立地為1,4-伸環己基、1,4-伸苯基、萘-2,6-二基、芴-2,7-二基、菲-2,7-二基、式(A-1)或式(A-2),這些環A1 、環A2 、環A3 及環A4 中,至少一個氫可經氟、氯、甲基或乙基取代,其中,環A1 、環A2 、環A3 或環A4 的至少一個為式(A-1)或式(A-2),Q1 及Q2 獨立地為-CH2 -、-O-、-N(R8 )-或-S-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況,
Figure 03_image007
Z2 、Z3 及Z4 獨立地為單鍵、-(CH2 )2 -、-C≡C-C≡C-、-C≡C-、-COO-、-OCO-、-CH=CHCOO-、-OCOCH=CH-、-CH=CH-、-CH=CHCO-、-COCH=CH-、-COS-、-SCO-、-CH=CHCOS-或-SCOCH=CH-; Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經-Sp1 -P1 或-Sp2 -P2 取代,在存在多個Sp1 或Sp2 的情況下,任意兩個可不同; P1 及P2 獨立地為式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)所表示的基,
Figure 03_image019
式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)及式(1e-1)中, X2 、X3 、X4 、X5 及X6 獨立地為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況。
The compound according to claim 3, wherein, in formula (1-1) to formula (1-3), ring A 1 , ring A 2 , ring A 3 and ring A 4 are independently 1,4-ring-extended Hexyl, 1,4-phenylene, naphthalene-2,6-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl, formula (A-1) or formula (A-2) , in these ring A 1 , ring A 2 , ring A 3 and ring A 4 , at least one hydrogen may be substituted by fluorine, chlorine, methyl or ethyl, wherein ring A 1 , ring A 2 , ring A 3 or ring At least one of A 4 is formula (A-1) or formula (A-2), Q 1 and Q 2 are independently -CH 2 -, -O-, -N(R 8 )- or -S-, and this where, R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - may be substituted by -CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine,
Figure 03_image007
Z 2 , Z 3 and Z 4 are independently a single bond, -(CH 2 ) 2 -, -C≡CC≡C-, -C≡C-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH=CH-, -CH=CHCO-, -COCH=CH-, -COS-, -SCO-, -CH=CHCOS- or -SCOCH=CH-; Sp 1 and Sp 2 independent is a single bond or an alkylene group having 1 to 10 carbon atoms, in the Sp 1 and Sp 2 , at least one -CH 2 - may be substituted by -O-, -COO-, -OCOO- or -OCO-, at least One -(CH 2 ) 2 - can be substituted by -CH=CH-, at least one hydrogen can be substituted by -Sp 1 -P 1 or -Sp 2 -P 2 , in the presence of multiple Sp 1 or Sp 2 , Any two can be different; P 1 and P 2 are independently formula (1b-1), formula (1b-2), formula (1b-3), formula (1b-4), formula (1b-5), formula (1c-1), the base represented by the formula (1d-1), the formula (1d-2) or the formula (1e-1),
Figure 03_image019
Equation (1b-1), Equation (1b-2), Equation (1b-3), Equation (1b-4), Equation (1b-5), Equation (1c-1), Equation (1d-1), Equation In (1d-2) and formula (1e-1), X 2 , X 3 , X 4 , X 5 and X 6 are independently -N(-R 9 )-, -O- or -S-, where , R 9 is hydrogen or an alkyl group with 1 to 15 carbon atoms, in said R 9 , at least one -CH 2 - can be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 9 is fluorine or chlorine.
如請求項3所述的化合物,其中,式(1-1)至式(1-3)所表示的化合物中,Z2 、Z3 或Z4 的任一個為-COO-或-OCO-,Q1 為-CH2 -或-N(R8 )-,Q2 為-N(R8 )-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況。The compound according to claim 3, wherein in the compounds represented by formula (1-1) to formula (1-3), any one of Z 2 , Z 3 or Z 4 is -COO- or -OCO-, Q 1 is -CH 2 - or -N(R 8 )-, Q 2 is -N(R 8 )-, here, R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in the R 8 , At least one -CH 2 - can be substituted by -O- or -S-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine , but there is no case where R 8 is fluorine or chlorine. 如請求項1或請求項2所述的化合物,其由式(1-1-11-1)至式(1-1-11-2)、式(1-2-11-1)至式(1-2-11-4)、式(1-1-12-1)至式(1-1-12-2)、式(1-2-12-1)至式(1-2-12-4)、式(1-1-21-1)至式(1-1-21-2)、式(1-2-21-1)至式(1-2-21-4)、式(1-1-22-1)至式(1-1-22-2)及式(1-2-22-1)至式(1-2-22-4)的任一者表示;
Figure 03_image021
Figure 03_image023
Figure 03_image025
Figure 03_image027
這些式中, Sp1 及Sp2 獨立地為單鍵或碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-、-COO-、-OCOO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-取代,至少一個氫可經-Sp1 -P1 或-Sp2 -P2 取代; P1 、P2 、Sp1 及Sp2 以外的部分結構中,至少一個氫可經氟、氯、甲基或乙基取代; Q1 為-CH2 -或-N(-R8 )-,Q2 為-N(-R8 )-,此處,R8 為氫或碳數1至15的烷基,所述R8 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R8 為氟或氯的情況, P1 及P2 獨立地為式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)所表示的基,
Figure 03_image019
式(1b-1)、式(1b-2)、式(1b-3)、式(1b-4)、式(1b-5)、式(1c-1)、式(1d-1)、式(1d-2)或式(1e-1)中,X2 、X3 、X4 、X5 及X6 獨立地為-N(-R9 )-、-O-或-S-,此處,R9 為氫或碳數1至15的烷基,所述R9 中,至少一個-CH2 -可經-O-或-S-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,但不存在R9 為氟或氯的情況。
The compound according to claim 1 or claim 2, which is composed of formula (1-1-11-1) to formula (1-1-11-2), formula (1-2-11-1) to formula ( 1-2-11-4), formula (1-1-12-1) to formula (1-1-12-2), formula (1-2-12-1) to formula (1-2-12- 4), formula (1-1-21-1) to formula (1-1-21-2), formula (1-2-21-1) to formula (1-2-21-4), formula (1 -1-22-1) to formula (1-1-22-2) and any one of formula (1-2-22-1) to formula (1-2-22-4) represents;
Figure 03_image021
Figure 03_image023
Figure 03_image025
Figure 03_image027
In these formulas, Sp 1 and Sp 2 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and in the Sp 1 and Sp 2 , at least one -CH 2 - may be through -O-, -COO-, -OCOO- or -OCO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, at least one hydrogen can be substituted by -Sp 1 -P 1 or -Sp 2 -P 2 ; P 1 , In partial structures other than P 2 , Sp 1 and Sp 2 , at least one hydrogen may be substituted by fluorine, chlorine, methyl or ethyl; Q 1 is -CH 2 - or -N(-R 8 )-, Q 2 is -N(-R 8 )-, where R 8 is hydrogen or an alkyl group having 1 to 15 carbon atoms, in said R 8 , at least one -CH 2 - may be substituted by -O- or -S-, at least One -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 8 is fluorine or chlorine, P 1 and P 2 independently formula (1b-1), formula (1b-2), formula (1b-3), formula (1b-4), formula (1b-5), formula (1c-1), formula (1d-1) ), the base represented by formula (1d-2) or formula (1e-1),
Figure 03_image019
Equation (1b-1), Equation (1b-2), Equation (1b-3), Equation (1b-4), Equation (1b-5), Equation (1c-1), Equation (1d-1), Equation In (1d-2) or formula (1e-1), X 2 , X 3 , X 4 , X 5 and X 6 are independently -N(-R 9 )-, -O- or -S-, where , R 9 is hydrogen or an alkyl group with 1 to 15 carbon atoms, in said R 9 , at least one -CH 2 - can be substituted by -O- or -S-, and at least one -(CH 2 ) 2 - can be substituted by - CH=CH- or -C≡C- substituted, at least one hydrogen can be substituted by fluorine or chlorine, but there is no case where R 9 is fluorine or chlorine.
如請求項7所述的化合物,其中,式(1-1-11-1)至式(1-1-11-2)、式(1-2-11-1)至式(1-2-11-4)、式(1-1-12-1)至式(1-1-12-2)、式(1-2-12-1)至式(1-2-12-4)、式(1-1-21-1)至式(1-1-21-2)、式(1-2-21-1)至式(1-2-21-4)、式(1-1-22-1)至式(1-1-22-2)或式(1-2-22-1)至式(1-2-22-4)所表示的化合物中,Sp1 及Sp2 獨立地為碳數1至10的伸烷基,所述Sp1 及Sp2 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟、氯或-Sp1 -P1 或-Sp2 -P2 取代。The compound according to claim 7, wherein formula (1-1-11-1) to formula (1-1-11-2), formula (1-2-11-1) to formula (1-2- 11-4), formula (1-1-12-1) to formula (1-1-12-2), formula (1-2-12-1) to formula (1-2-12-4), formula (1-1-21-1) to formula (1-1-21-2), formula (1-2-21-1) to formula (1-2-21-4), formula (1-1-22) -1) In the compounds represented by formula (1-1-22-2) or formula (1-2-22-1) to formula (1-2-22-4), Sp 1 and Sp 2 are independently Alkylene with 1 to 10 carbon atoms, among the Sp 1 and Sp 2 , at least one -CH 2 - can be substituted by -O-, and at least one hydrogen can be substituted by fluorine, chlorine or -Sp 1 -P 1 or -Sp 2 -P 2 substituted. 一種液晶組成物,含有至少一種如請求項1至請求項8中任一項所述的化合物。A liquid crystal composition containing at least one compound according to any one of claim 1 to claim 8. 如請求項9所述的液晶組成物,其還含有選自式(2)至式(4)所表示的化合物的群組中的至少一種化合物;
Figure 03_image029
式(2)至式(4)中, R11 及R12 獨立地為碳數1至10的烷基或碳數2至10的烯基,所述R11 及R12 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; 環B1 、環B2 、環B3 及環B4 獨立地為1,4-伸環己基、1,4-伸苯基、2-氟-1,4-伸苯基、2,5-二氟-1,4-伸苯基或嘧啶-2,5-二基; Z11 、Z12 及Z13 獨立地為單鍵、-(CH2 )2 -、-CH=CH-、-C≡C-或-COO-。
The liquid crystal composition according to claim 9, further comprising at least one compound selected from the group of compounds represented by formula (2) to formula (4);
Figure 03_image029
In formulas (2) to (4), R 11 and R 12 are independently an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 11 and R 12 , at least one -CH 2 - may be substituted by -O-, at least one hydrogen may be substituted by fluorine; Ring B 1 , Ring B 2 , Ring B 3 and Ring B 4 are independently 1,4-cyclohexylene, 1,4-phenylene , 2-fluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene or pyrimidine-2,5-diyl; Z 11 , Z 12 and Z 13 are independently single bonds , -(CH 2 ) 2 -, -CH=CH-, -C≡C- or -COO-.
如請求項9或請求項10所述的液晶組成物,其還含有選自式(5)至式(7)所表示的化合物的群組中的至少一種化合物;
Figure 03_image031
式(5)至式(7)中, R13 為碳數1至10的烷基或碳數2至10的烯基,所述R13 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; X11 為氟、氯、-OCF3 、-OCHF2 、-CF3 、-CHF2 、-CH2 F、-OCF2 CHF2 或-OCF2 CHFCF3 ; 環C1 、環C2 及環C3 獨立地為1,4-伸環己基、至少一個氫可經氟取代的1,4-伸苯基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基或嘧啶-2,5-二基; Z14 、Z15 及Z16 獨立地為單鍵、-(CH2 )2 -、-CH=CH-、-CH=CF-、-CF=CF-、-C≡C-、-COO-、-CF2 O-、-OCF2 -、-CH2 O-、-CH=CF-CF2 O-、-CF=CF-CF2 O-或-(CH2 )4 -; L11 及L12 獨立地為氫或氟。
The liquid crystal composition according to claim 9 or claim 10, further comprising at least one compound selected from the group of compounds represented by formula (5) to formula (7);
Figure 03_image031
In formulas (5) to (7), R 13 is an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 13 , at least one -CH 2 - may be substituted by -O- , at least one hydrogen can be substituted by fluorine; X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 or -OCF 2 CHFCF 3 ; ring C 1 , Ring C 2 and Ring C 3 are independently 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be substituted with fluorine, tetrahydropyran-2,5-diyl, 1 ,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl; Z 14 , Z 15 and Z 16 are independently a single bond, -(CH 2 ) 2 -, -CH=CH- , -CH=CF-, -CF=CF-, -C≡C-, -COO-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -CH=CF-CF 2 O-, -CF=CF-CF 2 O- or -(CH 2 ) 4 -; L 11 and L 12 are independently hydrogen or fluorine.
如請求項9或請求項10所述的液晶組成物,其還含有選自式(8)所表示的化合物的群組中的至少一種化合物;
Figure 03_image033
式(8)中, R14 為碳數1至10的烷基或碳數2至10的烯基,所述R14 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; X12 為-C≡N或-C≡C-C≡N; 環D1 獨立地為1,4-伸環己基、至少一個氫可經氟取代的1,4-伸苯基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基或嘧啶-2,5-二基; Z17 獨立地為單鍵、-(CH2 )2 -、-C≡C-、-COO-、-CF2 O-、-OCF2 -或-CH2 O-; L13 及L14 獨立地為氫或氟; i為1、2、3或4。
The liquid crystal composition according to claim 9 or claim 10, further comprising at least one compound selected from the group of compounds represented by formula (8);
Figure 03_image033
In formula (8), R 14 is an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 14 , at least one -CH 2 - may be substituted by -O-, and at least one hydrogen may be substituted by -O-. Substituted by fluorine; X 12 is -C≡N or -C≡CC≡N; Ring D 1 is independently 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen can be substituted by fluorine, tetrakis Hydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl; Z 17 is independently a single bond, -(CH 2 ) 2 - , -C≡C-, -COO-, -CF 2 O-, -OCF 2 - or -CH 2 O-; L 13 and L 14 are independently hydrogen or fluorine; i is 1, 2, 3 or 4.
如請求項9或請求項10所述的液晶組成物,其還含有選自式(9)至式(15)、式(DB-1)及式(DB-2)所表示的化合物的群組中的至少一種化合物;
Figure 03_image035
Figure 03_image037
式(9)至式(15)中, R15 及R16 獨立地為碳數1至10的烷基或碳數2至10的烯基,所述R15 及R16 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代; R17 為氫、氟、碳數1至10的烷基或碳數2至10的烯基,所述R17 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代,但不存在R17 為氟的情況; 環E1 、環E2 、環E3 及環E4 獨立地為1,4-伸環己基、1,4-伸環己烯基、至少一個氫可經氟取代的1,4-伸苯基、四氫吡喃-2,5-二基或十氫萘-2,6-二基; 環E5 及環E6 獨立地為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、四氫吡喃-2,5-二基或十氫萘-2,6-二基; Z18 、Z19 、Z20 及Z21 獨立地為單鍵、-(CH2 )2 -、-COO-、-CH2 O-、-OCF2 -或-OCF2 -(CH2 )2 -; L15 及L16 獨立地為氟或氯; S11 為氫或甲基; X獨立地為-CHF-或-CF2 -; j、k、m、n、p、q、r及s獨立地為0或1,k、m、n及p的和為0、1、2或3,q、r及s的和為0、1、2或3,t為1、2或3; 式(DB-1)及式(DB-2)中, X100 獨立地為-S-、-O-或-CH2 -; a100 及a200 獨立地為0、1或2,a100 及a200 的和為0、1、2或3; R100 及R200 獨立地為氫、碳數1至15的烷基或碳數2至10的烯基,所述R100 及R200 中,至少一個-CH2 -可經-O-取代,至少一個氫可經氟取代,但不存在R100 及R200 為氟的情況; A100 及A200 獨立地為1,2-伸環丙基、1,3-伸環丁基、1,3-伸環戊基、1,3-伸環戊烯基、1,4-伸環己基、1,4-伸環己烯基、1,4-伸環庚基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、2,6,7-三氧雜雙環[2.2.2]辛烷-1,4-二基、1,4-伸苯基、萘-2,6-二基、四氫吡喃-2,5-二基、二氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、吡啶-2,5-二基、嘧啶-2,5-二基、9,10-二氫菲-2,7-二基、9H-氧雜蒽-2,6-二基或9H-芴-2,7-二基,所述A100 及A200 中,至少一個氫可經氟、氯、-CF3 、-CHF2 、-CH2 F、-OCF3 、-OCHF2 、-OCH2 F或-C≡N取代; Z100 及Z200 獨立地為單鍵或碳數1至6的伸烷基,所述Z100 及Z200 中,至少一個-CH2 -可經-O-、-S-、-CO-、-COO-、-OCO-、-CF2 O-、-OCF2 -、-(CH2 )3 O-、-O(CH2 )3 -、-CH=CH-CH2 O-、-OCH2 -CH=CH-或-SiH2 -取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代; L100 及L101 獨立地為氟、氯、-CF3 或-CHF2 ; L102 、L103 、L104 及L105 獨立地為氫、氟、氯、-CF3 、-CHF2 、-CH2 F、-OCF3 、-OCHF2 或-OCH2 F,不存在L102 、L103 、L104 及L105 全部為氫的情況,但L102 、L103 、L104 及L105 的任意一個或兩個可為氫。
The liquid crystal composition according to claim 9 or claim 10, further comprising a compound selected from the group consisting of compounds represented by formula (9) to formula (15), formula (DB-1) and formula (DB-2) at least one compound in;
Figure 03_image035
Figure 03_image037
In formulas (9) to (15), R 15 and R 16 are independently an alkyl group having 1 to 10 carbon atoms or an alkenyl group having 2 to 10 carbon atoms, and in said R 15 and R 16 , at least one -CH 2 - can be substituted by -O-, at least one hydrogen can be substituted by fluorine; R 17 is hydrogen, fluorine, alkyl with 1 to 10 carbons or alkenyl with 2 to 10 carbons, among the R 17 , at least one -CH 2 - can be substituted by -O-, at least one hydrogen can be substituted by fluorine, but there is no case where R 17 is fluorine; ring E 1 , ring E 2 , ring E 3 and ring E 4 are independently 1,4 - cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl or decahydronaphthalene-2,6 -diyl; Ring E 5 and Ring E 6 are independently 1,4-cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene, tetrahydropyran-2,5-di or decahydronaphthalene-2,6-diyl; Z 18 , Z 19 , Z 20 and Z 21 are independently a single bond, -(CH 2 ) 2 -, -COO-, -CH 2 O-, -OCF 2 - or -OCF 2 -(CH 2 ) 2 -; L 15 and L 16 are independently fluorine or chlorine; S 11 is hydrogen or methyl; X is independently -CHF- or -CF 2 -; j, k , m, n, p, q, r, and s are independently 0 or 1, the sum of k, m, n, and p is 0, 1, 2, or 3, and the sum of q, r, and s is 0, 1, 2 or 3, t is 1, 2 or 3; In formula (DB-1) and formula (DB-2), X 100 is independently -S-, -O- or -CH 2 -; a 100 and a 200 are independently R 100 and R 200 are independently hydrogen, alkyl having 1 to 15 carbons or alkene having 2 to 10 carbons group, in the R 100 and R 200 , at least one -CH 2 - can be substituted by -O-, and at least one hydrogen can be substituted by fluorine, but there is no case where R 100 and R 200 are fluorine; A 100 and A 200 independently 1,2-cyclopentylene, 1,3-cyclobutyl, 1,3-cyclopentylene, 1,3-cyclopentenyl, 1,4-cyclohexylene, 1, 4-cyclohexenyl, 1,4-cycloheptide, decalin-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, 2,6 ,7-Trioxabicyclo[2.2.2]octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, 9,10-diyl Dihydrophenanthrene-2,7-diyl, 9H-oxanthene-2,6-diyl or 9H-fluorene-2,7-diyl, in A 100 and A 200 , at least one hydrogen may be fluorine , chlorine, -C F 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F or -C≡N substituted; Z 100 and Z 200 are independently a single bond or an alkylene having 1 to 6 carbon atoms base, in the Z 100 and Z 200 , at least one -CH 2 - can be via -O-, -S-, -CO-, -COO-, -OCO-, -CF 2 O-, -OCF 2 -, -(CH 2 ) 3 O-, -O(CH 2 ) 3 -, -CH=CH-CH 2 O-, -OCH 2 -CH=CH- or -SiH 2 - substituted, at least one -(CH 2 ) 2- can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine; L 100 and L 101 are independently fluorine, chlorine, -CF 3 or -CHF 2 ; L 102 , L 103 , L 104 and L 105 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 or -OCH 2 F, L 102 , L 103 absent , L 104 and L 105 are all hydrogen, but any one or both of L 102 , L 103 , L 104 and L 105 may be hydrogen.
如請求項9或請求項10所述的液晶組成物,其含有選自式(16)所表示的化合物的群組中的至少一種聚合性化合物;
Figure 03_image039
式(16)中, 環F及環I獨立地為環己基、環己烯基、苯基、1-萘基、2-萘基、四氫吡喃-2-基、1,3-二噁烷-2-基、嘧啶-2-基或吡啶-2-基,這些環F及環I中,至少一個氫可經氟、氯、碳數1至12的烷基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代; 環G為1,4-伸環己基、1,4-伸環己烯基、1,4-伸苯基、萘-1,2-二基、萘-1,3-二基、萘-1,4-二基、萘-1,5-二基、萘-1,6-二基、萘-1,7-二基、萘-1,8-二基、萘-2,3-二基、萘-2,6-二基、萘-2,7-二基、四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基或吡啶-2,5-二基,這些環G中,至少一個氫可經氟、氯、碳數1至12的烷基、碳數1至12的烷氧基、或者至少一個氫經氟或氯取代的碳數1至12的烷基取代; Z22 及Z23 獨立地為單鍵或碳數1至10的伸烷基,所述Z22 及Z23 中,至少一個-CH2 -可經-O-、-CO-、-COO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-或-C(CH3 )=C(CH3 )-取代,至少一個氫可經氟或氯取代; Sp11 、Sp12 及Sp13 獨立地為單鍵或碳數1至10的伸烷基,所述Sp11 、Sp12 及Sp13 中,至少一個-CH2 -可經-O-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代; u為0、1或2; f、g及h獨立地為0、1、2、3或4,而且f、g及h的和為2以上, P11 、P12 及P13 獨立地為選自式(P-1)至式(P-5)所表示的基的群組中的聚合性基;
Figure 03_image041
式(P-1)至式(P-5)中, M11 為氫、氟、氯或碳數1至5的烷基,所述M11 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代;M12 及M13 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基。
The liquid crystal composition according to claim 9 or claim 10, comprising at least one polymerizable compound selected from the group of compounds represented by formula (16);
Figure 03_image039
In formula (16), ring F and ring I are independently cyclohexyl, cyclohexenyl, phenyl, 1-naphthyl, 2-naphthyl, tetrahydropyran-2-yl, 1,3-dioxyl Alkyl-2-yl, pyrimidin-2-yl or pyridin-2-yl, in these ring F and ring I, at least one hydrogen can be fluorine, chlorine, alkyl having 1 to 12 carbon atoms, or at least one hydrogen can be fluorine Or chlorine-substituted alkyl group with 1 to 12 carbon atoms; Ring G is 1,4-cyclohexylene, 1,4-cyclohexenyl, 1,4-phenylene, naphthalene-1,2-di base, naphthalene-1,3-diyl, naphthalene-1,4-diyl, naphthalene-1,5-diyl, naphthalene-1,6-diyl, naphthalene-1,7-diyl, naphthalene-1 ,8-diyl, naphthalene-2,3-diyl, naphthalene-2,6-diyl, naphthalene-2,7-diyl, tetrahydropyran-2,5-diyl, 1,3-diyl Oxane-2,5-diyl, pyrimidine-2,5-diyl or pyridine-2,5-diyl, in these rings G, at least one hydrogen can be through fluorine, chlorine, alkyl having 1 to 12 carbons , an alkoxy group having 1 to 12 carbon atoms, or at least one hydrogen is substituted by an alkyl group having 1 to 12 carbon atoms substituted by fluorine or chlorine; Z 22 and Z 23 are independently a single bond or an alkylene having 1 to 10 carbon atoms Base, in said Z 22 and Z 23 , at least one -CH 2 - can be substituted by -O-, -CO-, -COO- or -OCO-, and at least one -(CH 2 ) 2 - can be substituted by -CH= CH-, -C(CH 3 )=CH-, -CH=C(CH 3 )- or -C(CH 3 )=C(CH 3 )- substituted, at least one hydrogen may be substituted by fluorine or chlorine; Sp 11 , Sp 12 and Sp 13 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and among the Sp 11 , Sp 12 and Sp 13 , at least one -CH 2 - may be through -O-, -COO-, -OCO- or -OCOO- substituted, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, at least one hydrogen can be substituted by fluorine or chlorine; u is 0, 1 or 2 f, g and h are independently 0, 1, 2, 3 or 4, and the sum of f, g and h is 2 or more, and P 11 , P 12 and P 13 are independently selected from the formula (P-1) to a polymerizable group in the group of groups represented by formula (P-5);
Figure 03_image041
In formula (P-1) to formula (P-5), M 11 is hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbon atoms, in said M 11 , at least one hydrogen may be substituted by fluorine or chlorine, at least One -CH 2 - may be substituted by -O-; M 12 and M 13 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbons, or at least one hydrogen with 1 to 5 carbons substituted with fluorine or chlorine the alkyl group.
如請求項9或請求項10所述的液晶組成物,其含有選自式(16-1)至式(16-28)所表示的化合物的群組中的至少一種聚合性化合物;
Figure 03_image043
Figure 03_image045
Figure 03_image047
式(16-1)至式(16-28)中, Sp11 、Sp12 及Sp13 獨立地為單鍵或碳數1至10的伸烷基,所述Sp11 、Sp12 及Sp13 中,至少一個-CH2 -可經-O-、-COO-、-OCO-或-OCOO-取代,至少一個-(CH2 )2 -可經-CH=CH-或-C≡C-取代,至少一個氫可經氟或氯取代,u為0、1或2,g及h獨立地為0、1、2、3或4, Z23 獨立地為單鍵或碳數1至10的伸烷基,所述Z23 中,至少一個-CH2 -可經-O-、-CO-、-COO-或-OCO-取代,至少一個-(CH2 )2 -可經-CH=CH-、-C(CH3 )=CH-、-CH=C(CH3 )-或-C(CH3 )=C(CH3 )-取代,至少一個氫可經氟或氯取代, P11 、P12 及P13 獨立地為選自式(P-1)至式(P-3)所表示的基的群組中的聚合性基;
Figure 03_image049
式(P-1)至式(P-3)中, M11 為氫、氟、氯或碳數1至5的烷基,所述M11 中,至少一個氫可經氟或氯取代,至少一個-CH2 -可經-O-取代;M12 及M13 獨立地為氫、氟、氯、碳數1至5的烷基、或者至少一個氫經氟或氯取代的碳數1至5的烷基。
The liquid crystal composition according to claim 9 or claim 10, comprising at least one polymerizable compound selected from the group of compounds represented by formula (16-1) to formula (16-28);
Figure 03_image043
Figure 03_image045
Figure 03_image047
In formula (16-1) to formula (16-28), Sp 11 , Sp 12 and Sp 13 are independently a single bond or an alkylene group having 1 to 10 carbon atoms, and among the Sp 11 , Sp 12 and Sp 13 , at least one -CH 2 - can be substituted by -O-, -COO-, -OCO- or -OCOO-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH- or -C≡C-, At least one hydrogen can be substituted by fluorine or chlorine, u is 0, 1 or 2, g and h are independently 0, 1, 2, 3 or 4, Z 23 is independently a single bond or an alkylene having 1 to 10 carbons base, in said Z 23 , at least one -CH 2 - can be substituted by -O-, -CO-, -COO- or -OCO-, at least one -(CH 2 ) 2 - can be substituted by -CH=CH-, -C(CH 3 )=CH-, -CH=C(CH 3 )- or -C(CH 3 )=C(CH 3 )- substituted, at least one hydrogen can be substituted by fluorine or chlorine, P 11 , P 12 and P 13 is independently a polymerizable group selected from the group of groups represented by formula (P-1) to formula (P-3);
Figure 03_image049
In formula (P-1) to formula (P-3), M 11 is hydrogen, fluorine, chlorine or an alkyl group having 1 to 5 carbons, and in said M 11 , at least one hydrogen may be substituted by fluorine or chlorine, at least One -CH 2 - may be substituted by -O-; M 12 and M 13 are independently hydrogen, fluorine, chlorine, alkyl with 1 to 5 carbons, or at least one hydrogen with 1 to 5 carbons substituted with fluorine or chlorine the alkyl group.
如請求項9或請求項10所述的液晶組成物,其還含有如請求項1所述的式(1)及如請求項14所述的式(16)以外的聚合性化合物、聚合起始劑、聚合抑制劑、光學活性化合物、抗氧化劑、紫外線吸收劑、光穩定劑、熱穩定劑及消泡劑的至少一種。The liquid crystal composition according to claim 9 or claim 10, further comprising a polymerizable compound other than formula (1) according to claim 1 and formula (16) according to claim 14, and a polymerization start At least one of an agent, a polymerization inhibitor, an optically active compound, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, and an antifoaming agent. 一種液晶顯示元件,含有如請求項9至請求項16中任一項所述的液晶組成物。A liquid crystal display element comprising the liquid crystal composition according to any one of claim 9 to claim 16.
TW110116194A 2020-06-09 2021-05-05 Compound, liquid crystal composition and liquid crystal display element TWI874651B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020099831 2020-06-09
JP2020-099831 2020-06-09

Publications (2)

Publication Number Publication Date
TW202208600A true TW202208600A (en) 2022-03-01
TWI874651B TWI874651B (en) 2025-03-01

Family

ID=78835657

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110116194A TWI874651B (en) 2020-06-09 2021-05-05 Compound, liquid crystal composition and liquid crystal display element

Country Status (3)

Country Link
JP (1) JP2021195365A (en)
CN (1) CN113773252B (en)
TW (1) TWI874651B (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009022309A1 (en) * 2009-05-22 2010-11-25 Merck Patent Gmbh liquid-crystal display
CN111032825A (en) * 2017-08-08 2020-04-17 默克专利股份有限公司 Liquid crystal medium and liquid crystal device
WO2019030153A1 (en) * 2017-08-08 2019-02-14 Merck Patent Gmbh Liquid crystal medium and liquid crystal device
WO2019206791A1 (en) * 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
US11939511B2 (en) * 2018-04-23 2024-03-26 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
CN112368260B (en) * 2018-07-04 2024-02-20 捷恩智株式会社 Compounds, liquid crystal compositions and liquid crystal display elements
CN112585244B (en) * 2018-08-22 2025-02-21 默克专利股份有限公司 Liquid crystal mixture and liquid crystal display

Also Published As

Publication number Publication date
TWI874651B (en) 2025-03-01
CN113773252A (en) 2021-12-10
JP2021195365A (en) 2021-12-27
CN113773252B (en) 2025-07-04

Similar Documents

Publication Publication Date Title
JP6248927B2 (en) Compound having four polymerizable groups, liquid crystal composition, and liquid crystal display device
TWI744235B (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display element
JP6850410B2 (en) Liquid crystal compounds, liquid crystal compositions and liquid crystal display devices with benzothiophene
JP6459975B2 (en) Piperidine derivatives, liquid crystal compositions, and liquid crystal display devices
JP6299969B2 (en) Polymerizable compound having conjugated bond, liquid crystal composition, and liquid crystal display device
JP2016011346A (en) Polymerizable compound, polymerizable composition, and liquid crystal display device
JP6098421B2 (en) Polymerizable compound having oxygen-containing five-membered ring, liquid crystal composition, and liquid crystal display device
CN111278800B (en) Polymerizable polar compound, liquid crystal composition, and liquid crystal display element
JP6435923B2 (en) Dihydropyran compound, liquid crystal composition, and liquid crystal display device
JP7505487B2 (en) Compound, liquid crystal composition and liquid crystal display device
TW201704455A (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display element
WO2020080120A1 (en) Compound, liquid crystal composition, and liquid crystal display element
JP6638814B2 (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display device
JP7226340B2 (en) Compound, liquid crystal composition and liquid crystal display element
CN110914233B (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display element
TW202006124A (en) Compound, liquid crystal composition and liquid crystal display element
JP7547913B2 (en) Compound, liquid crystal composition and liquid crystal display device
TWI874651B (en) Compound, liquid crystal composition and liquid crystal display element
TW202101076A (en) Compound, liquid crystal composition and liquid crystal display element
JP6507404B2 (en) Polymerizable compound, polymerizable composition and liquid crystal display device
TW202104557A (en) Compound, liquid-crystal composition, and liquid-crystal display element